BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25:658-663. [PMID: 9049215 DOI: 10.1002/hep.510250328] [Cited by in Crossref: 956] [Cited by in F6Publishing: 843] [Article Influence: 38.2] [Reference Citation Analysis]
Number Citing Articles
1 Liu YY, Li CP, Huai MS, Fu XM, Cui Z, Fan LL, Zhang S, Liu Y, Ma J, Li G. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression. PLoS One. 2015;10:e0120939. [PMID: 25816221 DOI: 10.1371/journal.pone.0120939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
2 Chen Q, You Y, Zhang Y, Zhang H, Bai L. Hepatocyte growth factor mediates a novel form of hepatic stem/progenitor cell-induced tolerance in a rat xenogeneic liver rejection model. Int Immunopharmacol 2021;90:107180. [PMID: 33221167 DOI: 10.1016/j.intimp.2020.107180] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Akoglu B, Kriener S, Martens S, Herrmann E, Hofmann WP, Milovic V, Zeuzem S, Faust D. Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients. Clin Exp Med. 2009;9:259-262. [PMID: 19296053 DOI: 10.1007/s10238-009-0042-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
4 de Haan A, van den Berg AP, van der Bij W, Hepkema BG, Bruin-van Dijk E, van der Gun I, M. Lems SP, H. Slooff MJ, Haagsma EB, M. H. de Leij LF, Prop AJ. RAPID DECREASES IN DONOR-SPECIFIC CYTOTOXIC T LYMPHOCYTE PRECURSOR FREQUENCIES AND GRAFT OUTCOME AFTER LIVER AND LUNG TRANSPLANTATION 1: . Transplantation 2001;71:785-91. [DOI: 10.1097/00007890-200103270-00017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
5 Sageshima J, Fuchinoue S, Hashimoto E, Koike T, Abe M, Nakajima I, Tanaka K, Agishi T. Histopathology of hepatic allograft rejection after living-related liver transplantation. Transplantation Proceedings 1998;30:3214-5. [DOI: 10.1016/s0041-1345(98)01000-8] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
6 van den Heuvel MC, de Jong KP, van der Horst ML, Poppema S, Slooff MJ, Gouw AS. Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree. Liver Transpl 2004;10:28-35. [PMID: 14755774 DOI: 10.1002/lt.20029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
7 Kita Y, Harihara Y, Sano K, Hirata M, Kubota K, Takayama T, Ohtomo K, Makuuchi M, Kita Y. Reversible hepatofugal portal flow after liver transplantation using a small-for-size graft from a living donor. Transplant Int 2001;14:217-22. [DOI: 10.1111/j.1432-2277.2001.tb00048.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
8 Sindhi R, Ashokkumar C, Higgs BW, Levy S, Soltys K, Bond G, Mazariegos G, Ranganathan S, Zeevi A. Profile of the Pleximmune blood test for transplant rejection risk prediction. Expert Rev Mol Diagn 2016;16:387-93. [PMID: 26760313 DOI: 10.1586/14737159.2016.1139455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
9 Sebagh M, Samuel D, Antonini TM, Coilly A, Degli Esposti D, Roche B, Karam V, Dos Santos A, Duclos-vallée J, Roque-afonso A, Ballot E, Guettier C, Blandin F, Saliba F, Azoulay D. Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients. Journal of Hepatology 2012;56:840-7. [DOI: 10.1016/j.jhep.2011.11.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
10 Penninga L, Wettergren A, Wilson CH, Chan A, Steinbrüchel DA, Gluud C, Penninga L. Antibody induction versus corticosteroid induction for liver transplant recipients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd010252] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Palmer W, Taner C, Keaveny A, Nakhleh R, Nguyen J, Rosser B. Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver Transplantation. Transplantation Proceedings 2018;50:3606-14. [DOI: 10.1016/j.transproceed.2018.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ekong UD, Bhagat H, Alonso EM. Once Daily Calcineurin Inhibitor Monotherapy in Pediatric Liver Transplantation. American Journal of Transplantation 2010;10:883-8. [DOI: 10.1111/j.1600-6143.2010.03061.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Portmann B, Koukoulis G. Pathology of the Liver Allograft. In: Berry CL, editor. Transplantation Pathology. Berlin: Springer Berlin Heidelberg; 1999. pp. 61-105. [DOI: 10.1007/978-3-642-59877-7_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
14 Stanca CM, Fiel MI, Kontorinis N, Agarwal K, Emre S, Schiano TD. Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation. 2007;84:180-186. [PMID: 17667809 DOI: 10.1097/01.tp.0000269609.08495.45] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
15 Sieders E, Hepkema BG, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, Bijleveld CM, van den Berg AP, Lems SP, Gouw AS. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation. Liver Transpl. 2005;11:1541-1549. [PMID: 16315307 DOI: 10.1002/lt.20521] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
16 Abou-Beih S, Masson S, Saunders R, Haugk B, Oakley F, Tiniakos D. Sinusoidal and pericellular fibrosis in adult post-transplant liver biopsies: association with hepatic stellate cell activation and patient outcome. Virchows Arch 2019;475:233-43. [PMID: 31201503 DOI: 10.1007/s00428-019-02585-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Fahrner R, Dondorf F, Ardelt M, Settmacher U, Rauchfuss F. Role of NK, NKT cells and macrophages in liver transplantation. World J Gastroenterol 2016; 22(27): 6135-6144 [PMID: 27468206 DOI: 10.3748/wjg.v22.i27.6135] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
18 Rodríguez-perálvarez M, De Luca L, Crespo G, Rubin Á, Marín S, Benlloch S, Colmenero J, Berenguer M, Navasa M, Tsochatzis E, De la Mata M. An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation. Clin Transplant 2017;31:e13005. [DOI: 10.1111/ctr.13005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
19 Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, Rela M, Heaton N, O'Grady JG. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl. 2004;10:1271-1278. [PMID: 15376307 DOI: 10.1002/lt.20233] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
20 Hu F, Wang H, Zhang S, Peng Y, Su L, Chang J, Liu G. Inhibition of myeloid differentiation factor 88 signaling mediated by histidine-grafted poly(β-amino ester) ester nanovector induces donor-specific liver allograft tolerance. Int J Nanomedicine 2015;10:4367-82. [PMID: 26185440 DOI: 10.2147/IJN.S81413] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Nafady-Hego H, Elgendy H, Moghazy WE, Fukuda K, Uemoto S. Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experience. Liver Transpl. 2011;17:976-984. [PMID: 21786404 DOI: 10.1002/lt.22278] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
22 Liu J, Gao Y, Wang S, Sun EW, Wang Y, Zhang Z, Shan YQ, Zhong SZ. Effect of operation-synchronizing transfusion of apoptotic spleen cells from donor rats on acute rejection of recipient rats after liver transplantation. World J Gastroenterol 2005; 11(8): 1161-1166 [PMID: 15754397 DOI: 10.3748/wjg.v11.i8.1161] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
23 Manzia T, Angelico R, Toti L, Grimaldi C, Sforza D, Vella I, Tariciotti L, Lenci I, Breshanaj G, Baiocchi L, Tisone G. Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients. Transplantation Proceedings 2018;50:175-83. [DOI: 10.1016/j.transproceed.2017.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Kaur S, Cotler S. Part IV. Advances in liver transplantation: Overview and status. Disease-a-Month 1999;45:149-83. [DOI: 10.1016/s0011-5029(99)90004-4] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
25 Gao W, Zhang L, Zhang Y, Sun C, Chen X, Wang Y. Adipose-derived mesenchymal stem cells promote liver regeneration and suppress rejection in small-for-size liver allograft. Transpl Immunol. 2017;45:1-7. [PMID: 28778713 DOI: 10.1016/j.trim.2017.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
26 Sebagh M, Samuel D. Place of the liver biopsy in liver transplantation. Journal of Hepatology 2004;41:897-901. [DOI: 10.1016/j.jhep.2004.10.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Demetris AJ; Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006;44:489-501. [DOI: 10.1002/hep.21280] [Cited by in Crossref: 256] [Cited by in F6Publishing: 194] [Article Influence: 16.0] [Reference Citation Analysis]
28 Haga H, Sakashita H, Wen M, Miyagawa-hayashino A, Egawa H, Manabe T. Correlation of conventional histology, clinical outcomes, and C4d immunostaining in ABO-incompatible liver transplantation. International Congress Series 2006;1292:25-31. [DOI: 10.1016/j.ics.2006.03.068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Dixon LR, Crawford JM. Early histologic changes in fibrosing cholestatic hepatitis C. Liver Transpl. 2007;13:219-226. [PMID: 17205558 DOI: 10.1002/lt.21011] [Cited by in Crossref: 83] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
30 Chapman WC, Brown RS Jr, Chavin KD, Sudan D, Koneru B, Junge G, Dong G, Patel D, Teperman L, Fung JJ. Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Transplantation 2017;101:341-9. [PMID: 28121741 DOI: 10.1097/TP.0000000000001524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
31 Lacaille F, Canioni D, Fournet JC, Revillon Y, Cezard JP, Goulet O. Centrilobular necrosis in children after combined liver and small bowel transplantation. Transplantation. 2002;73:252-257. [PMID: 11821740 DOI: 10.1097/00007890-200201270-00018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
32 DiMartini A, Dew MA, Chaiffetz D, Fitzgerald MG, Devera ME, Fontes P. Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival. Am J Transplant. 2011;11:1287-1295. [PMID: 21645258 DOI: 10.1111/j.1600-6143.2011.03496.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
33 Zekry A, Bishop GA, Bowen DG, Gleeson MM, Guney S, Painter DM, McCaughan GW. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transpl. 2002;8:292-301. [PMID: 11910576 DOI: 10.1053/jlts.2002.31655] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
34 Sundaram SS, Melin-Aldana H, Neighbors K, Alonso EM. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients. Liver Transpl 2006;12:58-64. [PMID: 16382471 DOI: 10.1002/lt.20661] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
35 Jain AB, Hamad I, Rakela J, Dodson F, Kramer D, Demetris J, Mcmichael J, Starzl TE, Fung JJ. A PROSPECTIVE RANDOMIZED TRIAL OF TACROLIMUS AND PREDNISONE VERSUS TACROLIMUS, PREDNISONE, AND MYCOPHENOLATE MOFETIL IN PRIMARY ADULT LIVER TRANSPLANT RECIPIENTS: An Interim Report1. Transplantation 1998;66:1395-8. [DOI: 10.1097/00007890-199811270-00024] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
36 Boix-Giner F, Millan O, San Segundo D, Muñoz-Cacho P, Mancebo E, Llorente S, Rafael-Valdivia L, Rimola A, Fábrega E, Mrowiec A, Allende L, Minguela A, Bolarín JM, Paz-Artal E, López-Hoyos M, Brunet M, Muro M. High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation. Int Immunol 2016;28:55-64. [PMID: 26270267 DOI: 10.1093/intimm/dxv048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
37 Niu J, Yue W, Song Y, Zhang Y, Qi X, Wang Z, Liu B, Shen H, Hu X. Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells. Clin Exp Immunol 2014;176:473-84. [PMID: 24527865 DOI: 10.1111/cei.12283] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
38 Hübscher SG. Central perivenulitis: a common and potentially important finding in late posttransplant liver biopsies. Liver Transpl 2008;14:596-600. [PMID: 18433067 DOI: 10.1002/lt.21451] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
39 Kato H, Usui M, Muraki Y, Okuda M, Nakatani K, Hayasaki A, Ito T, Iizawa Y, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Isaji S. Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period. Transplant Proc 2018;50:2684-9. [PMID: 30401377 DOI: 10.1016/j.transproceed.2018.03.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
40 Harimoto N, Ikegami T, Nakagawara H, Yamashita Y, Yoshizumi T, Uchiyama H, Soejima Y, Ikeda T, Shirabe K, Aishima S, Oda Y, Maehara Y. Chronic Immune-Mediated Reaction Syndrome as the Cause of Late Graft Mortality in Living-Donor Liver Transplantation for Primary Biliary Cirrhosis. Transplantation Proceedings 2014;46:1438-43. [DOI: 10.1016/j.transproceed.2014.02.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
41 Prieto B, Llorente E, González-pinto I, Alvarez FV. Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications. Clinical Chemistry and Laboratory Medicine 2008;46. [DOI: 10.1515/cclm.2008.123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
42 Machicao VI, Krishna M, Bonatti H, Aqel BA, Nguyen JH, Weigand SD, Rosser BG, Hughes C, Dickson RC. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation: Hepatitis C Recurrence after Liver Transplantation. Liver Transpl 2004;10:599-606. [DOI: 10.1002/lt.20107] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
43 Chai PF, Lee WS, Brown RM, Mcpartland JL, Foster K, Mckiernan PJ, Kelly DA. Childhood Autoimmune Liver Disease: Indications and Outcome of Liver Transplantation. Journal of Pediatric Gastroenterology & Nutrition 2010;50:295-302. [DOI: 10.1097/mpg.0b013e3181bf0ef7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
44 Ngo BT, Beiras-Fernandez A, Hammer C, Thein E. Hyperacute rejection in the xenogenic transplanted rat liver is triggered by the complement system only in the presence of leukocytes and free radical species. Xenotransplantation 2013;20:177-87. [PMID: 23656281 DOI: 10.1111/xen.12035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
45 Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl. 2009;15:1872-1881. [PMID: 19938138 DOI: 10.1002/lt.21954] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 6.2] [Reference Citation Analysis]
46 Trak-Smayra V, Contreras J, Dondero F, Durand F, Dubois S, Sommacale D, Marcellin P, Belghiti J, Degott C, Paradis V. Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation. Transplantation 2004;77:1755-60. [PMID: 15201678 DOI: 10.1097/01.tp.0000131172.75294.a9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
47 Negro F, Rubbia-Brandt L, Giostra E, Seium Y, Mentha G, Quadri R, Hadengue A. Hepatitis G virus infection among liver graft recipients: anatomoclinical correlations. Dig Dis Sci 1998;43:2577-83. [PMID: 9881485 DOI: 10.1023/a:1026674421447] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
48 Kaido T, Ogawa K, Fujimoto Y, Mori A, Hatano E, Okajima H, Uemoto S. Perioperative changes of procalcitonin levels in patients undergoing liver transplantation. Transpl Infect Dis 2014;16:790-6. [PMID: 25154523 DOI: 10.1111/tid.12282] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
49 Furuichi M, Fukuda A, Sakamoto S, Kasahara M, Miyairi I. Characteristics and Risk Factors of Late-onset Bloodstream Infection Beyond 6 Months After Liver Transplantation in Children. Pediatr Infect Dis J 2018;37:263-8. [PMID: 28859015 DOI: 10.1097/INF.0000000000001754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Gadano A, Durand F, Degott C, Dosquet C, Moreau R, Hadengue A, Widmann JJ, Vachiery F, Elman A, Sogni P, Yang S, Valla D, Bernuau J, Belghiti J, Erlinger S, Lebrec D. STUDIES OF PORTAL HEMODYNAMICS AND HEPATIC OXYGEN CONSUMPTION DURING ACUTE LIVER ALLOGRAFT REJECTION1: . Transplantation 1997;64:1188-92. [DOI: 10.1097/00007890-199710270-00018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
51 Tajima T, Hata K, Haga H, Nishikori M, Umeda K, Kusakabe J, Miyauchi H, Okamoto T, Ogawa E, Sonoda M, Hiramatsu H, Fujimoto M, Okajima H, Takita J, Takaori-Kondo A, Uemoto S. Post-transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants. Liver Transpl 2021;27:1165-80. [PMID: 33655645 DOI: 10.1002/lt.26034] [Reference Citation Analysis]
52 Scheenstra R, Torringa ML, Waalkens HJ, Middelveld EH, Peeters PM, Slooff MJ, Gouw AS, Verkade HJ, Bijleveld CM. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation. Liver Transpl. 2006;12:240-246. [PMID: 16447209 DOI: 10.1002/lt.20591] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
53 Ghanekar A, Kashfi A, Cattral M, Selzner N, McGilvray I, Selzner M, Renner E, Lilly L, Levy G, Grant D. Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C. Transplant Proc. 2012;44:1351-1356. [PMID: 22664014 DOI: 10.1016/j.transproceed.2012.01.117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
54 Tong H, Chen K, Chen H, Wu H, Lin H, Ni Z, Lin S. Emodin prolongs recipient survival time after orthotopic liver transplantation in rats by polarizing the Th1/Th2 paradigm to Th2. Anat Rec (Hoboken) 2011;294:445-52. [PMID: 21308995 DOI: 10.1002/ar.21352] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
55 Billing H, Breil T, Schmidt J, Tönshoff B, Schmitt C, Giese T, Engelmann G. Pharmacodynamic monitoring by residual NFAT-regulated gene expression in stable pediatric liver transplant recipients: NFAT-regulated gene expression in pediatric liver Tx. Pediatric Transplantation 2012;16:187-94. [DOI: 10.1111/j.1399-3046.2012.01660.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
56 Yoshida O, Dou L, Kimura S, Yokota S, Isse K, Robson SC, Geller DA, Thomson AW. CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection. Transpl Immunol 2015;32:76-83. [PMID: 25661084 DOI: 10.1016/j.trim.2015.01.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
57 Warle MC, Metselaar HJ, Kusters JG, Zondervan PE, Hop WCJ, Segeren KCA, Kwekkeboom J, Jzermans JNMI, Tilanus HW. Strain-specific in vitro cytokine production profiles do not predict rat liver allograft survival. Transplant Int 2004;17:779-86. [DOI: 10.1111/j.1432-2277.2004.tb00511.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
58 Figueras J, Prieto M, Bernardos A, Rimola A, Suarez F, de Urbina JO, Cuervas-mons V, Mata MDL. Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts. Transplant Int 2006;19:641-8. [DOI: 10.1111/j.1432-2277.2006.00326.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
59 Boyd A, Cain O, Chauhan A, Webb GJ. Medical liver biopsy: background, indications, procedure and histopathology. Frontline Gastroenterol 2020;11:40-7. [PMID: 31885839 DOI: 10.1136/flgastro-2018-101139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
60 Bahra M, Neumann UP, Jacob D, Berg T, Neuhaus R, Langrehr JM, Neuhaus P. Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C. Transpl Int. 2007;20:771-778. [PMID: 17617179 DOI: 10.1111/j.1432-2277.2007.00517.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
61 Fukazawa K, Yamada Y, Gologorsky E, Arheart KL, Pretto EA. Hemodynamic recovery following postreperfusion syndrome in liver transplantation. J Cardiothorac Vasc Anesth. 2014;28:994-1002. [PMID: 25107717 DOI: 10.1053/j.jvca.2014.02.017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
62 Castillo-Rama M, Sebagh M, Sasatomi E, Randhawa P, Isse K, Salgarkar AD, Ruppert K, Humar A, Demetris AJ. "Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort. Am J Transplant 2013;13:2966-77. [PMID: 24011021 DOI: 10.1111/ajt.12413] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
63 Shindoh J, Akamatsu N, Tanaka T, Kaneko J, Tamura S, Sakamoto Y, Hasegawa K, Sugawara Y, Makuuchi M, Kokudo N. Risk factors for acute liver allograft rejection and their influences on treatment outcomes of rescue therapy in living donor liver transplantation. Clin Transplant 2016;30:880-5. [DOI: 10.1111/ctr.12760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
64 Teufel U, Weitz J, Flechtenmacher C, Prietsch V, Schmidt J, Hoffmann GF, Kölker S, Engelmann G. High urgency liver transplantation in ornithine transcarbamylase deficiency presenting with acute liver failure. Pediatr Transplant. 2011;15:E110-E115. [PMID: 21884343 DOI: 10.1111/j.1399-3046.2009.01171.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
65 Caso-Maestro O, Jiménez-Romero C, Justo-Alonso I, Calvo-Pulido J, Lora-Pablos D, Marcacuzco-Quinto A, Cambra-Molero F, García-Sesma A, Pérez-Flecha M, Muñoz-Arce C, Loinaz-Segurola C, Manrique-Municio A. Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over. World J Gastroenterol 2018; 24(47): 5391-5402 [PMID: 30598583 DOI: 10.3748/wjg.v24.i47.5391] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Saco A, Diaz A, Hernandez M, Martinez D, Montironi C, Castillo P, Rakislova N, del Pino M, Martinez A, Ordi J. Validation of whole-slide imaging in the primary diagnosis of liver biopsies in a University Hospital. Digestive and Liver Disease 2017;49:1240-6. [DOI: 10.1016/j.dld.2017.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
67 Bahra M, Neumann UI, Jacob D, Puhl G, Klupp J, Langrehr JM, Berg T, Neuhaus P. MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course. Am J Transplant. 2005;5:406-411. [PMID: 15644002 DOI: 10.1111/j.1600-6143.2004.00706.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
68 Gao Z. Seeking Beyond Rejection: An Update on the Differential Diagnosis and a Practical Approach to Liver Allograft Biopsy Interpretation. Advances in Anatomic Pathology 2009;16:97-117. [DOI: 10.1097/pap.0b013e31819946aa] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Legaz I, Bolarin JM, Campillo JA, Moya RM, Luna A, Osuna E, Minguela A, Sanchez-Bueno F, Alvarez MR, Muro M. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease. Arch Med Sci 2021;17:682-93. [PMID: 34025838 DOI: 10.5114/aoms.2018.80651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Gül-Klein S, Kästner A, Haber PK, Krenzien F, Wabitsch S, Krannich A, Andreou A, Eurich D, Tacke F, Horst D, Pratschke J, Schmelzle M. Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections. J Hepatocell Carcinoma 2021;8:133-43. [PMID: 33777855 DOI: 10.2147/JHC.S292010] [Reference Citation Analysis]
71 Geissler I, Lamesch P, Witzigmann H, Jost U, Hauss J, Fangmann J. Splenohepatic arterial steal syndrome in liver transplantation: clinical features and management. Transplant Int 2002;15:139-41. [DOI: 10.1111/j.1432-2277.2002.tb00141.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
72 Lacotte S, Oldani G, Slits F, Orci LA, Rubbia-Brandt L, Morel P, Mentha G, Toso C. Alloimmune activation promotes anti-cancer cytotoxicity after rat liver transplantation. PLoS One 2014;9:e91515. [PMID: 24651497 DOI: 10.1371/journal.pone.0091515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
73 Kamei H, Masuda S, Nakamura T, Fujimoto Y, Oike F, Ogura Y, Takada Y, Hamajima N. Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation. Transpl Immunol 2013;28:14-7. [PMID: 23153768 DOI: 10.1016/j.trim.2012.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
74 Bartlett A. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat. Liver Transplantation 2002;8:458-68. [DOI: 10.1053/jlts.2002.32979] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
75 Tanaka K, Ozawa K, Teramukai S, Takada Y, Egawa H, Kaihara S, Fujimoto Y, Ogura Y, Kasahara M, Ono M, Sato H, Takai K, Fukushima M, Minato N. Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome. Liver Transpl 2006;12:792-800. [DOI: 10.1002/lt.20705] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
76 Varchetta S, Oliviero B, Francesca Donato M, Agnelli F, Rigamonti C, Paudice E, Arosio E, Berra M, Rossi G, Tinelli C. Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation. J Hepatol. 2009;50:314-322. [PMID: 19070924 DOI: 10.1016/j.jhep.2008.10.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
77 De Ruvo N, Cucchetti A, Lauro A, Masetti M, Cautero N, Di Benedetto F, Dazzi A, Del Gaudio M, Ravaioli M, Di Francesco F. Preliminary results of a “prope” tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation. Transplantation. 2005;80:8-12. [PMID: 16003226 DOI: 10.1097/01.tp.0000164349.54297.95] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
78 Huang HJ, Zheng ZY, Yu YH. Advances in research on antibody-mediated rejection after liver transplantation. Shijie Huaren Xiaohua Zazhi 2009; 17(33): 3420-3425 [DOI: 10.11569/wcjd.v17.i33.3420] [Reference Citation Analysis]
79 Penninga L, Wettergren A, Wilson CH, Chan AW, Steinbrüchel DA, Gluud C. Antibody induction versus corticosteroid induction for liver transplant recipients. Cochrane Database Syst Rev. 2014;5:CD010252. [PMID: 24880007 DOI: 10.1002/14651858.cd010252.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
80 Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. Hepatology. 1998;28:323-331. [PMID: 9695993 DOI: 10.1002/hep.510280206] [Cited by in Crossref: 195] [Cited by in F6Publishing: 139] [Article Influence: 8.1] [Reference Citation Analysis]
81 Hann A, Osei-Bordom DC, Neil DAH, Ronca V, Warner S, Perera MTPR. The Human Immune Response to Cadaveric and Living Donor Liver Allografts. Front Immunol 2020;11:1227. [PMID: 32655558 DOI: 10.3389/fimmu.2020.01227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
82 O'Keeffe C, Baird AW, Nolan N, McCormick PA. Mast cell hyperplasia in chronic rejection after liver transplantation. Liver Transpl 2002;8:50-7. [PMID: 11799486 DOI: 10.1053/jlts.2002.30343] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
83 Petrovic LM. Early recurrence of hepatitis C virus infection after liver transplantation. Liver Transpl 2006;12:S32-7. [PMID: 17051560 DOI: 10.1002/lt.20942] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
84 Bittmann I, Bottino A, Baretton GB, Gerbes AL, Zachoval R, Rau HG, Löhrs U. The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation--a clinico-pathological study. Virchows Arch. 2003;443:541-548. [PMID: 12884038 DOI: 10.1007/s00428-003-0861-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
85 Guardia-silva A, Stucchi R, Sampaio A, Milan A, Costa S, Boin I. Detection of Cytomegalovirus and Human Herpesvirus-6 DNA in Liver Biopsy Specimens and Their Correlation With Rejection After Liver Transplantation. Transplantation Proceedings 2012;44:2441-4. [DOI: 10.1016/j.transproceed.2012.07.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
86 Teicher E, Vincent I, Bonhomme-Faivre L, Abbara C, Barrail A, Boissonnas A, Duclos-Vallée JC, Taburet AM, Samuel D, Vittecoq D. Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study. Clin Pharmacokinet 2007;46:941-52. [PMID: 17922559 DOI: 10.2165/00003088-200746110-00002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
87 Loginov R, Halme L, Arola J, Höckerstedt K, Lautenschlager I. Intragraft immunological events associated with EBV DNAemia in liver transplant patients: EBV DNAEMIA AND INTRAGRAFT IMMUNOLOGICAL EVENTS. APMIS 2010;118:888-94. [DOI: 10.1111/j.1600-0463.2010.02675.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
88 Takakura K, Kiuchi T, Kasahara M, Uryuhara K, Uemoto S, Inomata Y, Tanaka K. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation: Cytometry crossmatch with T or B cells. Clin Transplantation 2001;15:309-16. [DOI: 10.1034/j.1399-0012.2001.150502.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
89 Demirhan B, Bilezikçi B, Haberal AN, Sevmiş Ş, Arat Z, Haberal M. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection. Liver Transpl 2008;14:214-9. [DOI: 10.1002/lt.21360] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
90 Okanami Y, Tsujimura K, Mizuno S, Tabata M, Isaji S, Akatsuka Y, Kuzushima K, Takahashi T, Uemoto S. Intracellular Interferon-γ Staining Analysis of Donor-Specific T-Cell Responses in Liver Transplant Recipients. Transplantation Proceedings 2012;44:548-54. [DOI: 10.1016/j.transproceed.2011.11.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
91 Ganschow R, Baade B, Hellwege HH, Broering DC, Rogiers X, Burdelski M. Interleukin-1 receptor antagonist in ascites indicates acute graft rejection after pediatric liver transplantation. Pediatr Transplant 2000;4:289-92. [PMID: 11079269 DOI: 10.1034/j.1399-3046.2000.00129.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
92 Freitas ACTD, Coelho JCU, Parolin MB, Matias JEF, Zeni Neto C, Gonçalves CG. Fatores de risco e conduta nas complicações do trato biliar no transplante hepático. Rev Col Bras Cir 2000;27:359-65. [DOI: 10.1590/s0100-69912000000600001] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
93 Wallia A, Schmidt K, Oakes DJ, Pollack T, Welsh N, Kling-Colson S, Gupta S, Fulkerson C, Aleppo G, Parikh N, Levitsky J, Norvell JP, Rademaker A, Molitch ME. Glycemic Control Reduces Infections in Post-Liver Transplant Patients: Results of a Prospective, Randomized Study. J Clin Endocrinol Metab 2017;102:451-9. [PMID: 27875061 DOI: 10.1210/jc.2016-3279] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
94 Millán O, Rafael-valdivia L, San Segundo D, Boix F, Castro-panete M, López-hoyos M, Muro M, Valero-hervás D, Rimola A, Navasa M, Muñoz P, Miras M, Andrés A, Guirado L, Pascual J, Brunet M. Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study. Clinical Immunology 2014;154:141-54. [DOI: 10.1016/j.clim.2014.07.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
95 Dahmen U, Li J, Dirsch O, Fiedler M, Lu M, Roggendorf M, Broelsch CE. A new model of hepatitis B virus reinfection: liver transplantation in the woodchuck1: . Transplantation 2002;74:373-80. [DOI: 10.1097/00007890-200208150-00014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
96 Li J, Lai X, Liao W, He Y, Liu Y, Gong J. The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance. Int Immunopharmacol. 2011;11:962-967. [PMID: 21376155 DOI: 10.1016/j.intimp.2011.02.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
97 Tan HH, Fiel MI, del Rio Martin J, Schiano TD. Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series. Liver Transpl 2009;15:634-9. [PMID: 19479807 DOI: 10.1002/lt.21727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
98 Vandermeulen M, Mohamed-Wais M, Erpicum P, Delbouille MH, Lechanteur C, Briquet A, Maggipinto G, Jouret F, Beguin Y, Detry O. Infusion of Allogeneic Mesenchymal Stromal Cells After Liver Transplantation: A 5-Year Follow-Up. Liver Transpl 2021. [PMID: 34605167 DOI: 10.1002/lt.26323] [Reference Citation Analysis]
99 Wang X, MacParland SA, Perciani CT. Immunological Determinants of Liver Transplant Outcomes Uncovered by the Rat Model. Transplantation 2021;105:1944-56. [PMID: 33417410 DOI: 10.1097/TP.0000000000003598] [Reference Citation Analysis]
100 Sakamoto S, Taira K, Egawa H, Takada Y. Cytomegalovirus infection with perineal pain after living donor liver transplantation: report of four cases. Transpl Infect Dis 2007;9:37-41. [PMID: 17313470 DOI: 10.1111/j.1399-3062.2006.00162.x] [Reference Citation Analysis]
101 Cho JY, Suh K, Lee HW, Cho E, Yang SH, Cho YB, Yi N, Kim MA, Jang J, Lee KU. The clinical significance of early histological rejection with or without biochemical abnormality in adult living donor liver transplantation for hepatitis B virus related end stage liver disease. Transplant Int 2007;20:37-44. [DOI: 10.1111/j.1432-2277.2006.00384.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
102 Åberg F, Nordin A, Toivonen L, Isoniemi H. Early Predictors of Long-term Outcomes of HCV-negative Liver Transplant Recipients Having Survived the First Postoperative Year. Transplantation 2016;100:382-90. [PMID: 26683515 DOI: 10.1097/TP.0000000000001038] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Bolognesi M, Quaglio C, Bombonato G, Guido M, Cavalletto L, Chemello L, Merkel C, Rugge M, Gatta A, Sacerdoti D. Hepatitis C virus reinfection in liver transplant patients: Evaluation of liver damage progression with echo-color doppler. Liver Transpl 2008;14:616-24. [DOI: 10.1002/lt.21407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
104 Charco R, Caralt M, Lladó L, Valdivieso A, Fabregat J, Matarranz A, Gonzalez-pinto I, Pardo F, Fábrega E, Bilbao I. A Prospective, Multicenter Study of Once-Daily Extended-Release Tacrolimus in De Novo Liver Transplant Recipients. Transplantation Proceedings 2011;43:718-23. [DOI: 10.1016/j.transproceed.2011.01.093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
105 De Simone P, Carrai P, Coletti L, Ghinolfi D, Petruccelli S, Precisi A, Campani D, Marchetti P, Filipponi F. Everolimus vs Mycophenolate Mofetil in Combination With Tacrolimus: A Propensity Score-matched Analysis in Liver Transplantation. Transplant Proc. 2018;50:3615-3620. [PMID: 30577246 DOI: 10.1016/j.transproceed.2018.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
106 Kerkar N, Morotti RA, Iyer K, Arnon R, Miloh T, Sturdevant M, Suchy F, Florman S, Emre S. Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients. Clin Transplant 2011;25:E584-91. [PMID: 21919961 DOI: 10.1111/j.1399-0012.2011.01494.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
107 Millar AJW, Spearman W, Mcculloch M, Goddard E, Raad J, Rode H, Kahn D, Cywes S. Liver transplantation for children - the Red Cross Children's Hospital experience. Pediatric Transplantation 2004;8:136-44. [DOI: 10.1046/j.1399-3046.2003.00131.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
108 Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, Randhawa P, Wu T, Krasinskas A, Fontes P, Cacciarelli T, Shakil AO, Murase N, Fung JJ, Starzl TE. Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations About Pathogenesis. The American Journal of Surgical Pathology 2004;28:658-69. [DOI: 10.1097/00000478-200405000-00015] [Cited by in Crossref: 80] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
109 Shetty S, Adams DH, Hubscher SG. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Review of Clinical Immunology 2014;8:645-61. [DOI: 10.1586/eci.12.65] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
110 Chen Y, Liang S, Long F, Li J, Gong J. Augmenter of liver regeneration attenuates acute rejection after rat liver transplantation. The American Journal of Surgery 2016;212:128-37. [DOI: 10.1016/j.amjsurg.2015.10.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
111 Jesudian A, Desale S, Julia J, Landry E, Maxwell C, Kallakury B, Laurin J, Shetty K. Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus. J Clin Exp Hepatol 2016;6:109-14. [PMID: 27493458 DOI: 10.1016/j.jceh.2015.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
112 Kehar M, Grunebaum E, Jimenez-Rivera C, Mozer-Glassberg Y, Jamal A, Ng VL, Avitzur Y. Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients. Pediatr Transplant 2020;24:e13737. [PMID: 32428390 DOI: 10.1111/petr.13737] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Gaweco AS, Wiesner RH, Yong S, Krom R, Porayko M, Chejfec G, McClatchey KD, Van Thiel DH. CD40L (CD154) expression in human liver allografts during chronic ductopenic rejection. Liver Transpl Surg. 1999;5:1-7. [PMID: 9873085 DOI: 10.1002/lt.500050108] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
114 Yang M, Ma Y, Ding J, Rao L, Li J. Preconditioning donor livers with cromolyn or compound 48/80 prolongs recipient survival in a rat orthotopic liver transplantation model. Transplant Proc 2014;46:1554-9. [PMID: 24935329 DOI: 10.1016/j.transproceed.2014.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Ganschow R, Lyons M, Grabhorn E, Venzke A, Broering D, Rogiers X, Hellwege H, Burdelski M. Experience with basiliximab in pediatric liver graft recipients. Transplantation Proceedings 2001;33:3606-7. [DOI: 10.1016/s0041-1345(01)02551-9] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
116 Wietzke-Braun P, Braun F, Sattler B, Ramadori G, Ringe B. Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis c virus related cirrhosis. World J Gastroenterol 2004; 10(15): 2213-2217 [PMID: 15259068 DOI: 10.3748/wjg.v10.i15.2213] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
117 Yeh MM, Larson AM, Tung BY, Swanson PE, Upton MP. Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis. Am J Surg Pathol 2006;30:727-33. [PMID: 16723850 DOI: 10.1097/00000478-200606000-00008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
118 Ogura Y, Krams SM, Martinez OM, Kopiwoda S, Higgins JP, Esquivel CO, Strauss HW, Tait JF, Blankenberg FG. Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology 2000;214:795-800. [PMID: 10715048 DOI: 10.1148/radiology.214.3.r00mr34795] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
119 Qi H, Chen G, Huang Y, Si Z, Li J. Foxp3-modified bone marrow mesenchymal stem cells promotes liver allograft tolerance through the generation of regulatory T cells in rats. J Transl Med 2015;13:274. [PMID: 26293578 DOI: 10.1186/s12967-015-0638-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
120 Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, Cohard M, Reynes M, Chevallier M, Ducerf C. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology. 2003;124:642-650. [PMID: 12612903 DOI: 10.1053/gast.2003.50095] [Cited by in Crossref: 282] [Cited by in F6Publishing: 250] [Article Influence: 14.8] [Reference Citation Analysis]
121 Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, Langrehr JM. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transplant 2006;20:211-20. [DOI: 10.1111/j.1399-0012.2005.00471.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 62] [Article Influence: 5.0] [Reference Citation Analysis]
122 Kamei H, Masuda S, Ishigami M, Nakamura T, Fujimoto Y, Takada Y, Hamajima N. Association of interleukin4 gene polymorphisms of recipients and donors with acute rejection following living donor liver transplantation. Clin Res Hepatol Gastroenterol 2016;40:179-85. [PMID: 26212175 DOI: 10.1016/j.clinre.2015.06.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Romero M, García-Monzón C, Clemente G, Salcedo M, Alvarez E, Majano PL, Moreno-Otero R. Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: evidence of modulation by corticosteroids. Liver Transpl. 2001;7:16-21. [PMID: 11150416 DOI: 10.1053/jlts.2001.20779] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
124 Stern M, Hirsch H, Cusini A, van Delden C, Manuel O, Meylan P, Boggian K, Mueller NJ, Dickenmann M. Cytomegalovirus Serology and Replication Remain Associated With Solid Organ Graft Rejection and Graft Loss in the Era of Prophylactic Treatment. Transplantation 2014;98:1013-8. [DOI: 10.1097/tp.0000000000000160] [Cited by in Crossref: 65] [Cited by in F6Publishing: 16] [Article Influence: 8.1] [Reference Citation Analysis]
125 Ghabril M, Dickson RC, Krishna M, Machicao V, Aranda-Michel J, Bonatti H, Nguyen JH. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence. Liver Transpl. 2011;17:685-694. [PMID: 21618689 DOI: 10.1002/lt.22250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
126 Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004;77:84-92. [PMID: 14724440 DOI: 10.1097/01.TP.0000095896.07048.BB] [Cited by in Crossref: 126] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
127 Dell-Olio D, Beath SV, de Ville de Goyet J, Clarke S, Davies P, Lloyd C, Protheroe S, Millar AJ, Kelly DA, Gupte GL. Isolated liver transplant in infants with short bowel syndrome: insights into outcomes and prognostic factors. J Pediatr Gastroenterol Nutr 2009;48:334-40. [PMID: 19274790 DOI: 10.1097/mpg.0b013e31818c6099] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
128 Górnicka B, Ziarkiewicz-wróblewska B, Bogdańska M, Ołdakowska-jedynak U, Wróblewski T, Morton M, Ziółkowski J, Pączek L, Krawczyk M, Wasiutyński A. Pathomorphological Features of Acute Rejection in Patients After Orthotopic Liver Transplantation: Own Experience. Transplantation Proceedings 2006;38:221-5. [DOI: 10.1016/j.transproceed.2006.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
129 Calia R, Lai C, Aceto P, Luciani M, Saraceni C, Avolio A, Agnes S. Psychological Risk Factors for Graft Rejection Among Liver Transplant Recipients. Transplantation Proceedings 2011;43:1123-7. [DOI: 10.1016/j.transproceed.2011.01.159] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
130 Qiu M, Chen Y, Chen L, Zeng J, Liu J. Transforming growth factor β1 and Fas ligand synergistically enhance immune tolerance in dendritic cells in liver transplantation. Journal of Surgical Research 2017;218:180-93. [DOI: 10.1016/j.jss.2017.05.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
131 Hong IC, Mullen PM, Precht AF, Khanna A, Li M, Behling C, Lopez VF, Chiou HC, Moss RB, Hart ME. Non-viral human IL-10 gene expression reduces acute rejection in heterotopic auxiliary liver transplantation in rats. Microsurgery 2003;23:432-6. [DOI: 10.1002/micr.10174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
132 Lee DH, Lee JY, Bae JS, Yi NJ, Lee KW, Suh KS, Kim H, Lee KB, Han JK. Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation. Radiology 2019;293:327-33. [PMID: 31502939 DOI: 10.1148/radiol.2019190064] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
133 Miyagawa-hayashino A, Haga H, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S, Tanaka K, Manabe T. Outcome and Risk Factors of De Novo Autoimmune Hepatitis in Living-Donor Liver Transplantation. Transplantation 2004;78:128-35. [DOI: 10.1097/01.tp.0000132328.33460.43] [Cited by in Crossref: 83] [Cited by in F6Publishing: 10] [Article Influence: 4.6] [Reference Citation Analysis]
134 de Magnée C, Brunée L, Tambucci R, Pire A, Scheers I, Sokal EM, Baldin P, Zech F, Eeckhoudt S, Reding R, Stephenne X. Is ABO-Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients? Children (Basel) 2021;8:600. [PMID: 34356579 DOI: 10.3390/children8070600] [Reference Citation Analysis]
135 Solez K, Racusen LC. The Banff classification revisited. Kidney International 2013;83:201-6. [DOI: 10.1038/ki.2012.395] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
136 Barbier L, Garcia S, Cros J, Borentain P, Botta-Fridlund D, Paradis V, Le Treut YP, Hardwigsen J. Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors. J Hepatol. 2013;59:1223-1230. [PMID: 23933266 DOI: 10.1016/j.jhep.2013.07.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
137 Maluf DG, Stravitz RT, Cotterell AH, Posner MP, Nakatsuka M, Sterling RK, Luketic VA, Shiffman ML, Ham JM, Marcos A, Behnke MK, Fisher RA. Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplant. 2005;5:149-156. [PMID: 15636624 DOI: 10.1111/j.1600-6143.2004.00654.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 96] [Article Influence: 6.8] [Reference Citation Analysis]
138 Rivero M, Crespo J, Mayorga M, Fábrega E, Casafont F, Pons-Romero F. Involvement of the Fas system in liver allograft rejection. Am J Gastroenterol. 2002;97:1501-1506. [PMID: 12094873 DOI: 10.1111/j.1572-0241.2002.05797.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
139 Beal EW, Black SM, Michaels A. Autoimmune Hepatitis in the Liver Transplant Graft. Clin Liver Dis 2017;21:381-401. [PMID: 28364820 DOI: 10.1016/j.cld.2016.12.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
140 Crosbie OM, Costello PJ, O'farrelly C, Hegarty JE. Changes in peripheral blood double-negative T-lymphocyte (CD3+ CD4− CD8−) populations associated with acute cellular rejection after liver transplantation. Liver Transpl 1998;4:141-5. [DOI: 10.1002/lt.500040207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
141 Núñez-Martínez O, De la Cruz G, Salcedo M, Molina J, De Diego A, Ripoll C, Calleja J, Alvarez E, Clemente G. Liver transplantation for autoimmune hepatitis: fulminant versus chronic hepatitis presentation. Transplant Proc 2003;35:1857-8. [PMID: 12962824 DOI: 10.1016/s0041-1345(03)00591-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
142 Krenzien F, Keshi E, Splith K, Griesel S, Kamali K, Sauer IM, Feldbrügge L, Pratschke J, Leder A, Schmelzle M. Diagnostic Biomarkers to Diagnose Acute Allograft Rejection After Liver Transplantation: Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies. Front Immunol 2019;10:758. [PMID: 31031758 DOI: 10.3389/fimmu.2019.00758] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
143 Arakawa Y, Shimada M, Utsunomiya T, Imura S, Morine Y, Ikemoto T, Hanaoka J. Effects of a whey peptide-based enteral formula diet on liver dysfunction following living donor liver transplantation. Surg Today 2014;44:44-9. [PMID: 23266751 DOI: 10.1007/s00595-012-0466-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
144 Tan HK, Marquez M, Wong F, Renner EL. Pretransplant Type 2 Hepatorenal Syndrome Is Associated With Persistently Impaired Renal Function After Liver Transplantation. Transplantation. 2015;99:1441-1446. [PMID: 25643142 DOI: 10.1097/tp.0000000000000557] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
145 Lladó L, Fabregat J, Castellote J, Ramos E, Torras J, Serrano T, Figueras J, Rafecas A. Sirolimus-based rescue therapy after rejection in liver transplantation. Clin Transplant 2009;23:89-95. [PMID: 19200220 DOI: 10.1111/j.1399-0012.2008.00906.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
146 Morris MW, Anderson C. The holy grail: a biomarker for acute rejection in liver transplantation. Journal of Surgical Research 2013;185:535-6. [DOI: 10.1016/j.jss.2012.08.058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
147 Weber A. Role of Histopathology. In: Clavien P, Trotter JF, editors. Medical Care of the Liver Transplant Patient. Oxford: Wiley-Blackwell; 2012. pp. 332-44. [DOI: 10.1002/9781444398441.ch30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
148 Kiyomoto T, Toyokawa H, Nakao A, Kaizu T, Demetris AJ, Starzl TE, Murase N. The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Transplantation 2006;81:438-44. [PMID: 16477232 DOI: 10.1097/01.tp.0000188948.72706.4d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
149 Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47:598-607. [PMID: 17692984 DOI: 10.1016/j.jhep.2007.07.006] [Cited by in Crossref: 444] [Cited by in F6Publishing: 390] [Article Influence: 29.6] [Reference Citation Analysis]
150 Peverelle M, Paleri S, Hughes J, De Cruz P, Gow PJ. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes. Inflamm Bowel Dis. 2020; Epub ahead of print. [PMID: 31944235 DOI: 10.1093/ibd/izz325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
151 Corruble E, Barry C, Varescon I, Falissard B, Castaing D, Samuel D. Depressive symptoms predict long-term mortality after liver transplantation. J Psychosom Res. 2011;71:32-37. [PMID: 21665010 DOI: 10.1016/j.jpsychores.2010.12.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
152 Haddad L, Marciano S, Cleres M, Zerega A, Piñero F, Orozco F, Braslavsky G, Mendizabal M, Gondolesi G, Gil O, Silva M, Mastai R, Imventarza O, Descalzi V, Gadano A. Characteristics of Liver Transplantation in Argentina: A Multicenter Study. Transplant Proc 2018;50:478-84. [PMID: 29579832 DOI: 10.1016/j.transproceed.2017.11.072] [Reference Citation Analysis]
153 Kato T, Gaynor JJ, Yoshida H, Montalvano M, Takahashi H, Pyrsopoulos N, Nishida S, Moon J, Selvaggi G, Levi D, Ruiz P, Schiff E, Tzakis A. Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. Transplantation. 2007;84:829-835. [PMID: 17984834 DOI: 10.1097/01.tp.0000282914.20578.7b] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
154 Madill-Thomsen K, Abouljoud M, Bhati C, Ciszek M, Durlik M, Feng S, Foroncewicz B, Francis I, Grąt M, Jurczyk K, Klintmalm G, Krasnodębski M, McCaughan G, Miquel R, Montano-Loza A, Moonka D, Mucha K, Myślak M, Pączek L, Perkowska-Ptasińska A, Piecha G, Reichman T, Sanchez-Fueyo A, Tronina O, Wawrzynowicz-Syczewska M, Więcek A, Zieniewicz K, Halloran PF. The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study. Am J Transplant 2020;20:2156-72. [PMID: 32090446 DOI: 10.1111/ajt.15828] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
155 Crespo G, Lens S, Gambato M, Carrión JA, Mariño Z, Londoño M, Miquel R, Bosch J, Navasa M, Forns X. Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C: Fibroscan and Outcomes in Post-LT Hepatitis C. American Journal of Transplantation 2014;14:375-83. [DOI: 10.1111/ajt.12594] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
156 Voutilainen SH, Kosola SK, Lohi J, Jahnukainen T, Pakarinen MP, Jalanko H. Expression of fibrosis-related genes in liver allografts: Association with histology and long-term outcome after pediatric liver transplantation. Clin Transplant 2021;:e14373. [PMID: 34043847 DOI: 10.1111/ctr.14373] [Reference Citation Analysis]
157 Egawa H, Nakanuma Y, Maehara Y, Uemoto S, Eguchi S, Sato Y, Shirabe K, Takatsuki M, Mori A, Yamamoto M, Tsubouchi H. Disease recurrence plays a minor role as a cause for retransplantation after living-donor liver transplantation for primary biliary cirrhosis: A multicenter study in Japan: Recurrence of pPBC after LT. Hepatol Res 2013;43:502-7. [DOI: 10.1111/j.1872-034x.2012.01108.x] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
158 Morard I, Dumortier J, Spahr L, Hadengue A, Majno P, Morel P, Mentha G, Giostra E. Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients. Liver Transpl. 2007;13:658-664. [PMID: 17457887 DOI: 10.1002/lt.21116] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
159 Lerut J, Van Thuyne V, Mathijs J, Lemaire J, Talpe S, Roggen F, Ciccarelli O, Zuckermann M, Goffette P, Hope J, Gianello P, Bazin H, Cornet A, Rahier J, Latinne D. Anti-CD2 Monoclonal Antibody and Tacrolimus in Adult Liver Transplantation: . Transplantation 2005;80:1186-93. [DOI: 10.1097/01.tp.0000173996.81192.f9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
160 Stravitz RT, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PS, Sterling RK, Manns MP, Norman GL, Lee WM; Acute Liver Failure Study Group. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011;53:517-26. [PMID: 21274872 DOI: 10.1002/hep.24080] [Cited by in Crossref: 174] [Cited by in F6Publishing: 136] [Article Influence: 15.8] [Reference Citation Analysis]
161 Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl. 2009;15:619-628. [PMID: 19479805 DOI: 10.1002/lt.21761] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
162 Hibi T, Shinoda M, Itano O, Obara H, Kitago M, Abe Y, Yagi H, Tanaka M, Hoshino K, Fujino A, Kuroda T, Kawachi S, Tanabe M, Shimazu M, Kitagawa Y. Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus-related cirrhosis. Hepatol Res. 2015;45:1178-1184. [PMID: 25594837 DOI: 10.1111/hepr.12486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
163 Bartlett AS, Mccall JL, Ameratunga R, Howden B, Ramadas R, Yeong M, Benjamin CD, Hess D, Munn SR. Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA. Journal of Surgical Research 2003;115:1-8. [DOI: 10.1016/s0022-4804(03)00131-8] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
164 Mendler M, Kwok H, Franco E, Baron P, Weissman J, Ojogho O. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity. Liver Transpl. 2008;14:1313-1322. [PMID: 18756485 DOI: 10.1002/lt.21529] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
165 Li DY, Xie SL, Wang GY, Dang XW. CD47 blockade alleviates acute rejection of allogeneic mouse liver transplantation by reducing ischemia/reperfusion injury. Biomed Pharmacother. 2020;123:109793. [PMID: 31884341 DOI: 10.1016/j.biopha.2019.109793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
166 Kataoka K, Seo S, Sugawara Y, Ota S, Imai Y, Takahashi T, Fukayama M, Kokudo N, Kurokawa M. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature. Leukemia & Lymphoma 2010;51:1494-501. [DOI: 10.3109/10428194.2010.492063] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
167 Cescon M, Grazi GL, Cucchetti A, Ravaioli M, Ercolani G, Vivarelli M, D'Errico A, Del Gaudio M, Pinna AD. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl. 2008;14:672-679. [PMID: 18433035 DOI: 10.1002/lt.21433] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
168 Kaneko J, Sugawara Y, Tamura S, Aoki T, Sakamoto Y, Hasegawa K, Yamashiki N, Kokudo N. De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation. 2013;95:1142-1147. [PMID: 23572128 DOI: 10.1097/tp.0b013e318288ca83] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
169 Lupo L, Panzera P, Tandoi F, Carbotta G, Giannelli G, Santantonio T, Rendina M, Gentile A, Memeo V. Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial. Transplantation. 2008;86:925-931. [PMID: 18852657 DOI: 10.1097/tp.0b013e318186b8a3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
170 Venkat VL, Ranganathan S, Mazariegos GV, Sun Q, Sindhi R. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients: Psc Recurrence in Pediatric Transplantation. Liver Transpl 2014;20:679-86. [DOI: 10.1002/lt.23868] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
171 Woolfson JP, Perez M, Chavhan GB, Johara FT, Lurz E, Kamath BM, Ng VL. Sarcopenia in Children With End-Stage Liver Disease on the Transplant Waiting List. Liver Transpl 2021;27:641-51. [PMID: 33460522 DOI: 10.1002/lt.25985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
172 Penninga L, Wettergren A, Wilson CH, Steinbrüchel DA, Gluud C, Penninga L. Immunosuppressive T cell antibody induction therapy for liver transplant recipients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007341.pub2] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
173 Galioto A, Morando F, Rosi S, Schipilliti M, Fasolato S, Magrin M, Frigo AC, Adami F, Cavallin M, Zanus G, Plebani M, Romano A, Sticca A, Cillo U, Gatta A, Angeli P. Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies: MGUS and liver transplantation. Transplant International 2012;25:25-33. [DOI: 10.1111/j.1432-2277.2011.01362.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
174 Yamamoto S, Okuda T, Yamasaki K, Tanaka H, Kubo S, Takemura S, Ikeda K, Minamiyama Y, Hirohashi K, Suehiro S. FK778 and FK506 Combination Therapy to Control Acute Rejection after Rat Liver Allotransplantation. Transplantation 2004;78:1618-25. [DOI: 10.1097/01.tp.0000144312.08782.16] [Cited by in Crossref: 10] [Article Influence: 0.6] [Reference Citation Analysis]
175 Francavilla R, Hadzic N, Underhill J, Heaton N, Rela M, Mieli-vergani G, Donaldson P. ROLE OF HLA COMPATIBILITY IN PEDIATRIC LIVER TRANSPLANTATION: . Transplantation 1998;66:53-8. [DOI: 10.1097/00007890-199807150-00009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
176 Ng IO, Chan KL, Shek WH, Lee JM, Fong DY, Lo CM, Fan ST. High frequency of chimerism in transplanted livers. Hepatology. 2003;38:989-998. [PMID: 14512886 DOI: 10.1002/hep.1840380425] [Cited by in Crossref: 75] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
177 Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. Liver Transpl. 2005;11:1395-1402. [PMID: 16237691 DOI: 10.1002/lt.20508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
178 Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl. 2004;10:1248-1255. [PMID: 15376308 DOI: 10.1002/lt.20232] [Cited by in Crossref: 113] [Cited by in F6Publishing: 92] [Article Influence: 6.6] [Reference Citation Analysis]
179 Pilat N, Schoppmann S, Stift J, Mazal P, Wekerle T, Berlakovich GA. No Evidence for Recipient-Derived Hepatocytes in Serial Biopsies of Sex-Mismatched Liver Transplants. Transplantation 2012;94:953-7. [DOI: 10.1097/tp.0b013e318269e68d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
180 Hong S, Lee K, Yoon K, Kim H, Kim H, Yi N, Suh K. Efficacy and Safety of Generic Mycophenolate Mofetil (My-rept) 500-Milligram Tablets in Primary Liver Transplant Recipients. Transplantation Proceedings 2017;49:1402-8. [DOI: 10.1016/j.transproceed.2017.02.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
181 Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl. 2004;10:199-207. [PMID: 14762857 DOI: 10.1002/lt.20074] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 6.9] [Reference Citation Analysis]
182 Bitetto D, Fabris C, Falleti E, Fornasiere E, Avellini C, Cmet S, Cussigh A, Fontanini E, Pirisi M, Corradini SG, Merli M, Molinaro A, Toniutto P. Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used. Transplantation. 2012;93:1038-1044. [PMID: 22495472 DOI: 10.1097/tp.0b013e31824df7f3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
183 Sebagh M, Azoulay D, Roche B, Hoti E, Karam V, Teicher E, Bonhomme-Faivre L, Saliba F, Duclos-Vallée JC, Samuel D. Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation. Liver Transpl 2011;17:798-808. [PMID: 21351239 DOI: 10.1002/lt.22282] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
184 Krampe K, Briem-richter A, Fischer L, Nashan B, Ganschow R. The value of immunoprophylaxis for cytomegalovirus infection with intravenous immunoglobulin in pediatric liver transplant recipients receiving a low-dose immunosupressive regimen. Pediatric Transplantation 2010;14:67-71. [DOI: 10.1111/j.1399-3046.2008.01120.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
185 Werner JM, Lang C, Scherer MN, Farkas SA, Geissler EK, Schlitt HJ, Hornung M. Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity? Transpl Immunol 2011;25:27-33. [PMID: 21635950 DOI: 10.1016/j.trim.2011.05.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
186 Innocenti F, Hepp J, Humeres R, Sanhueza E, Zapata R, Rios H, Suárez L, Sandoval R, Rius M, Zamboni M. Rapid steroid taper and neoral monotherapy in liver transplantation in Chile: a step in the right direction? Transplant Proc. 2004;36:1675-1676. [PMID: 15350449 DOI: 10.1016/j.transproceed.2004.06.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
187 Gómez-Manero N, Herrero JI, Quiroga J, Sangro B, Pardo F, Cienfuegos JA, Prieto J. Prognostic model for early acute rejection after liver transplantation. Liver Transpl. 2001;7:246-254. [PMID: 11244167 DOI: 10.1053/jlts.2001.22460] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
188 Okumura Y, Noda T, Eguchi H, Iwagami Y, Yamada D, Asaoka T, Wada H, Kawamoto K, Gotoh K, Takeda Y, Tanemura M, Marubashi S, Umeshita K, Doki Y, Mori M. Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus. Transplant Direct 2017;3:e207. [PMID: 28894794 DOI: 10.1097/TXD.0000000000000722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
189 Kristo I, Wilflingseder J, Kainz A, Marschalek J, Wekerle T, Mühlbacher F, Oberbauer R, Bodingbauer M. Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial. Transpl Int 2011;24:912-9. [PMID: 21672049 DOI: 10.1111/j.1432-2277.2011.01284.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
190 Roche B, Sebagh M, Canfora ML, Antonini T, Roque-Afonso AM, Delvart V, Saliba F, Duclos-Vallee JC, Castaing D, Samuel D. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis. Liver Transpl. 2008;14:1766-1777. [PMID: 19025933 DOI: 10.1002/lt.21635] [Cited by in Crossref: 114] [Cited by in F6Publishing: 93] [Article Influence: 8.8] [Reference Citation Analysis]
191 Pischke S, Gösling J, Engelmann I, Schlue J, Wölk B, Jäckel E, Meyer-Heithuis C, Lehmann U, Strassburg CP, Barg-Hock H, Becker T, Manns MP, Schulz T, Wedemeyer H, Heim A. High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis. J Hepatol 2012;56:1063-9. [PMID: 22245897 DOI: 10.1016/j.jhep.2011.12.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
192 Kobayashi S, Nagano H, Marubashi S, Hama N, Eguchi TAH, Takeda Y, Tanemura M, Doki Y, Mori M. Guanylate-binding protein 2 mRNA in peripheral blood leukocytes of liver transplant recipients as a marker for acute cellular rejection. Transplant International 2010;23:390-6. [DOI: 10.1111/j.1432-2277.2009.00991.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
193 Otero A, Varo E, de Urbina JO, Martín-Vivaldi R, Cuervas-Mons V, González-Pinto I, Rimola A, Bernardos A, Otero S, Maldonado J, Herrero JI, Barrao E, Domínguez-Granados R. A prospective randomized open study in liver transplant recipients: daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids. Liver Transpl 2009;15:1542-52. [PMID: 19877219 DOI: 10.1002/lt.21854] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
194 González IA, Lu HC, Alipour Z, Kulkarni SS, Stoll JM, Liss KHH, Dehner LP, He M. Clinicopathologic Characteristics of Centrilobular Injury in Pediatric Liver Transplantation. Liver Transpl 2021;27:416-24. [PMID: 33253466 DOI: 10.1002/lt.25958] [Reference Citation Analysis]
195 Chen Y, Luo F, Luo S, Wu Z, Zhou J. The augmenter of liver regeneration protects the kidneys after orthotopic liver transplantation possibly by upregulating HIF-1α and O2-sensitive K+ channels. Surg Today 2011;41:382-9. [DOI: 10.1007/s00595-010-4282-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
196 Vionnet J, Sempoux C, Pascual M, Sánchez-fueyo A, Colmenero J. Donor-specific antibodies in liver transplantation. Gastroenterología y Hepatología 2020;43:34-45. [DOI: 10.1016/j.gastrohep.2019.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
197 Selzner N, Guindi M, Renner EL, Berenguer M. Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients. Journal of Hepatology 2011;55:207-17. [DOI: 10.1016/j.jhep.2010.11.012] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 7.1] [Reference Citation Analysis]
198 Nelson DR, Soldevila-Pico C, Reed A, Abdelmalek MF, Hemming AW, Van der Werf WJ, Howard R, Davis GL. Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation. Liver Transpl. 2001;7:1064-1070. [PMID: 11753908 DOI: 10.1053/jlts.2001.29414] [Cited by in Crossref: 122] [Cited by in F6Publishing: 105] [Article Influence: 6.1] [Reference Citation Analysis]
199 Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S, Yamabe H, Manabe T, Tanaka K. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl. 2004;10:16-27. [PMID: 14755773 DOI: 10.1002/lt.20002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
200 Eguchi S, Hidaka M, Soyama A, Takatsuki M, Miyaaki H, Ichikawa T, Nakao K, Kanematsu T. Is liver-targeted FOXp3 staining beneficial after living-donor liver transplantation? Transpl Infect Dis 2012;14:156-62. [DOI: 10.1111/j.1399-3062.2011.00690.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
201 Vilela EG, Clemente WT, Mira RR, Torres HO, Veloso LF, Fonseca LP, de Carvalho E Fonseca LR, Franca Md, Lima AS. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Transpl Infect Dis 2009;11:132-6. [PMID: 18983416 DOI: 10.1111/j.1399-3062.2008.00350.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
202 Park J, Kim BW, Choi HJ, Hong SH, Park CS, Choi JH, Chae MS. Risk stratification for early bacteremia after living donor liver transplantation: a retrospective observational cohort study. BMC Surg 2020;20:2. [PMID: 32160890 DOI: 10.1186/s12893-019-0658-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
203 Buis CI, van der Steege G, Visser DS, Nolte IM, Hepkema BG, Nijsten M, Slooff MJH, Porte RJ. Heme Oxygenase-1 Genotype of the Donor Is Associated With Graft Survival After Liver Transplantation: HO-1 Polymorphisms and Outcome After Liver Transplantation. American Journal of Transplantation 2008;8:377-85. [DOI: 10.1111/j.1600-6143.2007.02048.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
204 Liu LU, Bodian CA, Gondolesi GE, Schwartz ME, Emre S, Roayaie S, Schiano TD. Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation. 2005;80:1072-1080. [PMID: 16278588 DOI: 10.1097/01.tp.0000176483.52769.5a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
205 Geramizadeh B, Motevalli D, Nikeghbalian S, Malek Hosseini SA. Histopathology of post-transplant liver biopsies, the first report from iran. Hepat Mon 2013;13:e9389. [PMID: 24032049 DOI: 10.5812/hepatmon.9389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
206 Li J, Gong J, Li P, Li M, Liu Y, Liang S, Gong J. Knockdown of microRNA-155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts. Transplantation. 2014;97:626-635. [PMID: 24531847 DOI: 10.1097/TP.0000000000000061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
207 Andreani P, Hoti E, de la Serna S, degli Esposti D, Sebagh M, Lemoine A, Ichai P, Saliba F, Castaing D, Azoulay D. Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance. HPB (Oxford). 2010;12:439-446. [PMID: 20815852 DOI: 10.1111/j.1477-2574.2010.00194.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
208 Shen ZY, Wu B, Liu T, Yang Y, Yin ML, Zheng WP, Zhang BY, Song HL. Immunomodulatory effects of bone marrow mesenchymal stem cells overexpressing heme oxygenase-1: Protective effects on acute rejection following reduced-size liver transplantation in a rat model. Cell Immunol. 2017;313:10-24. [PMID: 28069109 DOI: 10.1016/j.cellimm.2016.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
209 Sakashita H, Haga H, Ashihara E, Wen MC, Tsuji H, Miyagawa-Hayashino A, Egawa H, Takada Y, Maekawa T, Uemoto S, Manabe T. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007;20:676-84. [PMID: 17431411 DOI: 10.1038/modpathol.3800784] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
210 Geuken E, Visser D, Kuipers F, Blokzijl H, Leuvenink HG, de Jong KP, Peeters PM, Jansen PL, Slooff MJ, Gouw AS, Porte RJ. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol. 2004;41:1017-1025. [PMID: 15582136 DOI: 10.1016/j.jhep.2004.08.023] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 4.5] [Reference Citation Analysis]
211 Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, Clausen OP, Bjoro K. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl. 2005;11:1361-1369. [PMID: 16184522 DOI: 10.1002/lt.20444] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
212 Zhao W, Zhang Z, Zhao Q, Liu M, Wang Y. Inhibition of Interferon Regulatory Factor 4 Attenuates Acute Liver Allograft Rejection in Mice. Scand J Immunol 2015;82:262-8. [DOI: 10.1111/sji.12318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
213 Manzia TM, Angelico R, Toti L, Belardi C, Cillis A, Quaranta C, Tariciotti L, Katari R, Mogul A, Sforza D, Orlando G, Tisone G. The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy. Dig Liver Dis 2016;48:315-20. [PMID: 26682720 DOI: 10.1016/j.dld.2015.11.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
214 Bolognesi M, Sacerdoti D, Mescoli C, Nava V, Bombonato G, Merkel C, Merenda R, Angeli P, Rugge M, Gatta A. Acute Liver Rejection: Accuracy and Predictive Values of Doppler US Measurements—Initial Experience. Radiology 2005;235:651-8. [DOI: 10.1148/radiol.2352040506] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
215 Reis H, Wohlschläger J, Hagemann S, Wenzel P, Bechmann LP, Suttorp AC, Schlattjan MJ, Herzer K, Canbay A, Baba HA. (Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts. Liver Int 2015;35:905-13. [PMID: 24750688 DOI: 10.1111/liv.12572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
216 Demetris AJ. Evolution of hepatitis C virus in liver allografts. Liver Transpl. 2009;15 Suppl 2:S35-S41. [PMID: 19876940 DOI: 10.1002/lt.21890] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
217 Kim PT, Demetris AJ, O'Leary JG. Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'. Curr Opin Organ Transplant 2016;21:209-18. [PMID: 26918881 DOI: 10.1097/MOT.0000000000000275] [Cited by in Crossref: 39] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
218 Warlé MC, Metselaar HJ, Kusters JG, Zondervan PE, Hop WC, Segeren KC, Kwekkeboom J, Ijzermans JN, Tilanus HW. Strain-specific in vitro cytokine production profiles do not predict rat liver allograft survival. Transpl Int 2005;17:779-86. [PMID: 15703923 DOI: 10.1007/s00147-004-0774-8] [Reference Citation Analysis]
219 Schmeding M, Dankof A, Krenn V, Krukemeyer MG, Koch M, Spinelli A, Langrehr JM, Neumann UP, Neuhaus P. C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 2006;6:523-30. [PMID: 16468961 DOI: 10.1111/j.1600-6143.2005.01180.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
220 Grabhorn E, Schulz A, Helmke K, Hinrichs B, Rogiers X, Broering DC, Burdelski M, Ganschow R. Short- and Long-Term Results of Liver Transplantation in Infants Aged Less than 6 Months. Transplantation 2004;78:235-41. [DOI: 10.1097/01.tp.0000128189.54868.18] [Cited by in Crossref: 54] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
221 Ascha MS, Ascha ML, Hanouneh IA. Management of immunosuppressant agents following liver transplantation: Less is more. World J Hepatol 2016; 8(3): 148-161 [PMID: 26839639 DOI: 10.4254/wjh.v8.i3.148] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
222 Siroen MP, Warlé MC, Teerlink T, Nijveldt RJ, Kuipers EJ, Metselaar HJ, Tilanus HW, Kuik DJ, van der Sijp JR, Meijer S. The transplanted liver graft is capable of clearing asymmetric dimethylarginine. Liver Transpl. 2004;10:1524-1530. [PMID: 15558588 DOI: 10.1002/lt.20286] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
223 Bellamy CO, Herriot MM, Harrison DJ, Bathgate AJ. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology. 2007;50:739-749. [PMID: 17493238 DOI: 10.1111/j.1365-2559.2007.02677.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
224 Mcgill JM, Kwiatkowski AP. Cholestatic Liver Diseases in Adults. American Journal of Gastroenterology 1998;93:684-91. [DOI: 10.1111/j.1572-0241.1998.206_a.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
225 Kerkar N, Vergani D. De novo autoimmune hepatitis –is this different in adults compared to children? Journal of Autoimmunity 2018;95:26-33. [DOI: 10.1016/j.jaut.2018.10.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
226 Wang GY, Li H, Liu W, Zhang J, Zhu HB, Wang GS, Zhang Q, Yang Y, Chen GH. Elevated blood eosinophil count is a valuable biomarker for predicting late acute cellular rejection after liver transplantation. Transplant Proc 2013;45:1198-200. [PMID: 23622658 DOI: 10.1016/j.transproceed.2012.10.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
227 Ashokkumar C, Ganguly B, Townsend R, White J, Levy S, Moritz M, Mazariegos G, Sun Q, Sindhi R. Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens. Sci Rep 2015;5:15218. [PMID: 26472085 DOI: 10.1038/srep15218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
228 Takada Y, Kaido T, Asonuma K, Sakurai H, Kubo S, Kiuchi T, Inomata Y, Isaji S, Tsumura H, Teramukai S. Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation. Liver Transpl. 2013;19:896-906. [PMID: 23696054 DOI: 10.1002/lt.23679] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
229 Fayek SA. The value of C4d deposit in post liver transplant liver biopsies. Transpl Immunol. 2012;27:166-170. [PMID: 22975227 DOI: 10.1016/j.trim.2012.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
230 Di Maira T, Sapisochin G, Lilly L, Fonés V, Berenguer M. Posttransplant Calcineurin Inhibitors Levels and Intrapatient Variability Are Not Associated With Long-term Outcomes Following Liver Transplantation. Transplantation 2020;104:1201-9. [PMID: 31609904 DOI: 10.1097/TP.0000000000002987] [Reference Citation Analysis]
231 Lovell MO, Speeg KV, Halff GA, Molina DK, Sharkey FE. Acute hepatic allograft rejection: A comparison of patients with and without centrilobular alterations during first rejection episode: Centrilobular Hepatic Allograft Rejection. Liver Transpl 2004;10:369-73. [DOI: 10.1002/lt.20094] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
232 Monti L, Salsano M, Candusso M, Avolio AW, Soglia G, Marino M, Francalanci P, Spada M, Toma P. Diagnosis of Acute Rejection of Liver Grafts in Young Children Using Acoustic Radiation Force Impulse Imaging. AJR Am J Roentgenol 2020;215:1229-37. [PMID: 32877250 DOI: 10.2214/AJR.19.22057] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Adeyi OA. Acute cellular rejection in intra-abdominal solid organ allografts – immunology under the light microscope. Diagnostic Histopathology 2012;18:297-306. [DOI: 10.1016/j.mpdhp.2012.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
234 Mücke VT, Gerharz J, Jakobi K, Thomas D, Ferreirós Bouzas N, Mücke MM, Trötschler S, Weiler N, Welker MW, Zeuzem S, Pfeilschifter J, Grammatikos G. Low Serum Levels of (Dihydro-)Ceramides Reflect Liver Graft Dysfunction in a Real-World Cohort of Patients Post Liver Transplantation. Int J Mol Sci 2018;19:E991. [PMID: 29587453 DOI: 10.3390/ijms19040991] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
235 Maciel NB, Schwambach KH, Blatt CR. LIVER TRANSPLANTATION: TACROLIMUS BLOOD LEVELS VARIATION AND SURVIVAL, REJECTION AND DEATH OUTCOMES. Arq Gastroenterol 2021;58:370-6. [PMID: 34705973 DOI: 10.1590/S0004-2803.202100000-62] [Reference Citation Analysis]
236 Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2008;14:245-251. [PMID: 18236405 DOI: 10.1002/lt.21394] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 6.1] [Reference Citation Analysis]
237 Bitetto D, Fabris C, Falleti E, Fornasiere E, Fumolo E, Fontanini E, Cussigh A, Occhino G, Baccarani U, Pirisi M. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int. 2010;30:417-444. [PMID: 19849776 DOI: 10.1111/j.1478-3231.2009.02154.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
238 Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Uemoto S, Manabe T. Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome. Transpl Int. 2009;22:303-312. [PMID: 19040488 DOI: 10.1111/j.1432-2277.2008.00803.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
239 Liu YN, Wei JM, Qiao JC, Zhu MW. Effects of omega-3 fatty acid transfusion on acute rejection in rat liver transplantation. Shijie Huaren Xiaohua Zazhi 2009; 17(16): 1609-1613 [DOI: 10.11569/wcjd.v17.i16.1609] [Reference Citation Analysis]
240 Nemes B, Polak W, Ther G, Hendriks H, Kóbori L, Porte RJ, Sárváry E, de Jong KP, Doros A, Gerlei Z, van den Berg AP, Fehérvári I, Görög D, Peeters PM, Járay J, Slooff MJ. Analysis of differences in outcome of two European liver transplant centers. Transpl Int 2006;19:372-80. [PMID: 16623872 DOI: 10.1111/j.1432-2277.2006.00287.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
241 Ringe B, Braun F, Schütz E, Füzesi L, Lorf T, Canelo R, Oellerich M, Ramadori G. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation. 2001;71:508-515. [PMID: 11258429 DOI: 10.1097/00007890-200102270-00005] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 3.4] [Reference Citation Analysis]
242 Wiesner RH, Fung JJ. Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl. 2011;17 Suppl 3:S1-S9. [PMID: 21850697 DOI: 10.1002/lt.22410] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
243 De Simone P, Carrai P, Precisi A, Petruccelli S, Baldoni L, Balzano E, Ducci J, Caneschi F, Coletti L, Campani D. Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function. Transpl Int. 2009;22:279-286. [PMID: 19054383 DOI: 10.1111/j.1432-2277.2008.00768.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
244 Sugimoto H, Kato K, Hirota M, Takeda S, Kamei H, Nakamura T, Kiuchi T, Nakao A. Serial measurement of Doppler hepatic hemodynamic parameters for the diagnosis of acute rejection after live donor liver transplantation. Liver Transpl 2009;15:1119-25. [DOI: 10.1002/lt.21777] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
245 Bartlett AS, Ramadas R, Furness S, Gane E, McCall JL. The natural history of acute histologic rejection without biochemical graft dysfunction in orthotopic liver transplantation: a systematic review. Liver Transpl. 2002;8:1147-1153. [PMID: 12474154 DOI: 10.1053/jlts.2002.36240] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
246 Bradley BA. Rejection and recipient age. Transpl Immunol. 2002;10:125-132. [PMID: 12216942 DOI: 10.1016/s0966-3274(02)00058-8] [Cited by in Crossref: 68] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
247 Wahab MA, Abdel-Khalek EE, Elshoubary M, Yassen AM, Salah T, Sultan AM, Fathy O, Elmorshedi M, Shiha U, Elsadany M, Adly R, Samy M, Shehta A. Predictive Factors of De Novo Malignancies After Living-Donor Liver Transplantation: A Single-Center Experience. Transplant Proc 2021;53:636-44. [PMID: 33549346 DOI: 10.1016/j.transproceed.2021.01.033] [Reference Citation Analysis]
248 Jiang M, Han D. Auxiliary liver-heart transplantation in the rat: a new microsurgical model inducing tolerance. Transplantation Proceedings 2004;36:1607-9. [DOI: 10.1016/j.transproceed.2004.04.073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
249 Ma B, Yang JY, Song WJ, Ding R, Zhang ZC, Ji HC, Zhang X, Wang JL, Yang XS, Tao KS, Dou KF, Li X. Combining Exosomes Derived from Immature DCs with Donor Antigen-Specific Treg Cells Induces Tolerance in a Rat Liver Allograft Model. Sci Rep 2016;6:32971. [PMID: 27640806 DOI: 10.1038/srep32971] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
250 Dahmen U, Dirsch O, Li J, Fiedle M, Lu M, Rispeter K, Picucci M, Broelsch CE, Roggendorf M. Adoptive transfer of immunity: a new strategy to interfere with severe hepatitis virus reinfection after woodchuck liver transplantation. Transplantation. 2004;77:965-972. [PMID: 15087755 DOI: 10.1097/01.tp.0000113804.35096.8e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
251 Coffin CS, Burak KW, Hart J, Gao ZH. The impact of pathologist experience on liver transplant biopsy interpretation. Mod Pathol 2006;19:832-8. [PMID: 16575397 DOI: 10.1038/modpathol.3800605] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
252 Song DE, Jung D, Hwang S, Park B, Yu E. Characterization of Histopathological Features that Differentiate Hepatitis B Virus Infection from Acute Cellular Rejection. Korean J Pathol 2009;43:535. [DOI: 10.4132/koreanjpathol.2009.43.6.535] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
253 Miyagawa-Hayashino A, Tsuruyama T, Egawa H, Haga H, Sakashita H, Okuno T, Toyokuni S, Tamaki K, Yamabe H, Manabe T. FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol. 2007;171:1499-1508. [PMID: 17823283 DOI: 10.2353/ajpath.2007.070027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
254 Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, Mills AS, Contos MJ, Coterell A, Maluf D. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transpl. 2007;13:975-983. [PMID: 17600360 DOI: 10.1002/lt.21117] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 7.1] [Reference Citation Analysis]
255 Crespo G, Castro-Narro G, García-Juárez I, Benítez C, Ruiz P, Sastre L, Colmenero J, Miquel R, Sánchez-Fueyo A, Forns X. Usefulness of liver stiffness measurement during acute cellular rejection in liver transplantation. Liver Transpl. 2016;22:298-304. [PMID: 26609794 DOI: 10.1002/lt.24376] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
256 Dahmen U, Li J, Dirsch O, Gu YL, Polywka S, Doebel L, Shen K, Broelsch CE. Adoptive transfer of donor-derived immunity by liver transplantation: a potential avenue to prevent hepatitis B virus reinfection. J Viral Hepat. 2003;10:31-36. [PMID: 12558909 DOI: 10.1046/j.1365-2893.2003.00391.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
257 Toby TK, Abecassis M, Kim K, Thomas PM, Fellers RT, LeDuc RD, Kelleher NL, Demetris J, Levitsky J. Proteoforms in Peripheral Blood Mononuclear Cells as Novel Rejection Biomarkers in Liver Transplant Recipients. Am J Transplant 2017;17:2458-67. [PMID: 28510335 DOI: 10.1111/ajt.14359] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
258 Sergi C, Arnold JC, Rau W, Otto HF, Hofmann WJ. Single nucleotide insertion in the 5'-untranslated region of hepatitis C virus with clearance of the viral RNA in a liver transplant recipient during acute hepatitis B virus superinfection. Liver 2002;22:79-82. [PMID: 11906622 DOI: 10.1046/j.0106-9543.2001.00001.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
259 Lee SJ, Kim KW, Kim JH, Kim SY, Lee JS, Kim HJ, Jung D, Song G, Hwang S, Yu ES, Lee J, Lee S. Doppler Sonography of Patients With and Without Acute Cellular Rejection After Right-Lobe Living Donor Liver Transplantation. Journal of Ultrasound in Medicine 2012;31:845-51. [DOI: 10.7863/jum.2012.31.6.845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
260 Morioka D, Egawa H, Kasahara M, Jo T, Sakamoto S, Ogura Y, Haga H, Takada Y, Shimada H, Tanaka K. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl. 2007;13:80-90. [PMID: 16964594 DOI: 10.1002/lt.20856] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
261 Grassi A, Quarneti C, Ravaioli M, Bianchini F, Susca M, D’Errico A, Piscaglia F, Tamè MR, Andreone P, Grazi G. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C. Liver Transpl. 2006;12:1673-1681. [PMID: 17031825 DOI: 10.1002/lt.20882] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
262 Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med 2013;210:2223-37. [PMID: 24081947 DOI: 10.1084/jem.20131219] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
263 Nakazawa Y, Jonsson JR, Walker NI, Kerlin P, Steadman C, Lynch SV, Strong RW, Clouston AD. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection: Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection. Hepatology 2000;32:1240-7. [DOI: 10.1053/jhep.2000.20350] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
264 Murakawa Y, Miyagawa-hayashino A, Ogura Y, Egawa H, Okamoto S, Soejima Y, Kurosawa M, Sumiyoshi S, Uemoto S, Haga H. Liver transplantation for severe hepatitis in patients with common variable immunodeficiency: Hepatic failure in immunodeficiency. Pediatric Transplantation 2012;16:E210-6. [DOI: 10.1111/j.1399-3046.2011.01545.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
265 Hautz T, Brandacher G, Zelger B, Gorantla VS, Lee AW, Pratschke J, Schneeberger S. Immunologic aspects and rejection in solid organ versus reconstructive transplantation. Transplant Proc. 2010;42:3347-3353. [PMID: 21094778 DOI: 10.1016/j.transproceed.2010.09.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
266 Drebber U, Torbenson M, Wedemeyer I, Dienes H. Aktuelle Aspekte zur Histopathologie im Rahmen der Lebertransplantation. Pathologe 2011;32:113-23. [DOI: 10.1007/s00292-010-1405-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
267 Leung KK, Deeb M, Fischer SE, Gulamhusein A. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Semin Liver Dis 2021;41:409-20. [PMID: 34182588 DOI: 10.1055/s-0041-1730950] [Reference Citation Analysis]
268 Liu Z, Yu X, Ren W, Zhang M, Wang Ho, Sun Y, Jin L, Wang F, Shi M. CD152 and PD-1 down-regulation on CD8 T cells is associated with human acute liver allograft rejection. Transplant Proc 2014;46:3511-4. [PMID: 25498082 DOI: 10.1016/j.transproceed.2014.06.079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
269 Tamura A, Li XK, Funeshima N, Enosawa S, Amemiya H, Kitajima M, Suzuki S. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. Surgery. 2000;127:47-54. [PMID: 10660758 DOI: 10.1067/msy.2000.100884] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
270 Barbetta A, Meeberg G, Rocque B, Barhouma S, Weaver C, Gilmour S, Faytrouni F, Guttman O, Zielsdorf S, Etesami K, Kwon Y, Yanni G, Campbell P, Shapiro J, Emamaullee J. Immunologic benefits of maternal living donor allografts in pediatric liver transplantation: fewer rejection episodes and no evidence of de novo allosensitization. Pediatr Transplant 2021;:e14197. [PMID: 34806273 DOI: 10.1111/petr.14197] [Reference Citation Analysis]
271 Henkel SAF, Salgado CM, Reyes-Mugica M, Soltys KA, Strauss K, Mazariegos GV, Squires RH, McKiernan PJ, Zhang X, Squires JE. Long-term liver transplant outcomes for progressive familial intrahepatic cholestasis type 1: The Pittsburgh experience. Pediatr Transplant 2021;:e14108. [PMID: 34339082 DOI: 10.1111/petr.14108] [Reference Citation Analysis]
272 Hirata Y, Sanada Y, Urahashi T, Ihara Y, Yamada N, Okada N, Katano T, Otomo S, Ushijima K, Mizuta K. Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience. Transplant Proc 2018;50:60-5. [PMID: 29407332 DOI: 10.1016/j.transproceed.2017.11.008] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
273 Walter T, Dumortier J, Guillaud O, Hervieu V, Scoazec JY, Boillot O. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center. Liver Transpl. 2007;13:294-301. [PMID: 17256784 DOI: 10.1002/lt.21000] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
274 Mandal S, Miraglia R, Maruzzelli L, Liotta R, Tuzzolino F, Spada M, Riva S, Luca A. US-guided percutaneous liver biopsy in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 2014;58:756-61. [PMID: 24509302 DOI: 10.1097/MPG.0000000000000328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
275 Hashimoto M, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Bloodstream infection after living donor liver transplantation. Scand J Infect Dis. 2008;40:509-516. [PMID: 18584539 DOI: 10.1080/00365540701824116] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
276 Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, Everhart J, Detre KM. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology. 1998;28:638-645. [PMID: 9731552 DOI: 10.1002/hep.510280306] [Cited by in Crossref: 360] [Cited by in F6Publishing: 289] [Article Influence: 15.0] [Reference Citation Analysis]
277 Rostved AA, Sassi M, Kurtzhals JA, Sørensen SS, Rasmussen A, Ross C, Gogineni E, Huber C, Kutty G, Kovacs JA, Helweg-Larsen J. Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii. Transplantation 2013;96:834-42. [PMID: 23903011 DOI: 10.1097/TP.0b013e3182a1618c] [Cited by in Crossref: 45] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
278 Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K. Clinical Outcomes of Living Donor Liver Transplantation for Hepatitis C Virus (HCV)-Positive Patients: . Transplantation 2006;81:350-4. [DOI: 10.1097/01.tp.0000197554.16093.d1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
279 Tzakis AG, Tryphonopoulos P, Kato T, Nishida S, Levi DM, Madariaga JR, Gaynor JJ, De Faria W, Regev A, Esquenazi V, Weppler D, Ruiz P, Miller J. PRELIMINARY EXPERIENCE WITH ALEMTUZUMAB (CAMPATH-1H) AND LOW-DOSE TACROLIMUS IMMUNOSUPPRESSION IN ADULT LIVER TRANSPLANTATION: . Transplantation 2004;77:1209-14. [DOI: 10.1097/01.tp.0000116562.15920.43] [Cited by in Crossref: 92] [Cited by in F6Publishing: 20] [Article Influence: 5.1] [Reference Citation Analysis]
280 Volpin R, Angeli P, Galioto A, Fasolato S, Neri D, Barbazza F, Merenda R, Del Piccolo F, Strazzabosco M, Casagrande F. Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial. Liver Transpl. 2002;8:527-534. [PMID: 12037783 DOI: 10.1053/jlts.2002.33456] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
281 Sun X, Gong ZJ, Wang ZW, Li T, Zhang JY, Sun HC, Liu S, Huang L, Huang C, Peng ZH. IDO-competent-DCs induced by IFN-γ attenuate acute rejection in rat liver transplantation. J Clin Immunol 2012;32:837-47. [PMID: 22454246 DOI: 10.1007/s10875-012-9681-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
282 Sun L, Shi T, Qiao H, Jiang X, Jiang H, Krissansen GW, Sun X. Hepatic overexpression of heme oxygenase-1 improves liver allograft survival by expanding T regulatory cells. J Surg Res. 2011;166:e187-e194. [PMID: 21227452 DOI: 10.1016/j.jss.2010.11.917] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
283 Figueiredo AJ, Cunha MX, Mota AF, Furtado AL. Histological alterations found in the ureter during organ preservation and early phases of renal transplantation. Transplant Proc 2005;37:2743-5. [PMID: 16182797 DOI: 10.1016/j.transproceed.2005.05.047] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
284 Schlegel A, Kron P, Graf R, Clavien PA, Dutkowski P. Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. Ann Surg. 2014;260:931-937; discussion 937-938. [PMID: 25243553 DOI: 10.1097/sla.0000000000000941] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 8.9] [Reference Citation Analysis]
285 Bu X, Zheng Z, Yu Y, Zeng L, Jiang Y. Significance of C4d deposition in the diagnosis of rejection after liver transplantation. Transplant Proc. 2006;38:1418-1421. [PMID: 16797320 DOI: 10.1016/j.transproceed.2006.03.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
286 Bilezikçi B, Demirhan B, Şar A, Arat Z, Karakayalı H, Haberal M. Hepatic Stellate Cells in Biopsies From Liver Allografts With Acute Rejection. Transplantation Proceedings 2006;38:589-93. [DOI: 10.1016/j.transproceed.2005.12.096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
287 Kunugi S, Shimizu A, Ishii E, Kuwahara N, Arai T, Kataoka M, Masuda Y, Nagasaka S, Fukuda Y. The Pathological Characteristics of Acute Antibody-Mediated Rejection in DA-to-Lewis Rat Orthotopic Liver Transplantation. Transplantation Proceedings 2011;43:2737-40. [DOI: 10.1016/j.transproceed.2011.04.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
288 Lautenschlager I, Linnavuori K, Höckerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 2000;69:2561-6. [PMID: 10910277 DOI: 10.1097/00007890-200006270-00015] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 3.7] [Reference Citation Analysis]
289 Shirabe K, Yoshimatsu M, Motomura T, Takeishi K, Toshima T, Muto J, Matono R, Taketomi A, Uchiyama H, Maehara Y. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transpl. 2011;17:1073-1080. [PMID: 21542128 DOI: 10.1002/lt.22324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
290 Satapathy SK, Sclair S, Fiel MI, Del Rio Martin J, Schiano T. Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation. Hepatol Res. 2011;41:328-339. [PMID: 21426450 DOI: 10.1111/j.1872-034x.2011.00781.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
291 Jain A, Sharma R, Ryan C, Tsoulfas G, Orloff M, Abt P, Kashyap R, Batzold P, Sauberman L, Safadjou S. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction. Liver Transpl. 2008;14:202-209. [PMID: 18236395 DOI: 10.1002/lt.21348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
292 Sanz X, Pareja L, Rius A, Rodenas P, Abdón N, Gálvez J, Esteban L, Escribà JM, Borràs JM, Ribes J. Definition of a SNOMED CT pathology subset and microglossary, based on 1.17 million biological samples from the Catalan Pathology Registry. Journal of Biomedical Informatics 2018;78:167-76. [DOI: 10.1016/j.jbi.2017.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
293 Schotters FL, Beime J, Briem-Richter A, Binder T, Herden U, Grabhorn EF. Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation. World J Hepatol 2021; 13(6): 673-685 [PMID: 34239702 DOI: 10.4254/wjh.v13.i6.673] [Reference Citation Analysis]
294 Friman S, Tisone G, Nevens F, Lehner F, Santaniello W, Bechstein WO, Zhuvarel SV, Isoniemi H, Rummo OO, Klempnauer J, Anaokar S, Hurst M, Kazeem G, Undre N, Trunečka P. Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study. Transplant Direct 2021;7:e722. [PMID: 34263020 DOI: 10.1097/TXD.0000000000001166] [Reference Citation Analysis]
295 Wang F, Yamaguchi Y, Furuhashi T, Uchino S, Kihara S, Yamada S, Mori K, Ogawa M. Recipient Blood Pre-Transplant Transfusion Prolongs Hepatic Allograft Survival in Rats. Journal of Surgical Research 2006;135:52-60. [DOI: 10.1016/j.jss.2006.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
296 Kubota N, Sugitani M, Takano S, Sheikh A, Takayama T, Haga H, Tanaka K, Yamabe H. Correlation between acute rejection severity and CD8-positive T cells in living related liver transplantation. Transplant Immunology 2006;16:60-4. [DOI: 10.1016/j.trim.2006.03.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
297 Mergental H, Kriz J, Honsova E, Kudla M, Pantoflicek T, Tcherentsova K, Kocik M, Saudek F, Ryska M. Gemcitabine does not prevent acute rejection of the transplanted liver in rats. Transpl Int 2005;17:687-91. [DOI: 10.1007/s00147-004-0752-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
298 Cheng L, Zhao L, Li D, Liu Z, Chen G, Tian F, Li X, Wang S. Role of cholangiocyte bile Acid transporters in large bile duct injury after rat liver transplantation. Transplantation 2010;90:127-34. [PMID: 20548267 DOI: 10.1097/TP.0b013e3181e0deaf] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
299 Merli M, Gentili F, Giusto M, Attili AF, Corradini SG, Mennini G, Rossi M, Corsi A, Bianco P. Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis? Dig Liver Dis. 2009;41:345-349. [PMID: 19162574 DOI: 10.1016/j.dld.2008.09.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
300 Asaoka T, Marubashi S, Kobayashi S, Hama N, Eguchi H, Takeda Y, Tanemura M, Wada H, Takemasa I, Takahashi H, Ruiz P, Doki Y, Mori M, Nagano H. Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation. J Surg Res 2012;178:1003-14. [PMID: 22889476 DOI: 10.1016/j.jss.2012.07.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
301 Lautenschlager I, Härmä M, Höckerstedt K, Linnavuori K, Loginov R, Taskinen E. Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. J Hepatol. 2002;37:648-654. [PMID: 12399232 DOI: 10.1016/s0168-8278(02)00246-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
302 Tannapfel A, Kohlhaw K, Schwarz R, Wenzke M, Köckerling F, Ebelt J, Hauss J, Wittekind C. Apoptosis and the expression of Fas and Fas-ligand antigen after orthotopic liver transplantation. Transplantation Proceedings 1998;30:2358-9. [DOI: 10.1016/s0041-1345(98)00653-8] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
303 Hibi T, Tanabe M, Hoshino K, Fuchimoto Y, Kawachi S, Itano O, Obara H, Shinoda M, Shimojima N, Matsubara K, Morikawa Y, Kitagawa Y. Cyclosporine A-based immunotherapy in adult living donor liver transplantation: accurate and improved therapeutic drug monitoring by 4-hr intravenous infusion. Transplantation. 2011;92:100-105. [PMID: 21546866 DOI: 10.1097/tp.0b013e31821dcae3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
304 Mele TS, Kneteman NM, Zhu LF, Ramassar V, Urmson J, Halloran B, Churchill TA, Jewell L, Kane K, Halloran PF. IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts. Am J Transplant 2003;3:942-51. [PMID: 12859528 DOI: 10.1034/j.1600-6143.2003.00153.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
305 Boix F, Millan O, San Segundo D, Mancebo E, Rimola A, Fabrega E, Fortuna V, Mrowiec A, Castro-Panete MJ, Peña Jde L, Llorente S, Minguela A, Bolarin JM, Paz-Artal E, Lopez-Hoyos M, Brunet M, Muro M. High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients. Immunobiology 2016;221:595-603. [PMID: 26850323 DOI: 10.1016/j.imbio.2016.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
306 Dong JY, Yin H, Li RD, Ding GS, Fu ZR, Wu YM, Wang ZX. The relationship between adenosine triphosphate within CD4(+) T lymphocytes and acute rejection after liver transplantation. Clin Transplant 2011;25:E292-6. [PMID: 21470308 DOI: 10.1111/j.1399-0012.2011.01429.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
307 Hai Nam N, Taura K, Koyama Y, Nishio T, Yamamoto G, Uemoto Y, Kimura Y, Xuefeng L, Nakamura D, Yoshino K, Ogawa E, Okamoto T, Yoshizawa A, Seo S, Iwaisako K, Yoh T, Hata K, Masui T, Okajima H, Haga H, Uemoto S, Hatano E. Increased Expressions of Programmed Death Ligand 1 and Galectin 9 in Transplant Recipients Who Achieved Tolerance After Immunosuppression Withdrawal. Liver Transpl 2021. [PMID: 34655506 DOI: 10.1002/lt.26336] [Reference Citation Analysis]
308 Sung PS, Han JW, Seo C, Ahn J, Lee SK, Nam HC, Choi HJ, You YK, Jang JW, Choi JY, Yoon SK. Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant. Front Pharmacol 2021;12:685176. [PMID: 34326770 DOI: 10.3389/fphar.2021.685176] [Reference Citation Analysis]
309 Morita M, Fujino M, Jiang G, Kitazawa Y, Xie L, Azuma M, Yagita H, Nagao S, Sugioka A, Kurosawa Y, Takahara S, Fung J, Qian S, Lu L, Li XK. PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant 2010;10:40-6. [PMID: 19889124 DOI: 10.1111/j.1600-6143.2009.02859.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 5.7] [Reference Citation Analysis]
310 Dao M, Habès D, Taupin JL, Mussini C, Redon MJ, Suberbielle C, Jacquemin E, Gonzales E, Guettier C. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients. Liver Transpl 2018;24:897-907. [PMID: 29704327 DOI: 10.1002/lt.25187] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
311 Hashim M, Alsebaey A, Ragab A, Soliman HE, Waked I. Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study. Annals of Hepatology 2020;19:541-5. [DOI: 10.5604/01.3001.0012.2246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
312 Taubert R, Pischke S, Schlue J, Wedemeyer H, Noyan F, Heim A, Lehner F, Barg-hock H, Klempnauer J, Olek S, Manns MP, Hardtke-wolenski M, Jaeckel E. Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts: Treg Enrichment in Rejected Liver Allografts. American Journal of Transplantation 2012;12:3425-36. [DOI: 10.1111/j.1600-6143.2012.04264.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
313 Deng Y, Zhao L, Lu X. A multidrug cocktail approach attenuates ischemic-type biliary lesions in liver transplantation from non-heart-beating donors. Medical Hypotheses 2016;91:47-52. [DOI: 10.1016/j.mehy.2016.04.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
314 Krasinskas AM, Demetris AJ, Poterucha JJ, Abraham SC. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers. Liver Transpl 2008;14:625-32. [DOI: 10.1002/lt.21404] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
315 Chae MS, Lee N, Choi HJ, Chung HS, Park CS, Lee J, Choi JH, Hong SH. Comparison of Liver Graft Regeneration Between ABO-Compatible and ABO-Incompatible Living Donor Liver Transplantation: A Propensity Score Matching Analysis. Ann Transplant 2018;23:507-19. [PMID: 30050031 DOI: 10.12659/AOT.908787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
316 Rock NM, Anghileri E, Cousin VL, Petit LM, McLin VA. Vitamin D Insufficiency Prior to Paediatric Liver Transplantation Is Associated with Early T-Cell Mediated Rejection. Children (Basel) 2021;8:612. [PMID: 34356591 DOI: 10.3390/children8070612] [Reference Citation Analysis]
317 Longerich T, Flechtenmacher C, Schirmacher P. [Quality and quantity in hepatopathology. Diagnostic and clinically relevant grading for non-tumourous liver diseases]. Pathologe 2008;29:15-26. [PMID: 18210114 DOI: 10.1007/s00292-007-0963-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
318 Habib S, Malik S, Fu B, Chang J, Nalesnik M, Humar A, Shaikh OS. Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral Therapy. Gastroenterology Res 2015;8:281-90. [PMID: 27785310 DOI: 10.14740/gr694w] [Reference Citation Analysis]
319 Idilman R, Erden E, Kuzu I, Ersoz S, Karayalcin S. The fate of recipient-derived hepatocytes in sex-mismatched liver allograft following liver transplantation. Clin Transplant. 2007;21:202-206. [PMID: 17425745 DOI: 10.1111/j.1399-0012.2006.00623.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
320 Takahashi H, Kato T, Delacruz V, Nishida S, Selvaggi G, Weppler D, Island E, Moon JI, Levi DM, Tzakis AG, Ruiz P. Analysis of Acute and Chronic Rejection in Multiple Organ Allografts From Retransplantation and Autopsy Cases of Multivisceral Transplantation. Transplantation 2008;85:1610-6. [DOI: 10.1097/tp.0b013e318174d857] [Cited by in Crossref: 18] [Article Influence: 1.3] [Reference Citation Analysis]
321 Zhang J, Yamaguchi Y, Mori K, Okabe K, Hidaka H, Ohshiro H, Uchino S, Ishihara K, Furuhashi T, Yamada S, Ogawa M. A Serine Protease Inhibitor, N-α-Tosyl-l-lysine Chloromethyl Ketone, Prolongs Rat Hepatic Allograft Survival. Journal of Surgical Research 2001;96:296-303. [DOI: 10.1006/jsre.2000.6065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
322 Sedivy R, Gollackner B, Casati B, Mittlböck M, Kaserer K, Steininger R, Wrba F. Apoptotic hepatocytes in rejection and vascular occlusion in liver allograft specimens. Histopathology 2002;32:503-7. [DOI: 10.1046/j.1365-2559.1998.00427.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
323 Farid WRR, Pan Q, van der Meer AJP, de Ruiter PE, Ramakrishnaiah V, de Jonge J, Kwekkeboom J, Janssen HLA, Metselaar HJ, Tilanus HW, Kazemier G, van der Laan LJ. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012;18:290-7. [DOI: 10.1002/lt.22438] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 13.2] [Reference Citation Analysis]
324 Andreu H, Rimola A, Bruguera M, Navasa M, Cirera I, Grande L, Garcia-valdecasas J, Rodes J. Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy: . Transplantation 2002;73:1936-43. [DOI: 10.1097/00007890-200206270-00016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
325 Souza P, Prihoda TJ, Hoyumpa AM, Sharkey FE. Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C. Human Pathology 2009;40:92-7. [DOI: 10.1016/j.humpath.2008.06.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
326 Kwon J, Hanouneh I, Allende D, Yerian L, Diago T, Eghtesad B, Zein N. De Novo Autoimmune Hepatitis Following Liver Transplantation. Transplantation Proceedings 2018;50:1451-6. [DOI: 10.1016/j.transproceed.2018.02.066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
327 Ekong UD, McKiernan P, Martinez M, Lobritto S, Kelly D, Ng VL, Alonso EM, Avitzur Y. Long-term outcomes of de novo autoimmune hepatitis in pediatric liver transplant recipients. Pediatr Transplant. 2017;21. [PMID: 28556542 DOI: 10.1111/petr.12945] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
328 Yoshida O, Kimura S, Dou L, Matta BM, Yokota S, Ross MA, Geller DA, Thomson AW. DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance. Am J Transplant. 2014;14:1791-1805. [PMID: 24935196 DOI: 10.1111/ajt.12757] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
329 Kontorinis N, Agarwal K, Elhajj N, Fiel MI, Schiano TD. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl. 2006;12:827-830. [PMID: 16628699 DOI: 10.1002/lt.20706] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
330 Demetris AJ, Lunz JG 3rd, Randhawa P, Wu T, Nalesnik M, Thomson AW. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective. Transpl Int 2009;22:120-41. [PMID: 18980624 DOI: 10.1111/j.1432-2277.2008.00765.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
331 Chen Q, Zhou R, Zhang Y, Zhu S, Xiao C, Gong J, Li K, Tang H, Sun C, Zhang J. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p. Transpl Immunol 2018;51:21-9. [PMID: 30092337 DOI: 10.1016/j.trim.2018.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
332 Dʼantiga L, Dhawan A, Portmann B, Francavilla R, Rela M, Heaton N, Mieli-vergani G. LATE CELLULAR REJECTION IN PAEDIATRIC LIVER TRANSPLANTATION: AETIOLOGY AND OUTCOME. Transplantation 2002;73:80-4. [DOI: 10.1097/00007890-200201150-00015] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
333 Peeters PM, Sieders E, vd Heuvel M, Bijleveld CM, de Jong KP, TenVergert EM, Slooff MJ, Gouw AS. Predictive factors for portal fibrosis in pediatric liver transplant recipients. Transplantation. 2000;70:1581-1587. [PMID: 11152219 DOI: 10.1097/00007890-200012150-00008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
334 Hanouneh IA, Zein NN, Lopez R, Yerian L, Fung J, Eghtesad B. IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimens. Int J Organ Transplant Med. 2010;1:7-14. [PMID: 25013557 DOI: 10.1016/s0016-5085(08)63573-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
335 Jin H, Dahmen U, Liu A, Huang H, Gu Y, Dirsch O. Prolonged Cold Ischemia Does Not Trigger Lethal Rejection or Accelerate the Acute Rejection in Two Allogeneic Rat Liver Transplantation Models. Journal of Surgical Research 2012;175:322-32. [DOI: 10.1016/j.jss.2011.03.078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
336 Bernstein DL, Lobritto S, Iuga A, Remotti H, Schiano T, Fiel MI, Balwani M. Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients. Mol Genet Metab. 2018;124:11-19. [PMID: 29655841 DOI: 10.1016/j.ymgme.2018.03.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
337 Walter T, Dumortier J, Guillaud O, Hervieu V, Paliard P, Scoazec JY, Boillot O. Rejection under alpha interferon therapy in liver transplant recipients. Am J Transplant. 2007;7:177-184. [PMID: 17227566 DOI: 10.1111/j.1600-6143.2006.01590.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
338 Hamdani S, Thiolat A, Naserian S, Grondin C, Moutereau S, Hulin A, Calderaro J, Grimbert P, Cohen JL, Azoulay D, Pilon C. Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats. World J Gastroenterol 2017; 23(38): 6962-6972 [PMID: 29097869 DOI: 10.3748/wjg.v23.i38.6962] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
339 Baba HA, Theurer S, Canbay A, Schwertheim S, Lainka E, Kälsch J, Wohlschläger J. [Liver transplantation. Current aspects of pretransplantation diagnosis and rejection]. Pathologe 2020;41:505-14. [PMID: 32776226 DOI: 10.1007/s00292-020-00813-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
340 Shi Y, Hu S, Song Q, Yu S, Zhou X, Yin J, Qin L, Qian H. Gene silencing of 4-1BB by RNA interference inhibits acute rejection in rats with liver transplantation. Biomed Res Int 2013;2013:192738. [PMID: 23484089 DOI: 10.1155/2013/192738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
341 Linder KE, Baker WL, Rochon C, May ST, Sheiner PA, Martin ST. Evaluation of Posttransplantation Diabetes Mellitus After Liver Transplantation: Assessment of Insulin Administration as a Risk Factor. Ann Pharmacother. 2016;50:369-375. [PMID: 26847860 DOI: 10.1177/1060028015627662] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
342 Curry MP. Systematic investigation of elevated transaminases during the third posttransplant month. Liver Transpl. 2013;19 Suppl 2:S17-S22. [PMID: 24019297 DOI: 10.1002/lt.23737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
343 Trunečka P, Boillot O, Seehofer D, Pinna AD, Fischer L, Ericzon BG, Troisi RI, Baccarani U, Ortiz de Urbina J, Wall W; Tacrolimus Prolonged Release Liver Study Group. Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. Am J Transplant 2010;10:2313-23. [PMID: 20840481 DOI: 10.1111/j.1600-6143.2010.03255.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
344 Prieto M, Valdivieso A, Gastaca M, Pijoan JI, Ruiz P, Ventoso A, Palomares I, Ortiz de Urbina J. Hepaticojejunostomy in Orthotopic Liver Transplant: A Retrospective Case Control Study. Transplant Proc 2019;51:58-61. [PMID: 30661893 DOI: 10.1016/j.transproceed.2018.03.135] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
345 de la Peña-moral JM, Pons JA, Tome S, Gude F, Miras M, Bermejo J, Ramirez P, Berenguer M, Varo E, Forteza J, Parrilla P. Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach: Acute rejection vs recurrent HCV after LT. Hepatol Res 2015;45:423-31. [DOI: 10.1111/hepr.12369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
346 Klintmalm GB, Washburn WK, Rudich SM, Heffron TG, Teperman LW, Fasola C, Eckhoff DE, Netto GJ, Katz E. Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study. Liver Transpl. 2007;13:1521-1531. [PMID: 17969201 DOI: 10.1002/lt.21182] [Cited by in Crossref: 107] [Cited by in F6Publishing: 86] [Article Influence: 7.6] [Reference Citation Analysis]
347 Khan AW, Fuller BJ, Shah SR, Davidson BR, Rolles K. A prospective randomized trial of N-acetyl cysteine administration during cold preservation of the donor liver for transplantation. Annals of Hepatology 2005;4:121-6. [DOI: 10.1016/s1665-2681(19)32075-7] [Cited by in Crossref: 22] [Article Influence: 1.3] [Reference Citation Analysis]
348 Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Cheng B, Bodenheimer H, Thung SN, Chung RT, Schwartz ME, Bodian C, Branch AD. Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology 2005;42:1420-8. [DOI: 10.1002/hep.20947] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
349 Adams DH, Sanchez-Fueyo A, Samuel D. From immunosuppression to tolerance. J Hepatol. 2015;62:S170-S185. [PMID: 25920086 DOI: 10.1016/j.jhep.2015.02.042] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 13.8] [Reference Citation Analysis]
350 Karimi MH, Motazedian M, Abedi F, Yaghobi R, Geramizadeh B, Nikeghbalian S. Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients. Gene 2012;504:127-32. [DOI: 10.1016/j.gene.2012.04.055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
351 Figueiredo AJ, Cunha MX, Mota AF, Furtado AL. Ureteric lesions detected in normally functioning kidney allografts: risk factors and clinical implications. Transplant Proc 2005;37:2762-4. [PMID: 16182804 DOI: 10.1016/j.transproceed.2005.05.006] [Reference Citation Analysis]
352 Millán O, Ruiz P, Fortuna V, Navasa M, Brunet M. Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients. Liver Int 2020;40:931-46. [PMID: 31883422 DOI: 10.1111/liv.14339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Protzer U, Böhm F, Longerich T, Seebach J, Heidary Navid M, Friemel J, Marques-Maggio E, Bawohl M, Heikenwalder M, Schirmacher P, Dutkowski P, Clavien PA, Schemmer P, Schnitzler P, Gotthardt D, Müllhaupt B, Weber A. Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantation. Mod Pathol 2015;28:523-32. [PMID: 25412844 DOI: 10.1038/modpathol.2014.147] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
354 Komatsu H, Inui A, Fujisawa T, Sogo T, Miyagawa Y, Inui M, Uemoto S, Inomata Y, Tanaka K. Severe late acute allograft rejection in a child after living-related auxiliary partial orthotopic liver transplantation for ornithine transcarbamylase deficiency: Late acute allograft rejection after auxillary liver transplantation. J Clin Transplant 1999;13:300-4. [DOI: 10.1034/j.1399-0012.1999.130404.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
355 Egawa H, Uemoto S, Inomata Y, Shapiro AM, Asonuma K, Kiuchi T, Okajima H, Itou K, Tanaka K. Biliary complications in pediatric living related liver transplantation. Surgery. 1998;124:901-910. [PMID: 9823405 DOI: 10.1016/s0039-6060(98)70015-7] [Cited by in Crossref: 100] [Cited by in F6Publishing: 1] [Article Influence: 4.2] [Reference Citation Analysis]
356 Masuda Y, Nakazawa Y, Matsuda K, Sano K, Mita A, Ohno Y, Urata K, Ikegami T, Miwa S, Miyagawa S. Clinicopathological features of hepatitis C virus disease after living donor liver transplantation: relationship with in situ hybridisation data. Pathology 2011;43:156-60. [PMID: 21233678 DOI: 10.1097/PAT.0b013e32834317ed] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
357 Dopazo C, Bilbao I, Castells LL, Sapisochin G, Moreiras C, Campos-Varela I, Echeverri J, Caralt M, Lázaro JL, Charco R. Analysis of adult 20-year survivors after liver transplantation. Hepatol Int. 2015;9:461-470. [PMID: 25788182 DOI: 10.1007/s12072-014-9577-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
358 Yoshida EM, Marotta PJ, Greig PD, Kneteman NM, Marleau D, Cantarovich M, Peltekian KM, Lilly LB, Scudamore CH, Bain VG, Wall WJ, Roy A, Balshaw RF, Barkun JS. Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial. Liver Transpl 2005;11:1064-72. [DOI: 10.1002/lt.20490] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 6.1] [Reference Citation Analysis]
359 Norero B, Serrano CA, Sanchez-fueyo A, Duarte I, Torres J, Ocquetau M, Barrera F, Arrese M, Soza A, Benítez C. Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key. Annals of Hepatology 2017;16:94-106. [DOI: 10.5604/16652681.1226820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
360 Ueda D, Hori T, Nguyen JH, Uemoto S. Muromonab-CD3 therapy for refractory rejections after liver transplantation: a single-center experience during two decades in Japan. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:885-91. [DOI: 10.1007/s00534-010-0288-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
361 Hübscher SG. What is the long-term outcome of the liver allograft? J Hepatol. 2011;55:702-717. [PMID: 21426919 DOI: 10.1016/j.jhep.2011.03.005] [Cited by in Crossref: 93] [Cited by in F6Publishing: 74] [Article Influence: 8.5] [Reference Citation Analysis]
362 Sun B, Gao J, Shi W, Guo Y, Fan J, Zhang J, Li X, Liu G. The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients. Pharmacogenomics 2019;20:447-56. [PMID: 30799725 DOI: 10.2217/pgs-2018-0198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
363 Fiel MI, Schiano T. Acute cellular rejection and its sequelae developing in a 42-year-old man after liver transplantation. Hepatology 2009;50:650-1. [PMID: 19642164 DOI: 10.1002/hep.23161] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
364 Nakazawa Y, Walker NI, Kerlin P, Steadman C, Lynch SV, Strong RW, Clouston AD. CLINICOPATHOLOGICAL ANALYSIS OF LIVER ALLOGRAFT BIOPSIES WITH LATE CENTRILOBULAR NECROSIS: A Comparative Study in 54 Patients. Transplantation. [DOI: 10.1097/00007890-200004270-00014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
365 González I, Lu H, Ritter JH, Maluf HM, Dehner LP, He M. Clinicopathologic characteristics of de novo nodular regenerative hyperplasia in pediatric liver transplant. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
366 Mukherjee S, Rogge J, Weaver L, Schafer D. De novo cryptogenic hepatitis after sustained eradication of hepatitis C following liver transplantation. Transplantation Proceedings 2004;36:1494-7. [DOI: 10.1016/j.transproceed.2004.05.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
367 Schirren CA, Zachoval R, Gerlach JT, Ulsenheimer A, Gruener NH, Diepolder HM, Baretton G, Schraut W, Rau H, Nitschko H, Pape GR, Jung M. Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination. Journal of Hepatology 2003;39:397-404. [DOI: 10.1016/s0168-8278(03)00266-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
368 Wu B, Song HL, Yang Y, Yin ML, Zhang BY, Cao Y, Dong C, Shen ZY. Improvement of Liver Transplantation Outcome by Heme Oxygenase-1-Transduced Bone Marrow Mesenchymal Stem Cells in Rats. Stem Cells Int. 2016;2016:9235073. [PMID: 26862332 DOI: 10.1155/2016/9235073] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
369 Borgogna C, Toniutto P, Smirne C, Azzimonti B, Rittà M, Avellini C, Fabris C, Landolfo S, Gariglio M, Pirisi M. Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts. Histopathology. 2009;54:837-846. [PMID: 19635103 DOI: 10.1111/j.1365-2559.2009.03311.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
370 Lerut J, Mathys J, Verbaandert C, Talpe S, Ciccarelli O, Lemaire J, Bonaccorsi-Riani E, Vanthuyne V, Hetsch N, Roggen F, Reyck CD, Goffette P, Latinne D, Orlando G, Rahier J, Sempoux C, Wallemacq P, Laterre PF, Gianello P. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. Ann Surg 2008;248:956-67. [PMID: 19092340 DOI: 10.1097/SLA.0b013e31819009c9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
371 Kim JM, Kwon CH, Joh JW, Sinn DH, Lee S, Choi GS, Lee SK. Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study. Liver Transpl. 2016;22:209-216. [PMID: 26360125 DOI: 10.1002/lt.24336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
372 Chaudhry S, Kato Y, Weiner J, Alonso-Guallart P, Baker S, Woodland DC 4th, Lefkowitch JH, Duran-Struuck R, Sondermeijer HP, Zitsman J, Sears ML, Wu A, Karolewski B, Houck PJ, Martinez M, Kato T, Sykes M, Griesemer AD. Transient-mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates. Transplantation 2020;104:1580-90. [PMID: 32732835 DOI: 10.1097/TP.0000000000003263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
373 Boix F, Legaz I, Minhas A, Alfaro R, Jiménez-Coll V, Mrowiec A, Martínez-Banaclocha H, Galián JA, Botella C, Moya-Quiles MR, Sanchez-Bueno F, Robles R, de la Peña-Moral J, Ramirez P, Pons JA, Minguela A, Muro M. Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients. Clin Exp Immunol 2021;203:315-28. [PMID: 33025622 DOI: 10.1111/cei.13533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
374 Saliba F, De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Jonas S, Sudan D, Fischer L, Duvoux C. Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant. 2013;13:1734-1745. [PMID: 23714399 DOI: 10.1111/ajt.12280] [Cited by in Crossref: 117] [Cited by in F6Publishing: 94] [Article Influence: 13.0] [Reference Citation Analysis]
375 Bahra M, Neumann UP, Jacob D, Langrehr JM, Berg T, Neuhaus R, Neuhaus P. Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy). Transplantation. 2007;83:351-353. [PMID: 17297412 DOI: 10.1097/01.tp.0000250575.92788.aa] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
376 Machicao VI, Srinivas TR, Hemming AW, Soldevila-Pico C, Firpi RJ, Reed AI, Morelli GJ, Nelson DR, Abdelmalek MF. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 2006;12:754-61. [PMID: 16528716 DOI: 10.1002/lt.20686] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
377 Yang F, Jiang Y, Cai QC, Zheng ZY, Song YN, Lv LZ. Expression and significance of RANTES in rejection of combined liver-kidney transplantation in rats. Shijie Huaren Xiaohua Zazhi 2008; 16(28): 3221-3224 [DOI: 10.11569/wcjd.v16.i28.3221] [Reference Citation Analysis]
378 De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Saliba F, Jonas S, Sudan D, Fung J, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Witte S, Jiang H, Hexham JM, Junge G;  H2304 Study Group. Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant. 2012;12:3008-3020. [PMID: 22882750 DOI: 10.1111/j.1600-6143.2012.04212.x] [Cited by in Crossref: 210] [Cited by in F6Publishing: 178] [Article Influence: 21.0] [Reference Citation Analysis]
379 Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011;17:641-649. [PMID: 21618684 DOI: 10.1002/lt.22258] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
380 Inui A, Sogo T, Komatsu H, Miyakawa H, Fujisawa T. Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation. Liver Transpl. 2005;11:504-507. [PMID: 15838910 DOI: 10.1002/lt.20404] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
381 González-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, Rosen CB, Wiesner RH. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl. 2001;7:302-310. [PMID: 11303289 DOI: 10.1053/jlts.2001.21449] [Cited by in Crossref: 142] [Cited by in F6Publishing: 109] [Article Influence: 6.8] [Reference Citation Analysis]
382 Gruener NH, Jung M, Ulsenheimer A, Gerlach JT, Zachoval R, Diepolder HM, Baretton G, Schauer R, Pape GR, Schirren CA. Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation. Liver Transpl 2004;10:1487-96. [DOI: 10.1002/lt.20300] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
383 Hasegawa T, Sasaki T, Kimura T, Oimatsu N, Okada A, Mushiake S, Hoshida Y, Dono K, Kato T. Marked hyperbilirubinemia caused by acute cellular rejection combined with preservation injury in an infant undergoing living-related liver transplantation. Pediatric Transplantation 2002;6:513-7. [DOI: 10.1034/j.1399-3046.2002.02008.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
384 Rodríguez-Perálvarez M, Germani G, Papastergiou V, Tsochatzis E, Thalassinos E, Luong TV, Rolando N, Dhillon AP, Patch D, O’Beirne J. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. J Hepatol. 2013;58:262-270. [PMID: 23023010 DOI: 10.1016/j.jhep.2012.09.019] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
385 Eurich D, Neumann UP, Boas-knoop S, Neuhaus R, Kiessling A, Yahyazadeh A, Trautwein C, Wasmuth H, Puhl G, Neuhaus P, Bahra M. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease: YKL-40-variants and liver transplantation. J Gastroenterol Hepatol 2013;28:153-60. [DOI: 10.1111/j.1440-1746.2012.07270.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
386 Wu H, Xu X, Li J, Gong J, Li M. TIM‑4 blockade of KCs combined with exogenous TGF‑β injection helps to reverse acute rejection and prolong the survival rate of mice receiving liver allografts. Int J Mol Med 2018;42:346-58. [PMID: 29620252 DOI: 10.3892/ijmm.2018.3606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
387 Wilson CH, Asher JF, Manas DM, Wilson CH. Immunosuppressive T cell antibodies for liver transplant recipients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007341] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
388 Fiel MI, Agarwal K, Stanca C, Elhajj N, Kontorinis N, Thung SN, Schiano TD. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl 2008;14:861-71. [DOI: 10.1002/lt.21447] [Cited by in Crossref: 93] [Cited by in F6Publishing: 68] [Article Influence: 6.6] [Reference Citation Analysis]
389 Bathgate AJ, Hynd P, Sommerville D, Hayes PC. The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg 1999;5:475-9. [PMID: 10545533 DOI: 10.1002/lt.500050608] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
390 Eurich D, Boas-Knoop S, Yahyazadeh A, Neuhaus R, Somasundaram R, Ruehl M, Puhl G, Neuhaus P, Neumann UP, Bahra M. Role of mannose-binding lectin-2 polymorphism in the development of acute cellular rejection after transplantation for hepatitis C virus-induced liver disease. Transpl Infect Dis 2012;14:488-95. [PMID: 22650645 DOI: 10.1111/j.1399-3062.2012.00747.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
391 Wang R, Shen Z, Yang L, Yin M, Zheng W, Wu B, Liu T, Song H. Protective effects of heme oxygenase-1-transduced bone marrow-derived mesenchymal stem cells on reduced‑size liver transplantation: Role of autophagy regulated by the ERK/mTOR signaling pathway. Int J Mol Med 2017;40:1537-48. [PMID: 28901391 DOI: 10.3892/ijmm.2017.3121] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
392 Pelletier SJ, Raymond DP, Crabtree TD, Iezzoni JC, Sawyer RG, Hahn YS, Pruett TL. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation. Hepatology 2000;32:375-81. [DOI: 10.1053/jhep.2000.9089] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
393 Usui M, Kuriyama N, Kisawada M, Hamada T, Mizuno S, Sakurai H, Tabata M, Imai H, Okamoto K, Uemoto S. Tissue factor expression demonstrates severe sinusoidal endothelial cell damage during rejection after living-donor liver transplantation. J Hepatobiliary Pancreat Surg. 2009;16:513-520. [PMID: 19370302 DOI: 10.1007/s00534-009-0095-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
394 Demetris A, Crawford JM, Minervini MI, Nalesnik M, Ochoa E, Randhawa P, Sasatomi E, Wu T. Transplantation Pathology of the Liver. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1169-229. [DOI: 10.1016/b978-141604059-0.50047-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
395 Dahmen U, Li J, Dirsch O, Fiedler M, Roggendorf M, Broelsch C. Establishment of liver transplantation in woodchuck. Transplantation Proceedings 2002;34:2314-5. [DOI: 10.1016/s0041-1345(02)03250-5] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
396 Drachenberg CB, Odorico J, Demetris AJ, Arend L, Bajema IM, Bruijn JA, Cantarovich D, Cathro HP, Chapman J, Dimosthenous K. Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant. 2008;8:1237-1249. [PMID: 18444939 DOI: 10.1111/j.1600-6143.2008.02212.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 82] [Article Influence: 8.6] [Reference Citation Analysis]
397 Wu Y, Tao Y, Liang L, Wang Y, Xu G, Qu H, Cheng Y, Liang T. Metabonomic Profile of Rats with Acute Liver Rejection. OMICS: A Journal of Integrative Biology 2009;13:81-91. [DOI: 10.1089/omi.2008.0061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
398 Dopazo C, Charco R, Caralt M, Pando E, Lázaro JL, Gómez-Gavara C, Castells L, Bilbao I. Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction. Can J Gastroenterol Hepatol 2018;2018:1672621. [PMID: 30186817 DOI: 10.1155/2018/1672621] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
399 Yi NJ, Suh KS, Cho JY, Kwon CH, Lee KW, Joh JW, Lee SK, Kim SI, Lee KU. Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2007;13:451-458. [PMID: 17318862 DOI: 10.1002/lt.21043] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
400 Paterno F, Shiller M, Tillery G, O'Leary JG, Susskind B, Trotter J, Klintmalm GB. Bortezomib for acute antibody-mediated rejection in liver transplantation. Am J Transplant 2012;12:2526-31. [PMID: 22681986 DOI: 10.1111/j.1600-6143.2012.04126.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.7] [Reference Citation Analysis]
401 Lee C, Eldeen F, Chan K, Wu T, Soong R, Wu T, Chou H, Lee W. Bortezomib Is Effective to Treat Acute Humoral Rejection After Liver Transplantation. Transplantation Proceedings 2012;44:529-31. [DOI: 10.1016/j.transproceed.2012.01.051] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
402 Zhang AB, Zheng SS, Jia CK, Wang Y. Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotoic liver transplantation. World J Gastroenterol 2003; 9(5): 1067-1071 [PMID: 12717858 DOI: 10.3748/wjg.v9.i5.1067] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
403 Hao C, Anwei M, Bing C, Baiyong S, Weixia Z, Chuan S, Erzhen C, Xiaxing D, Weihua Q, Weiping Y. Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: prediction of occurrence of leukopenia. Liver Transpl. 2008;14:1165-1173. [PMID: 18668650 DOI: 10.1002/lt.21600] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
404 Xu L, Ling J, Su C, Su YW, Xu Y, Jiang Z. Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries. Front Med (Lausanne) 2021;8:756435. [PMID: 34869457 DOI: 10.3389/fmed.2021.756435] [Reference Citation Analysis]
405 Sampaio AM, Guardia AC, Milan A, Sasaki AN, Andrade PD, Bonon SH, Stucchi RS, Botelho Costa SC, Boin IF. Co-infection and clinical impact of human herpesvirus 5 and 6 in liver transplantation. Transplant Proc. 2012;44:2455-2458. [PMID: 23026619 DOI: 10.1016/j.transproceed.2012.07.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
406 Chen X, Wang L, Deng Y, Li X, Li G, Zhou J, Cheng D, Yang Y, Yang Q, Chen G, Wang G. Inhibition of Autophagy Prolongs Recipient Survival Through Promoting CD8+ T Cell Apoptosis in a Rat Liver Transplantation Model. Front Immunol 2019;10:1356. [PMID: 31258533 DOI: 10.3389/fimmu.2019.01356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
407 Kehar M, Parekh RS, Stunguris J, De Angelis M, Van Roestel K, Ghanekar A, Cattral M, Fecteau A, Ling S, Kamath BM, Jones N, Avitzur Y, Grant D, Ng VL. Superior Outcomes and Reduced Wait Times in Pediatric Recipients of Living Donor Liver Transplantation. Transplant Direct 2019;5:e430. [PMID: 30882035 DOI: 10.1097/TXD.0000000000000865] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
408 Salah A, Fujimoto M, Yoshizawa A, Yurugi K, Miyagawa-Hayashino A, Sumiyoshi S, Minamiguchi S, Uemoto S, Maekawa T, Haga H. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation. Liver Transpl 2014;20:200-9. [PMID: 24470446 DOI: 10.1002/lt.23789] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
409 Sultani B, Marget M, Briem-Richter A, Herrmann J, Meisner S, Grabhorn EF, Ozga AK, Weidemann S, Herden U, Fischer L, Sterneck M. Presence of donor specific HLA class 2 antibodies (DSA class 2) is associated with development of graft fibrosis more than 10 years after liver transplantation-a retrospective single center study. Clin Transplant 2021;35:e14336. [PMID: 33949011 DOI: 10.1111/ctr.14336] [Reference Citation Analysis]
410 Bueno J, Barret JP, Serracanta J, Arnó A, Collado JM, Valles C, Colominas MJ, Diez Y, Pont T, Salamero P. Logistics and strategy of multiorgan procurement involving total face allograft. Am J Transplant. 2011;11:1091-1097. [PMID: 21443675 DOI: 10.1111/j.1600-6143.2011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
411 Cholongitas E, Shusang V, Papatheodoridis GV, Marelli L, Manousou P, Rolando N, Patch D, Rolles K, Davidson B, Burroughs AK. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2008;14:138-143. [PMID: 18236447 DOI: 10.1002/lt.21260] [Cited by in Crossref: 131] [Cited by in F6Publishing: 92] [Article Influence: 9.4] [Reference Citation Analysis]
412 Nagai S, Ito M, Kamei H, Nakamura T, Ando H, Kiuchi T. Indirect immunohistochemical evaluation of graft fibrosis and interface hepatitis after pediatric liver transplantation. Pediatr Transplant. 2010;14:342-350. [PMID: 19744282 DOI: 10.1111/j.1399-3046.2009.01234.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
413 Duclos-vallée J, Féray C, Sebagh M, Teicher E, Roque-afonso A, Roche B, Azoulay D, Adam R, Bismuth H, Castaing D, Vittecoq D, Samuel D. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008;47:407-17. [DOI: 10.1002/hep.21990] [Cited by in Crossref: 155] [Cited by in F6Publishing: 134] [Article Influence: 10.3] [Reference Citation Analysis]
414 Del Bello A, Danjoux M, Congy-jolivet N, Lavayssière L, Esposito L, Muscari F, Kamar N. Histological long-term outcomes from acute antibody-mediated rejection following ABO-compatible liver transplantation: Outcome of antibody mediated rejection. Journal of Gastroenterology and Hepatology 2017;32:887-93. [DOI: 10.1111/jgh.13613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
415 Ashokkumar C, Soltys K, Mazariegos G, Bond G, Higgs BW, Ningappa M, Sun Q, Brown A, White J, Levy S, Fazzolare T, Remaley L, Dirling K, Harris P, Hartle T, Kachmar P, Nicely M, OʼToole L, Boehm B, Jativa N, Stanley P, Jaffe R, Ranganathan S, Zeevi A, Sindhi R. Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children. Transplantation 2017;101:131-40. [PMID: 26950712 DOI: 10.1097/TP.0000000000001076] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
416 Bahra M, Neumann U, Jacob D, Langrehr J, Neuhaus P. Repeated Steroid Pulse Therapies in HCV-Positive Liver Recipients: Significant Risk Factor for HCV-Related Graft Loss. Transplantation Proceedings 2005;37:1700-2. [DOI: 10.1016/j.transproceed.2005.03.081] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
417 Jiang W, Kong L, Wu X, Pu L, Wang X. Allograft Inflammatory Factor-1 is Up-regulated in Warm and Cold Ischemia-Reperfusion Injury in Rat Liver and May be Inhibited by FK506. Journal of Surgical Research 2011;165:158-64. [DOI: 10.1016/j.jss.2009.05.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
418 Habib S, Meister E, Habib S, Murakami T, Walker C, Rana A, Shaikh OS. Slower Fibrosis Progression Among Liver Transplant Recipients With Sustained Virological Response After Hepatitis C Treatment. Gastroenterology Res. 2015;8:237-246. [PMID: 27785303 DOI: 10.14740/gr686w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
419 Zhang K, Sun YL, Zhou SN, Xu RN, Liu ZW, Wang FS, Shi M. Circulating CXCR3-CCR6-CXCR5+CD4+ T cells are associated with acute allograft rejection in liver transplantation. Immunol Lett 2019;213:55-61. [PMID: 30849400 DOI: 10.1016/j.imlet.2019.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
420 Reiling J, Bridle KR, Gijbels M, Schaap FG, Jaskowski L, Santrampurwala N, Britton LJ, Campbell CM, Olde Damink SWM, Crawford DHG, Dejong CHC, Fawcett J. Low-Dose Lipopolysaccharide Causes Biliary Injury by Blood Biliary Barrier Impairment in a Rat Hepatic Ischemia/Reperfusion Model: Reiling et al. Liver Transpl 2017;23:194-206. [DOI: 10.1002/lt.24681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
421 Ormonde DG, de Boer WB, Kierath A, Bell R, Shilkin KB, House AK, Jeffrey GP, Reed WD. Banff schema for grading liver allograft rejection: utility in clinical practice. Liver Transpl Surg. 1999;5:261-268. [PMID: 10388498 DOI: 10.1002/lt.500050418] [Cited by in Crossref: 90] [Cited by in F6Publishing: 70] [Article Influence: 3.9] [Reference Citation Analysis]
422 Dankof A, Schmeding M, Morawietz L, Gunther R, Krukemeyer MG, Rudolph B, Koch M, Krenn V, Neumann U. Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection. Virchows Arch. 2005;447:87-93. [PMID: 15947944 DOI: 10.1007/s00428-005-1245-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
423 Yao J, Feng XW, Yu XB, Xie HY, Zhu LX, Yang Z, Wei BJ, Zheng SS, Zhou L. Recipient IL-6-572C/G genotype is associated with reduced incidence of acute rejection following liver transplantation. J Int Med Res 2013;41:356-64. [PMID: 23569034 DOI: 10.1177/0300060513477264] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
424 Fan H, Li LX, Han DD, Kou JT, Li P, He Q. Increase of peripheral Th17 lymphocytes during acute cellular rejection in liver transplant recipients. Hepatobiliary Pancreat Dis Int 2012;11:606-11. [PMID: 23232631 DOI: 10.1016/s1499-3872(12)60231-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
425 Bathgate AJ, Lee P, Hayes PC, Simpson KJ. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation. Liver Transpl. 2000;6:721-727. [PMID: 11084058 DOI: 10.1053/jlts.2000.18472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
426 Dattani N, Baker A, Quaglia A, Melendez HV, Rela M, Heaton N. Clinical and histological outcomes following living-related liver transplantation in children. Clinics and Research in Hepatology and Gastroenterology 2014;38:164-71. [DOI: 10.1016/j.clinre.2013.10.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
427 Janse M, de Rooij BJ, van Hoek B, van den Berg AP, Porte RJ, Blokzijl H, Coenraad MJ, Hepkema BG, Schaapherder AF, Ringers J. Recipient’s genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation. PLoS One. 2013;8:e72617. [PMID: 23977330 DOI: 10.1371/journal.pone.0072617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
428 Carotti S, Morini S, Corradini SG, Burza MA, Molinaro A, Carpino G, Merli M, De Santis A, Muda AO, Rossi M. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl. 2008;14:806-814. [PMID: 18508359 DOI: 10.1002/lt.21436] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
429 Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. Transpl Infect Dis. 2006;8:3-12. [PMID: 16623815 DOI: 10.1111/j.1399-3062.2006.00124.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
430 Yu YY, Ji J, Zhou GW, Shen BY, Chen H, Yan JQ, Peng CH, Li HW. Liver biopsy in evaluation of complications following liver transplantation. World J Gastroenterol 2004; 10(11): 1678-1681 [PMID: 15162551 DOI: 10.3748/wjg.v10.i11.1678] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
431 Miyagawa-Hayashino A, Egawa H, Yorifuji T, Hasegawa M, Haga H, Tsuruyama T, Wen MC, Sumazaki R, Manabe T, Uemoto S. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. Liver Transpl. 2009;15:610-618. [PMID: 19479804 DOI: 10.1002/lt.21686] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
432 Sastre L, García R, Gándara JG, Ruiz P, Lombardo J, Colmenero J, Navasa M, Crespo G. Incidence, Predictors, and Impact on Survival of Long-term Cardiovascular Events After Liver Transplantation. Transplantation 2020;104:317-25. [PMID: 31335770 DOI: 10.1097/TP.0000000000002852] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
433 Fasola CG, Klintmalm GB. Hepatitis C recurrence after liver transplantation: in search of the optimal immunosuppression to improve outcome. Current Opinion in Organ Transplantation 2006;11:637-42. [DOI: 10.1097/mot.0b013e328010d4c1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
434 Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR. Once-Daily Tacrolimus Extended Release Formulation: Experience at 2 Years Postconversion From a Prograf-Based Regimen in Stable Liver Transplant Recipients. Transplantation 2007;83:1639-42. [DOI: 10.1097/01.tp.0000265445.09987.f1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
435 Yamada Y, Hoshino K, Mori T, Kawaida M, Abe K, Ishihama H, Shimizu T, Takahashi N, Matsubara K, Hibi T, Abe Y, Yagi H, Shimojima N, Shinoda M, Kitago M, Obara H, Fuchimoto Y, Kameyama K, Kitagawa Y, Kuroda T. Successful living donor liver retransplantation for graft failure within 7 days due to acute de novo donor-specific anti-human leukocyte antigen antibody-mediated rejection: Re-LTx for graft failure secondary to de novo AMR. Hepatol Res 2018;48:E360-6. [DOI: 10.1111/hepr.12924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
436 Schnitzbauer AA, Sothmann J, Baier L, Bein T, Geissler EK, Scherer MN, Schlitt HJ. Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment: Results of a Pilot Study (PATRON07). Transplantation 2015;99:2565-75. [DOI: 10.1097/tp.0000000000000779] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
437 Kimura Y, Taura K, Hai Nam N, Uemoto Y, Yoshino K, Ikeno Y, Okuda Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Anazawa T, Fukumitsu K, Ito T, Yagi S, Kamo N, Seo S, Iwaisako K, Hata K, Imai T, Uemoto S. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation. Liver Transpl 2021;27:403-15. [PMID: 32780942 DOI: 10.1002/lt.25870] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
438 Detry O, Vandermeulen M, Delbouille MH, Somja J, Bletard N, Briquet A, Lechanteur C, Giet O, Baudoux E, Hannon M. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. J Hepatol. 2017;67:47-55. [PMID: 28284916 DOI: 10.1016/j.jhep.2017.03.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 12.0] [Reference Citation Analysis]
439 Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, Okuno T, Koyanagi I, Takada Y, Manabe T. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl. 2006;12:457-464. [PMID: 16498648 DOI: 10.1002/lt.20652] [Cited by in Crossref: 96] [Cited by in F6Publishing: 75] [Article Influence: 6.0] [Reference Citation Analysis]
440 Tippner C, Nashan B, Hoshino K, Schmidt-sandte E, Akimaru K, B??ker KH, Schlitt HJ. CLINICAL AND SUBCLINICAL ACUTE REJECTION EARLY AFTER LIVER TRANSPLANTATION: CONTRIBUTING FACTORS AND RELEVANCE FOR THE LONG-TERM COURSE. Transplantation 2001;72:1122-8. [DOI: 10.1097/00007890-200109270-00024] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
441 Olson JC, Wiesner RH. Immunomodulating therapy in liver transplantation: principles and practice. Immunotherapy 2012;4:793-805. [PMID: 22947008 DOI: 10.2217/imt.12.69] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
442 Engelmann G, Schmidt J, Weitz J, Flechtenmacher C, Schenk JP, Weigand MA, Lenhartz H, Wenning D, Holland-cunz S, Hoffmann GF, Martin E, Büchler MW, Schmitt CP, Burdelski M, Meyburg J. A new pediatric liver transplantation program in Southern Germany. The Heidelberg experience. Pediatric Transplantation 2010;14:12-8. [DOI: 10.1111/j.1399-3046.2009.01247.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
443 Legaz I, Boix F, López M, Alfaro R, Galián JA, Llorente S, Campillo JA, Botella C, Ramírez P, Sánchez-Bueno F, Pons JA, Moya-Quiles MR, Minguela A, Muro M. Influence of Preformed Antibodies in Liver Transplantation. J Clin Med 2020;9:E708. [PMID: 32151032 DOI: 10.3390/jcm9030708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
444 Wieczorek-Godlewska R, Płoski R, Perkowska-Ptasińska A, Tronina O, Sadowska A, Pacholczyk M, Lisik W, Durlik M. The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation. Clin Exp Hepatol 2017;3:152-8. [PMID: 29062905 DOI: 10.5114/ceh.2017.68401] [Reference Citation Analysis]
445 Nakano R, Yoshida O, Kimura S, Nakao T, Yokota S, Ono Y, Minervini MI, Geller DA, Thomson AW. Donor plasmacytoid dendritic cells modulate effector and regulatory T cell responses in mouse spontaneous liver transplant tolerance. Am J Transplant 2021;21:2040-55. [PMID: 33247989 DOI: 10.1111/ajt.16412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
446 Meng X, Gao W, Tang Y, Shen Z, Wang Z. Alterations of Serum IP-10 and TARC in Patients with Early Acute Rejection after Liver Transplantation. Cell Physiol Biochem 2017;41:1063-71. [DOI: 10.1159/000464114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
447 Pelletier SJ, Raymond DP, Crabtree TD, Berg CL, Iezzoni JC, Hahn YS, Sawyer RG, Pruett TL. Hepatitis C–induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology 2000;32:418-26. [DOI: 10.1053/jhep.2000.9408] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 2.5] [Reference Citation Analysis]
448 Wei Q, Xu X, Wang C, Zhuang R, Zhuang L, Zhou L, Xie H, Wu J, Zhang M, Shen Y, Wang W, Zheng S. Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma. Gut Liver 2016;10:604-10. [PMID: 27074818 DOI: 10.5009/gnl15017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
449 Scornik JC, Lauwers GY, Reed AI, Howard RJ, Dickson RC, Rosen CB. Infusion of donor spleen cells and rejection in liver transplant recipients. Clin Transplant 2000;14:55-60. [PMID: 10693636 DOI: 10.1034/j.1399-0012.2000.140110.x] [Reference Citation Analysis]
450 Ganschow R, Grabhorn E, Schulz A, Von Hugo A, Rogiers X, Burdelski M. Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients. Pediatr Transplant. 2005;9:741-745. [PMID: 16269045 DOI: 10.1111/j.1399-3046.2005.00371.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
451 Huang C, Huang S, Tang Y, Zhao Q, Wang D, Ju W, Yang L, Zhang J, Wu L, Chen M, Zhang Z, Zhu Z, Wang L, Zhu C, Zhang Y, Sun C, Xiong W, Shen Y, Chen X, Ma Y, Hu A, Zhu X, Rong J, Cai C, Guo Z, He X. Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease. BMJ Open 2020;10:e035374. [PMID: 32376754 DOI: 10.1136/bmjopen-2019-035374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
452 Lee CK, Nastasio S, Mitchell PD, Fawaz R, Elisofon SA, Vakili K, Kim HB, Nguyen D, Jonas MM. Transient elastography assessment of liver allograft fibrosis in pediatric transplant recipients. Pediatr Transplant 2020;24:e13736. [PMID: 32432836 DOI: 10.1111/petr.13736] [Reference Citation Analysis]
453 Bettens F, Tiercy JM, Campanile N, Giostra E, Majno P, Rubbia L, Roosnek E, Mentha G, Villard J. Microchimerism after liver transplantation: Absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity. Liver Transpl. 2005;11:290-297. [PMID: 15719407 DOI: 10.1002/lt.20360] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
454 Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, Martínez-Llordella M, López M, Angelico R, Bohne F, Sese P, Daoud F, Larcier P, Roelen DL, Claas F, Whitehouse G, Lerut J, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013;58:1824-35. [PMID: 23532679 DOI: 10.1002/hep.26426] [Cited by in Crossref: 193] [Cited by in F6Publishing: 171] [Article Influence: 21.4] [Reference Citation Analysis]
455 Wallia A, Parikh ND, Molitch ME, Mahler E, Tian L, Huang JJ, Levitsky J. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation. 2010;89:222-226. [PMID: 20098286 DOI: 10.1097/tp.0b013e3181c3c2ff] [Cited by in Crossref: 60] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
456 Bonaccorsi-Riani E, Pennycuick A, Londoño MC, Lozano JJ, Benítez C, Sawitzki B, Martínez-Picola M, Bohne F, Martínez-Llordella M, Miquel R, Rimola A, Sánchez-Fueyo A. Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation. Am J Transplant 2016;16:484-96. [PMID: 26517400 DOI: 10.1111/ajt.13488] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
457 Gouw AS, van den Heuvel MC, van den Berg AP, Slooff MJ, de Jong KP, Poppema S. The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection. Transplantation. 2002;73:243-247. [PMID: 11821738 DOI: 10.1097/00007890-200201270-00016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
458 Zhang A, Zhang M, Wang Y, Xie H, Zheng S. Calcitriol Prolongs Recipient Survival by Inducing Expression of Zinc-Finger Protein A20 and Inhibiting its Downstream Gene Following Rat Orthotopic Liver Transplantation. Immunopharmacology and Immunotoxicology 2008;28:591-600. [DOI: 10.1080/08923970601067003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
459 Samri A, Roque-afonso A, Beran O, Tateo M, Teicher E, Feray C, Sebagh M, Guettier C, Dussaix E, Vittecoq D, Samuel D, Autran B, Duclos-vallée J. Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV–HCV coinfected patients (ANRS-HC08 “THEVIC” trial). Journal of Hepatology 2009;51:1000-9. [DOI: 10.1016/j.jhep.2009.06.031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
460 Sasaki R, Miyaaki H, Narita S, Fukushima M, Haraguchi M, Miuma S, Hidaka M, Eguchi S, Okudaira S, Abe K, Nakao K. Serum Mac-2 binding protein glycosylation isomer as a biomarker of fibrosis in living donor liver transplant graft. Clin Transplant 2021;35:e14175. [PMID: 33247961 DOI: 10.1111/ctr.14175] [Reference Citation Analysis]
461 Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation. 2009;87:606-614. [PMID: 19307800 DOI: 10.1097/tp.0b013e318195a7cb] [Cited by in Crossref: 85] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
462 Burroughs AK, Patch DW, Stigliano R, Cecilioni L. Protocol biopsies in liver transplantation. Liver Transpl 2003;9:780-1. [DOI: 10.1002/lt.500090723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
463 Bastos-neves D, Salvalaggio PRDO, Almeida MDD. Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction. Hepatobiliary & Pancreatic Diseases International 2019;18:423-9. [DOI: 10.1016/j.hbpd.2019.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
464 Dubois M, Ronot M, Houssel-Debry P, Brun V, Rayar M, Auger M, Beuzit L, Turlin B, Aubé C, Paisant A. Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation. Eur J Gastroenterol Hepatol 2020;32:222-30. [PMID: 31464783 DOI: 10.1097/MEG.0000000000001500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
465 Cabrera R, Ararat M, Soldevila-Pico C, Dixon L, Pan JJ, Firpi R, Machicao V, Levy C, Nelson D, Morelli G. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl. 2009;15:216-222. [PMID: 19177434 DOI: 10.1002/lt.21666] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
466 Lautenschlager I, Höckerstedt K, Taskinen E. Histologic findings associated with CMV infection in liver transplantation. Transplant Proc 2003;35:819. [PMID: 12644152 DOI: 10.1016/s0041-1345(03)00084-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
467 Perrella O, Sbreglia C, Arenga G, Perrella A, Ferrara A, D'Antonio A, Di Costanzo G, Atripaldi L, Alone C, Sciano D. Acute rejection after liver transplantation: Is there a specific immunological pattern? Transplant Proc. 2006;38:3594-3596. [PMID: 17175341 DOI: 10.1016/j.transproceed.2006.10.102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
468 Burton JR, Rosen HR. Diagnosis and Management of Allograft Failure. Clinics in Liver Disease 2006;10:407-35. [DOI: 10.1016/j.cld.2006.05.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
469 Hübscher SG. Transplantation pathology. Seminars in Diagnostic Pathology 2006;23:170-81. [DOI: 10.1053/j.semdp.2006.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
470 Vítko Š, Margreiter R, Weimar W, Dantal J, Viljoen HG, Li Y, Jappe A, Cretin N. Everolimus (Certican) 12-Month Safety and Efficacy Versus Mycophenolate Mofetil in de Novo Renal Transplant Recipients. Transplantation 2004;78:1532-40. [DOI: 10.1097/01.tp.0000141094.34903.54] [Cited by in Crossref: 127] [Cited by in F6Publishing: 12] [Article Influence: 7.1] [Reference Citation Analysis]
471 Pleguezuelo M, Germani G, Burroughs AK. Liver Transplantation: Prevention and Treatment of Rejection. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 685-723. [DOI: 10.1002/9781444314403.ch42] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
472 Florman S, Schiano T, Kim L, Maman D, Levay A, Gondolesi G, Fishbein T, Emre S, Schwartz M, Miller C. The incidence and significance of late acute cellular rejection (> 1000 days) after liver transplantation. Clin Transplant. 2004;18:152-155. [PMID: 15016129 DOI: 10.1046/j.1399-0012.2003.00139.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
473 Yoon JH, Lee JY, Woo HS, Yu MH, Lee ES, Joo I, Lee KB, Yi NJ, Lee YJ, Han JK. Shear wave elastography in the evaluation of rejection or recurrent hepatitis after liver transplantation. Eur Radiol. 2013;23:1729-1737. [PMID: 23300037 DOI: 10.1007/s00330-012-2748-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
474 Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavaldà J, Moreno A, Torre-Cisneros J, Montejo JM, Fortun J, Muñoz P, Sabé N, Fariñas MC, Blanes-Julia M, López-Medrano F, Suárez-Benjumea A, Martinez-Atienza J, Rosso-Fernández C, Pérez-Romero P; TRANSGRIPE 1–2 Study Group. Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial. Clin Infect Dis 2017;64:829-38. [PMID: 28362949 DOI: 10.1093/cid/ciw855] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 12.8] [Reference Citation Analysis]
475 Guichelaar MM, Benson JT, Malinchoc M, Krom RA, Wiesner RH, Charlton MR. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant. 2003;3:885-890. [PMID: 12814481 DOI: 10.1034/j.1600-6143.2003.00165.x] [Cited by in Crossref: 205] [Cited by in F6Publishing: 170] [Article Influence: 11.4] [Reference Citation Analysis]
476 Antonini TM, Sebagh M, Roque-Afonso AM, Teicher E, Roche B, Sobesky R, Coilly A, Vaghefi P, Adam R, Vittecoq D. Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation. Am J Transplant. 2011;11:1686-1695. [PMID: 21749638 DOI: 10.1111/j.1600-6143.2011.03608.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
477 Hassoun Z, Shah V, Lohse CM, Pankratz VS, Petrovic LM. Centrilobular necrosis after orthotopic liver transplantation: Association with acute cellular rejection and impact on outcome. Liver Transpl 2004;10:480-7. [DOI: 10.1002/lt.20122] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
478 Couto CA, Bittencourt PL, Farias AQ, Lallee MP, Cançado EL, Massarollo PC, Mies S. Human polyclonal anti-hepatitis B surface antigen immunoglobulin reduces the frequency of acute rejection after liver transplantation for chronic hepatitis B. Rev Inst Med Trop Sao Paulo 2001;43:335-7. [PMID: 11781604 DOI: 10.1590/s0036-46652001000600007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
479 Yong-gang X, Ming-zhe W, Jin-yan Z, Zhi-hai P, Jun-ming X. Combination of N-(3׳,4׳-dimethoxycinnamoyl) anthranilic acid with cyclosporin A treatment preserves immunosuppressive effect and reduces the side effect of cyclosporin A in rat. European Journal of Pharmacology 2014;728:16-23. [DOI: 10.1016/j.ejphar.2014.01.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
480 Testro AG, Visvanathan K, Skinner N, Markovska V, Crowley P, Angus PW, Gow PJ. Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4. J Gastroenterol Hepatol. 2011;26:155-163. [PMID: 21175809 DOI: 10.1111/j.1440-1746.2010.06324.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
481 Musat AI, Pigott CM, Ellis TM, Agni RM, Leverson GE, Powell AJ, Richards KR, D'alessandro AM, Lucey MR. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation: Allosensitization and Liver Rejection. Liver Transpl 2013;19:1132-41. [DOI: 10.1002/lt.23707] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
482 Hu J, Wang Z, Tan CJ, Liao BY, Zhang X, Xu M, Dai Z, Qiu SJ, Huang XW, Sun J. Plasma microRNA, a potential biomarker for acute rejection after liver transplantation. Transplantation. 2013;95:991-999. [PMID: 23466638 DOI: 10.1097/tp.0b013e31828618d8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
483 Cookson S, Doherty DG, Todryk S, Gibbs P, Portmann B, O'Grady J, Rela M, Heaton N, Norris S. Hepatic expression of IL-15 mRNA is associated with liver graft acceptance. Transpl Immunol 2003;11:39-48. [PMID: 12727474 DOI: 10.1016/S0966-3274(02)00143-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
484 de Rooij BJ, van der Beek MT, van Hoek B, Vossen AC, Rogier Ten Hove W, Roos A, Schaapherder AF, Porte RJ, van der Reijden JJ, Coenraad MJ. Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation. J Hepatol. 2011;55:800-807. [PMID: 21334396 DOI: 10.1016/j.jhep.2011.01.039] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
485 Marcos A, Eghtesad B, Fung JJ, Fontes P, Patel K, Devera M, Marsh W, Gayowski T, Demetris AJ, Gray EA. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation. 2004;78:966-971. [PMID: 15480160 DOI: 10.1097/01.tp.0000142674.78268.01] [Cited by in Crossref: 138] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
486 Lucey MR. Serial liver biopsies: a gateway into understanding the long-term health of the liver allograft. J Hepatol. 2001;34:762-763. [PMID: 11434625 DOI: 10.1016/s0168-8278(01)00070-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
487 Marin JG, Levine M, Ensom MHH. Is C2 Monitoring or Another Limited Sampling Strategy Superior to C0 Monitoring in Improving Clinical Outcomes in Adult Liver Transplant Recipients? Therapeutic Drug Monitoring 2006;28:637-42. [DOI: 10.1097/01.ftd.0000243965.97964.ca] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
488 De Simone P, Saliba F, Dong G, Escrig C, Fischer L. Do patient characteristics influence efficacy and renal outcomes in liver transplant patients receiving everolimus? Clin Transplant. 2016;30:279-288. [PMID: 26717035 DOI: 10.1111/ctr.12687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
489 Barnes EJ, Abdel-rehim MM, Goulis Y, Ragab MA, Davies S, Dhillon A, Davidson B, Rolles K, Burroughs A. Applications and Limitations of Blood Eosinophilia for the Diagnosis of Acute Cellular Rejection in Liver Transplantation: Applications and Limitations of Blood Eosinophilia. American Journal of Transplantation 2003;3:432-8. [DOI: 10.1034/j.1600-6143.2003.00083.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
490 Ward SC, Schiano TD, Thung SN, Fiel MI. Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: Case-control study showing poor outcome and predictive features in the liver explant: Post-Liver Transplant Plasma Cell Hepatitis. Liver Transpl 2009;15:1826-33. [DOI: 10.1002/lt.21949] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
491 Schluckebier D, Cousin VL, Petit L, Belli D, Wildhaber B, Rougemont A, Villard J, Ferrari‐lacraz S, Mclin VA. Preformed and de novo DSA are associated with T‐cell–mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy. Pediatr Transplant 2020;24. [DOI: 10.1111/petr.13611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
492 Lee J, Romero R, Xu Y, Kim JS, Park JY, Kusanovic JP, Chaiworapongsa T, Hassan SS, Kim CJ. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol 2011;66:510-26. [PMID: 21951517 DOI: 10.1111/j.1600-0897.2011.01066.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
493 Vorasittha A, Sutherasan M, Taesombat W, Sirichindakul P, Nivatvong S, Nonthasoot B. A comparison of efficiency and safety between dual and triple immunosuppressive regimens in pediatric living donor liver transplantation at King Chulalongkorn Memorial Hospital. Transplantation Reports 2021;6:100088. [DOI: 10.1016/j.tpr.2021.100088] [Reference Citation Analysis]
494 Klintmalm GB, Feng S, Lake JR, Vargas HE, Wekerle T, Agnes S, Brown KA, Nashan B, Rostaing L, Meadows-Shropshire S, Agarwal M, Harler MB, Garcia-Valdecasas JC. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant 2014;14:1817-27. [PMID: 25041339 DOI: 10.1111/ajt.12810] [Cited by in Crossref: 75] [Cited by in F6Publishing: 58] [Article Influence: 10.7] [Reference Citation Analysis]
495 Unitt E, Gelson W, Davies SE, Coleman N, Alexander GJ. Minichromosome maintenance protein-2-positive portal tract lymphocytes distinguish acute cellular rejection from hepatitis C virus recurrence after liver transplantation. Liver Transpl. 2009;15:306-312. [PMID: 19243005 DOI: 10.1002/lt.21680] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
496 Koneru B, Shareef A, Dikdan G, Desai K, Klein KM, Peng B, Wachsberg RH, de la Torre AN, Debroy M, Fisher A, Wilson DJ, Samanta AK. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant. 2007;7:2788-2796. [PMID: 17949458 DOI: 10.1111/j.1600-6143.2007.02009.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
497 Shimizu S, Sakamoto S, Yamada M, Fukuda A, Yanagi Y, Uchida H, Mimori K, Shoji K, Funaki T, Miyairi I, Nakano N, Haga C, Yoshioka T, Imadome KI, Horikawa R, Kasahara M. Immunological features and complications in patients with glycogen storage disease 1b after living donor liver transplantation. Pediatr Transplant 2021;:e14104. [PMID: 34339091 DOI: 10.1111/petr.14104] [Reference Citation Analysis]
498 Fedoravicius A, Charlton M. Abnormal liver tests after liver transplantation. Clin Liver Dis (Hoboken) 2016;7:73-9. [PMID: 31041034 DOI: 10.1002/cld.540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
499 Polak WG, Miyamoto S, Nemes BA, Peeters PM, de Jong KP, Porte RJ, Slooff MJ. Sequential and simultaneous revascularization in adult orthotopic piggyback liver transplantation. Liver Transpl. 2005;11:934-940. [PMID: 16035059 DOI: 10.1002/lt.20513] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
500 Wei Q, Wang K, Yang M, Chen J, Shen T, Song P, Xie H, Zhou L, Zheng S, Xu X. Recipient gender and body mass index are associated with early acute rejection in donation after cardiac death liver transplantation. Clin Res Hepatol Gastroenterol 2020;44S:100004. [PMID: 33602482 DOI: 10.1016/j.clirex.2020.100004] [Reference Citation Analysis]
501 Vivarelli M, Burra P, La Barba G, Canova D, Senzolo M, Cucchetti A, D’Errico A, Guido M, Merenda R, Neri D. Influence of steroids on HCV recurrence after liver transplantation: A prospective study. J Hepatol. 2007;47:793-798. [PMID: 17928091 DOI: 10.1016/j.jhep.2007.07.023] [Cited by in Crossref: 83] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
502 Skogsberg U, Breimer ME, Friman S, Mjornstedt L, Molne J, Olausson M, Rydberg L, Svalander CT, Backman L. Adult ABO-incompatible liver transplantation, using A2 and B donors. Xenotransplantation 2006;13:154-9. [DOI: 10.1111/j.1399-3089.2006.00286.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
503 Longerich T, Schirmacher P. General aspects and pitfalls in liver transplant pathology. Clin Transplant 2006;20 Suppl 17:60-8. [PMID: 17100703 DOI: 10.1111/j.1399-0012.2006.00602.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
504 Giostra E, Kullak-ublick GA, Keller W, Fried R, Vanlemmens C, Kraehenbuhl S, Locher S, Egger H, Clavien P, Hadengue A, Mentha G, Morel P, Negro F. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation. Transplant Int 2004;17:169-76. [DOI: 10.1111/j.1432-2277.2004.tb00424.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
505 Kerkar N, Lakhole A. Pediatric liver transplantation: a North American perspective. Expert Rev Gastroenterol Hepatol 2016;10:949-59. [PMID: 26982346 DOI: 10.1586/17474124.2016.1166951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
506 Ruiz P, Martínez-Picola M, Santana M, Muñoz J, Pérez-Del-Pulgar S, Koutsoudakis G, Sastre L, Colmenero J, Crespo G, Navasa M. Torque Teno Virus Is Associated With the State of Immune Suppression Early After Liver Transplantation. Liver Transpl 2019;25:302-10. [PMID: 30375165 DOI: 10.1002/lt.25374] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
507 Zhang Y, Wang X, Mao L, Yang D, Gao W, Tian Z, Zhang M, Yang X, Ma K, Wu Y, Ni B. Dual roles of IL-22 at ischemia-reperfusion injury and acute rejection stages of rat allograft liver transplantation. Oncotarget 2017;8:115384-97. [PMID: 29383167 DOI: 10.18632/oncotarget.23266] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
508 Walter T, Scoazec JY, Guillaud O, Hervieu V, Chevallier P, Boillot O, Dumortier J. Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: biochemical, virological, and histological impact. Liver Transpl. 2009;15:54-63. [PMID: 19109834 DOI: 10.1002/lt.21652] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
509 Oertel M, Berr F, Schröder S, Schwarz R, Tannapfel A, Wenzke M, Lamesch P, Hauss J, Kohlhaw K. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors. Liver Transpl 2000;6:728-33. [PMID: 11084059 DOI: 10.1053/jlts.2000.18480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
510 Levitsky J, Kandpal M, Guo K, Kleiboeker S, Sinha R, Abecassis M. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Am J Transplant 2021. [PMID: 34510731 DOI: 10.1111/ajt.16835] [Reference Citation Analysis]
511 Morard I, Mentha G, Spahr L, Majno P, Hadengue A, Huber O, Morel P, Giostra E. Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels. Clin Transplant. 2006;20:96-101. [PMID: 16556162 DOI: 10.1111/j.1399-0012.2005.00447.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
512 Kim H, Yi NJ, Lee J, Kim J, Moon MR, Jeong J, Lee JM, You TS, Suh SW, Park MS, Choi Y, Hong G, Lee HW, Lee KW, Suh KS. Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation. Clin Mol Hepatol 2014;20:291-9. [PMID: 25320733 DOI: 10.3350/cmh.2014.20.3.291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
513 Cotler SJ, Ganger DR, Kaur S, Rosenblate H, Jakate S, Sullivan DG, Ng KW, Gretch DR, Jensen DM. Daily interferon therapy for hepatitis C virus infection in liver transplant recipients. Transplantation. 2001;71:261-266. [PMID: 11213071 DOI: 10.1097/00007890-200101270-00017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
514 Xin-Ding, Zheng ZY, Wang C, Zeng L, Jiang Y. ABO-incompatible liver transplantation: a pathological analysis of 2 cases. Shijie Huaren Xiaohua Zazhi 2008; 16(18): 2056-2060 [DOI: 10.11569/wcjd.v16.i18.2056] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
515 Shimizu A, Ishii E, Kuwahara N, Arai T, Kanzaki G, Higo S, Kajimoto Y, Nagasaka S, Masuda Y, Fukuda Y. Chronic Antibody-Mediated Responses May Mediate Chronic Rejection in Rat Orthotopic Liver Transplantation. Transplantation Proceedings 2013;45:1743-7. [DOI: 10.1016/j.transproceed.2013.02.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
516 First MR. First clinical experience with the new once-daily formulation of tacrolimus. Ther Drug Monit. 2008;30:159-166. [PMID: 18367975 DOI: 10.1097/ftd.0b013e318167909a] [Cited by in Crossref: 49] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
517 Randhawa P, Blakolmer K, Kashyap R, Raikow R, Nalesnik M, Demetris AJ, Jain A. Allograft Liver Biopsy in Patients With Epstein-Barr Virus–Associated Posttransplant Lymphoproliferative Disease: . The American Journal of Surgical Pathology 2001;25:324-30. [DOI: 10.1097/00000478-200103000-00006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
518 D'errico-grigioni A, Fiorentino M, Vasuri F, Gruppioni E, Fabbrizio B, Zucchini N, Ballardini G, Morelli C, Pinna AD, Grigioni WF. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation: HCV RNA and Protein After Liver Transplantation. Liver Transpl 2008;14:313-20. [DOI: 10.1002/lt.21375] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
519 Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl. 2002;8:505-513. [PMID: 12037780 DOI: 10.1053/jlts.2002.33485] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 3.9] [Reference Citation Analysis]
520 Boleslawski E, BenOthman S, Grabar S, Correia L, Podevin P, Chouzenoux S, Soubrane O, Calmus Y, Conti F. CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation. Clin Transplant. 2008;22:494-501. [PMID: 18565100 DOI: 10.1111/j.1399-0012.2008.00815.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
521 Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, Nalesnik MA, Randhawa P, Wu T, Zeevi A, Abu-elmagd K, Eghtesad B, Fontes P, Cacciarelli T, Marsh W, Geller D, Fung JJ. Real-time monitoring of acute liver-allograft rejection using the Banff schema1: . Transplantation 2002;74:1290-6. [DOI: 10.1097/00007890-200211150-00016] [Cited by in Crossref: 74] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
522 Hendrickson RJ, Sujka J, Fischer R, Manalang M, Daniel J, Andrews WS. Indications and efficacy of conversion from tacrolimus- to sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma. Pediatr Transplant 2019;23:e13369. [PMID: 30719825 DOI: 10.1111/petr.13369] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
523 Yang L, Shen ZY, Wang RR, Yin ML, Zheng WP, Wu B, Liu T, Song HL. Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation. World J Gastroenterol 2017; 23(19): 3449-3467 [PMID: 28596681 DOI: 10.3748/wjg.v23.i19.3449] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
524 Thurairajah PH, Carbone M, Bridgestock H, Thomas P, Hebbar S, Gunson BK, Shah T, Neuberger J. Late acute liver allograft rejection; a study of its natural history and graft survival in the current era. Transplantation. 2013;95:955-959. [PMID: 23442806 DOI: 10.1097/tp.0b013e3182845f6c] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
525 Price DC. Radioisotopic evaluation of the thyroid and the parathyroids. Radiol Clin North Am. 1993;31:991-1015. [PMID: 8362060 DOI: 10.1002/14651858.cd011639.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
526 Levy G, Villamil F, Samuel D, Sanjuan F, Grazi GL, Wu Y, Marotta P, Boillot O, Muehlbacher F, Klintmalm G. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation. 2004;77:1632-1638. [PMID: 15201658 DOI: 10.1097/01.tp.0000129095.51031.42] [Cited by in Crossref: 107] [Cited by in F6Publishing: 14] [Article Influence: 5.9] [Reference Citation Analysis]
527 Chae MS, Moon KU, Chung HS, Park CS, Lee J, Choi JH, Hong SH. Serum interleukin-6 and tumor necrosis factor-α are associated with early graft regeneration after living donor liver transplantation. PLoS One 2018;13:e0195262. [PMID: 29649247 DOI: 10.1371/journal.pone.0195262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
528 Pongpaibul A, Venick RS, McDiarmid SV, Lassman CR. Histopathology of de novo autoimmune hepatitis. Liver Transpl. 2012;18:811-818. [PMID: 22378542 DOI: 10.1002/lt.23422] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
529 Allen KJ, Rand EB, Hart J, Whitington PF. PROGNOSTIC IMPLICATIONS OF CENTRILOBULAR NECROSIS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS1: . Transplantation 1998;65:692-8. [DOI: 10.1097/00007890-199803150-00016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
530 Zhang C, Yang G, Lu D, Ling Y, Chen G, Zhou T. Expression of vascular endothelial growth factor and basic fibroblast growth factor in acute rejection reaction following rat orthotopic liver transplantation. Exp Ther Med. 2014;8:483-487. [PMID: 25009605 DOI: 10.3892/etm.2014.1779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
531 Puustinen L, Boyd S, Arkkila P, Isoniemi H, Arola J, Färkkilä M. Histologic surveillance after liver transplantation due to autoimmune hepatitis. Clin Transplant 2017;31:e12936. [DOI: 10.1111/ctr.12936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
532 Liu G, He X, Lu N, Qiu Y, Wang H. Attenuation of allograft rejection by intragraft inhibition of class II transcativator in high responder rat liver transplantation: Intragraft Inhibition of C II TA Attenuates Liver Graft Rejection. Microsurgery 2015;35:52-9. [DOI: 10.1002/micr.22265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
533 Liu TC, Nguyen TT, Torbenson MS. Concurrent increase in mitosis and apoptosis: a histological pattern of hepatic arterial flow abnormalities in post-transplant liver biopsies. Mod Pathol 2012;25:1594-8. [PMID: 22766789 DOI: 10.1038/modpathol.2012.116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
534 Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis 2017;19. [PMID: 28921781 DOI: 10.1111/tid.12779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
535 Sandrasegaran K, Ramaswamy R, Ghosh S, Tahir B, Akisik FM, Saxena R, Kwo P. Diffusion-weighted MRI of the transplanted liver. Clin Radiol. 2011;66:820-825. [PMID: 21621199 DOI: 10.1016/j.crad.2010.12.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
536 He Q, Fan H, Li J, Qi H. Decreased Circulating CD4+CD25highFoxp3+ T Cells During Acute Rejection in Liver Transplant Patients. Transplantation Proceedings 2011;43:1696-700. [DOI: 10.1016/j.transproceed.2011.03.084] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
537 Araiz JJ, Serrano MT, García-Gil FA, Lacruz EM, Lorente S, Sánchez JI, Suarez MA. Intention-to-treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list? Liver Transpl 2016;22:1186-96. [PMID: 27114030 DOI: 10.1002/lt.24474] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
538 Fischer L, Saliba F, Kaiser GM, De Carlis L, Metselaar HJ, De Simone P, Duvoux C, Nevens F, Fung JJ, Dong G, Rauer B, Junge G; H2304 Study Group. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. Transplantation. 2015;99:1455-1462. [PMID: 26151607 DOI: 10.1097/tp.0000000000000555] [Cited by in Crossref: 75] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
539 Jiménez-Castro MB, Elias-Miro M, Mendes-Braz M, Lemoine A, Rimola A, Rodés J, Casillas-Ramírez A, Peralta C. Tauroursodeoxycholic acid affects PPARγ and TLR4 in Steatotic liver transplantation. Am J Transplant 2012;12:3257-71. [PMID: 22994543 DOI: 10.1111/j.1600-6143.2012.04261.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
540 Soquet J, Chambon JP, Goffin Y, Jashari R. Acute rejection of a cryopreserved arterial homograft. Cell Tissue Bank 2015;16:331-3. [PMID: 25511467 DOI: 10.1007/s10561-014-9489-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
541 Zhang Y, Li S, Wang G, Peng Y, Zhang Q, Li H, Zhang J, Wang G, Yi S, Chen X, Xiang AP, Yang Y, Chen G. Mesenchymal stem cells for treatment of steroid-resistant acute rejection after liver transplantation. Liver Research 2017;1:140-5. [DOI: 10.1016/j.livres.2017.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
542 Gollackner B, Sedivy R, Rockenschaub S, Casati B, Wrba F, Langer F, Mittermayer C, Mittlböck M, Mühlbacher F, Steininger R. Increased apoptosis of hepatocytes in vascular occlusion after orthotopic liver transplantation. Transplant Int 2000;13:49-53. [DOI: 10.1111/j.1432-2277.2000.tb01036.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
543 Jain A, Kashyap R, Dodson F, Kramer D, Hamad I, Khan A, Eghestad B, Starzl T, Fung J. A PROSPECTIVE RANDOMIZED TRIAL OF TACROLIMUS AND PREDNISONE VERSUS TACROLIMUS, PREDNISONE AND MYCOPHENOLATE MOFETIL IN PRIMARY ADULT LIVER TRANSPLANTATION: A SINGLE CENTER REPORT1: . Transplantation 2001;72:1091-7. [DOI: 10.1097/00007890-200109270-00019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
544 Kim JM, Kwon CH, Yun IJ, Lee KW, Yu HC, Suh KS, Joh JW, Cho BH. A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients. Ann Surg Treat Res 2014;86:192-8. [PMID: 24783178 DOI: 10.4174/astr.2014.86.4.192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
545 Moncrief KJ, Savu A, Ma MM, Bain VG, Wong WW, Tandon P. The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience. Can J Gastroenterol. 2010;24:40-46. [PMID: 20186355 DOI: 10.1155/2010/830291] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
546 Lawrence ZE, Martinez M, Lobritto S, Chen J, Breslin N, Fox A, Vittorio J. Adherence, Medical Outcomes, and Health Care Costs in Adolescents/Young Adults Following Pediatric Liver Transplantation. Journal of Pediatric Gastroenterology & Nutrition 2020;70:183-9. [DOI: 10.1097/mpg.0000000000002553] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
547 Saxena R, Crawford JM, Navarro VJ, Friedman AL, Robert ME. Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation. Mod Pathol 2002;15:897-903. [PMID: 12218206 DOI: 10.1038/modpathol.3880626] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
548 Lodato F, Tamé MR, Colecchia A, Racchini C, Azzaroli F, D’Errico A, Casanova S, Pinna A, Roda E, Mazzella G. Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence. World J Gastroenterol 2006; 12(26): 4253-4255 [PMID: 16830387 DOI: 10.3748/wjg.v12.i26.4253] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
549 International Liver Pathology Study Group. Strategies for a Successful Anatomic Pathology Subspecialty Workgroup: The 26-Year Collaboration of "The Elves". Acad Pathol 2016;3:2374289516653766. [PMID: 28725770 DOI: 10.1177/2374289516653766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
550 Ward C, Robertson H, Forrest IA, Lordan J, Murphy D, Dark JH, Corris PA, Jones DE, Kirby JA. Hypothesis: epithelial-to-mesenchymal transition is a common cause of chronic allograft failure. Transplant Proc. 2005;37:977-980. [PMID: 15848596 DOI: 10.1016/j.transproceed.2004.12.203] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
551 Nicastro E, Giovannozzi S, Stroppa P, Casotti V, Callegaro AP, Tebaldi A, Farina C, Colledan M, DʼAntiga L. Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation. Transplantation 2017;101:804-10. [PMID: 27755504 DOI: 10.1097/TP.0000000000001531] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]
552 Mizuno S, Muraki Y, Nakatani K, Tanemura A, Kuriyama N, Ohsawa I, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Yamada T, Shiraki K, Takei Y, Nobori T, Okuda M, Isaji S. Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity. Clin Dev Immunol 2013;2013:982163. [PMID: 24187567 DOI: 10.1155/2013/982163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
553 Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, Chen P, Busuttil RW. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl. 2001;7:1023-1033. [PMID: 11753904 DOI: 10.1053/jlts.2001.29419] [Cited by in Crossref: 165] [Cited by in F6Publishing: 122] [Article Influence: 8.3] [Reference Citation Analysis]
554 Neil DA, Hübscher SG. Current views on rejection pathology in liver transplantation. Transpl Int. 2010;23:971-983. [PMID: 20723179 DOI: 10.1111/j.1432-2277.2010.01143.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 8.4] [Reference Citation Analysis]
555 Berardi S, Lodato F, Gramenzi A, D’Errico A, Lenzi M, Bontadini A, Morelli MC, Tamè MR, Piscaglia F, Biselli M. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? Gut. 2007;56:237-242. [PMID: 16798778 DOI: 10.1136/gut.2006.092064] [Cited by in Crossref: 91] [Cited by in F6Publishing: 67] [Article Influence: 5.7] [Reference Citation Analysis]
556 Lladó L, Fabregat J, Castellote J, Ramos E, Xiol X, Torras J, Serrano T, Baliellas C, Figueras J, Garcia-Gil A, Rafecas A; THOSIN Study Group. Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study. Liver Transpl 2008;14:1752-60. [PMID: 19025919 DOI: 10.1002/lt.21629] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
557 Mittal C, Qureshi W, Singla S, Ahmad U, Huang MA. Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure. Dig Dis Sci. 2014;59:674-680. [PMID: 24323177 DOI: 10.1007/s10620-013-2955-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
558 Blok MJ, Lautenschlager I, Goossens VJ, Middeldorp JM, Vink C, Höckerstedt K, Bruggeman CA. Diagnostic Implications of Human Cytomegalovirus Immediate Early-1 and pp67 mRNA Detection in Whole-Blood Samples from Liver Transplant Patients Using Nucleic Acid Sequence-Based Amplification. J Clin Microbiol 2000;38:4485-91. [DOI: 10.1128/jcm.38.12.4485-4491.2000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
559 Chung RT, Gordon FD, Curry MP, Schiano TD, Emre S, Corey K, Markmann JF, Hertl M, Pomposelli JJ, Pomfret EA. Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant. 2013;13:1047-1054. [PMID: 23356386 DOI: 10.1111/ajt.12083] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
560 Ruiz P, Sastre L, Crespo G, Blasi A, Colmenero J, García-valdecasas JC, Navasa M. Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list. Clin Transplant 2017;31:e13001. [DOI: 10.1111/ctr.13001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
561 Mi Y, Li R, Xu K, Jiang H, Sun X. Gene Transfer of Antisense B7.1 Attenuates Acute Rejection Against Liver Allografts in Rats. Journal of Investigative Surgery 2010;23:87-93. [DOI: 10.3109/08941930903469359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
562 Neil DA, Hubscher SG. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts. Hepatology. 2002;35:639-651. [PMID: 11870379 DOI: 10.1053/jhep.2002.31726] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
563 Arikan C, Nart D, Kilic M, Yuksekkaya HA, Aydogdu S. Association of mast cells and liver allograft rejection. Pediatr Transplant 2008;12:347-52. [PMID: 18435610 DOI: 10.1111/j.1399-3046.2007.00819.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
564 Badawy A, Kaido T, Yoshizawa A, Yagi S, Fukumitsu K, Okajima H, Uemoto S. Human leukocyte antigen compatibility and lymphocyte cross-matching play no significant role in the current adult-to-adult living donor liver transplantation. Clin Transplant 2018;32:e13234. [DOI: 10.1111/ctr.13234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
565 McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. Liver Transpl. 2004;10:975-985. [PMID: 15390322 DOI: 10.1002/lt.20213] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
566 Thangarajah D, O’Meara M, Dhawan A. Management of acute rejection in paediatric liver transplantation. Paediatr Drugs. 2013;15:459-471. [PMID: 23925711 DOI: 10.1007/s40272-013-0034-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
567 van den Heuvel MC, Gouw AS, Boot M, Slooff MJ, Poppema S, de Jong KP. The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regeneration. J Hepatol 2006;44:947-55. [PMID: 16310280 DOI: 10.1016/j.jhep.2005.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
568 Dinges S, Morard I, Heim M, Dufour J, Müllhaupt B, Giostra E, Clavien P, Mentha G, Negro F; for the Swiss Association for the Study of the Liver (SASL 17). Pegylated interferon-alpha 2a /ribavirin treatment of recurrent hepatitis C after liver transplantation. Transplant Infectious Disease 2009;11:33-9. [DOI: 10.1111/j.1399-3062.2008.00359.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
569 Rodríguez-Perálvarez M, Guerrero M, De Luca L, Gros B, Thorburn D, Patch D, Aumente MD, Westbrook R, Fernández R, Amado V, Aguilar P, Montero JL, O'Beirne J, Briceño J, Tsochatzis E, De la Mata M. Area Under Trough Concentrations of Tacrolimus as a Predictor of Progressive Renal Impairment After Liver Transplantation. Transplantation 2019;103:2539-48. [PMID: 31107827 DOI: 10.1097/TP.0000000000002760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
570 Ganschow R, Broering DC, Stuerenburg I, Rogiers X, Hellwege HH, Burdelski M. First experience with basiliximab in pediatric liver graft recipients. Pediatr Transplant 2001;5:353-8. [PMID: 11560755 DOI: 10.1034/j.1399-3046.2001.00020.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
571 Gabler WL. National Toxicology program report on fluoride and cancer. J Oreg Dent Assoc. 1991;60:32-33. [PMID: 1856781 DOI: 10.1016/s0140-6736(97)06478-7] [Cited by in Crossref: 320] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
572 Briem-Richter A, Leuschner A, Krieger T, Grabhorn E, Fischer L, Nashan B, Haag F, Ganschow R. Peripheral blood biomarkers for the characterization of alloimmune reactivity after pediatric liver transplantation. Pediatr Transplant 2013;17:757-64. [PMID: 24164827 DOI: 10.1111/petr.12161] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
573 Dobbels F, Vanhaecke J, Dupont L, Nevens F, Verleden G, Pirenne J, De Geest S. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497-1504. [PMID: 19461486 DOI: 10.1097/TP.0b013e3181a440ae] [Cited by in Crossref: 168] [Cited by in F6Publishing: 37] [Article Influence: 12.9] [Reference Citation Analysis]
574 Guy-Viterbo V, Baudet H, Elens L, Haufroid V, Lacaille F, Girard M, Debray D, Chardot C, Reding R, Wallemacq P, Musuamba F. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. Pharmacogenomics 2014;15:1207-21. [PMID: 25141896 DOI: 10.2217/pgs.14.75] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
575 Centeno MA, Bes DF, Sasbón JS. Mortality risk factors of a pediatric population with fulminant hepatic failure undergoing orthotopic liver transplantation in a pediatric intensive care unit*: . Pediatric Critical Care Medicine 2002;3:227-33. [DOI: 10.1097/00130478-200207000-00004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
576 Eurich D, Boas-Knoop S, Ruehl M, Schulz M, Carrillo ED, Berg T, Neuhaus R, Neuhaus P, Neumann UP, Bahra M. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation. Liver Transpl. 2011;17:289-298. [PMID: 21384511 DOI: 10.1002/lt.22235] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
577 Maggi U, Nita G, Gatti S, Antonelli B, Paolo R, Como G, Messa P, Rossi G. Hyperbilirubinemia after liver transplantation: the role of coupled plasma filtration adsorption. Transplant Proc. 2013;45:2715-2717. [PMID: 24034030 DOI: 10.1016/j.transproceed.2013.07.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
578 Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl 2007;13:1717-27. [PMID: 18044750 DOI: 10.1002/lt.21292] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
579 Kubo S, Uemoto S, Furukawa H, Umeshita K, Tachibana D; Japanese Liver Transplantation Society. Pregnancy outcomes after living donor liver transplantation: results from a Japanese survey. Liver Transpl. 2014;20:576-583. [PMID: 24478123 DOI: 10.1002/lt.23837] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
580 Leong J, Huprikar S, Schiano T. Outcomes of spontaneous bacterial peritonitis in liver transplant recipients with allograft failure. Transpl Infect Dis. 2016;18:545-551. [PMID: 27261101 DOI: 10.1111/tid.12565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
581 Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Cardeau-Desangles I, Guitard J, Dörr G, Milongo D, Suc B, Duffas JP, Alric L, Bureau C, Guilbeau-Frugier C, Rostaing L, Kamar N. De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients. Transpl Int. 2015;28:1371-1382. [PMID: 26303035 DOI: 10.1111/tri.12654] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
582 Cillo U, Saracino L, Vitale A, Bertacco A, Salizzoni M, Lupo F, Colledan M, Corno V, Rossi G, Reggiani P, Baccarani U, Bresàdola V, De Carlis L, Mangoni I, Ramirez Morales R, Agnes S, Nure E. Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial. Liver Transpl 2019;25:242-51. [DOI: 10.1002/lt.25400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
583 Sebagh M, Blakolmer K, Falissard B, Roche B, Emile J, Bismuth H, Samuel D, Reynès M. Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: Reliability of the 1999 Banff schema: Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: Reliability of the 1999 Banff schema. Hepatology 2002;35:117-25. [DOI: 10.1053/jhep.2002.30085] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
584 Eurich D, Boas-Knoop S, Bahra M, Neuhaus R, Somasundaram R, Neuhaus P, Neumann U, Seehofer D. Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy. Transplantation. 2012;93:644-649. [PMID: 22411462 DOI: 10.1097/tp.0b013e318244f774] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
585 Dirsch O, Li J, He Q, Ji Y, Gu YL, Dahmen U. Induction of rejection after small-for-size liver transplantation: size matters. J Invest Surg. 2008;21:288-298. [PMID: 19160137 DOI: 10.1080/08941930802216823] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
586 Doria C, di Francesco F, Marino IR, Ramirez CB, Frank A, Iaria M, Galati SA, Farber JL. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts. Transplant Proc 2006;38:3597-600. [PMID: 17175342 DOI: 10.1016/j.transproceed.2006.10.175] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
587 Oldani G, Peloso A, Vijgen S, Wilson EM, Slits F, Gex Q, Morel P, Delaune V, Orci LA, Yamaguchi T, Kobayashi T, Rubbia-Brandt L, Nakauchi H, Lacotte S, Toso C. Chimeric liver transplantation reveals interspecific graft remodelling. J Hepatol. 2018;69:1025-1036. [PMID: 30031887 DOI: 10.1016/j.jhep.2018.07.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
588 Regev A, Molina E, Moura R, Bejarano PA, Khaled A, Ruiz P, Arheart K, Berho M, Drachenberg CB, Mendez P. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl. 2004;10:1233-1239. [PMID: 15376303 DOI: 10.1002/lt.20245] [Cited by in Crossref: 102] [Cited by in F6Publishing: 84] [Article Influence: 6.0] [Reference Citation Analysis]
589 Sebagh M, Debette M, Samuel D, Emile JF, Falissard B, Cailliez V, Shouval D, Bismuth H, Reynès M. "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection. Hepatology 1999;30:1144-50. [PMID: 10534334 DOI: 10.1002/hep.510300514] [Cited by in Crossref: 81] [Cited by in F6Publishing: 61] [Article Influence: 3.5] [Reference Citation Analysis]
590 Fink SA, Brown RS. Liver Transplantation: Indications, Preoperative Evaluation and Posttransplantation Management. Clinical Hepatology. Berlin: Springer Berlin Heidelberg; 2010. pp. 1353-81. [DOI: 10.1007/978-3-642-04519-6_49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
591 Penninga L, Wettergren A, Wilson CH, Chan A, Steinbrüchel DA, Gluud C, Penninga L. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd010253] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
592 Haydon GH, Neuberger J. Liver transplantation of patients in end-stage cirrhosis. Best Practice & Research Clinical Gastroenterology 2000;14:1049-73. [DOI: 10.1053/bega.2000.0146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
593 Lipson EJ, Fiel MI, Florman SS, Korenblat KM. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant 2005;19:487-91. [DOI: 10.1111/j.1399-0012.2005.00372.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
594 Uemura T, Ikegami T, Sanchez EQ, Jennings LW, Narasimhan G, McKenna GJ, Randall HB, Chinnakotla S, Levy MF, Goldstein RM. Late acute rejection after liver transplantation impacts patient survival. Clin Transplant. 2008;22:316-323. [PMID: 18190550 DOI: 10.1111/j.1399-0012.2007.00788.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
595 Xie L, Ichimaru N, Morita M, Chen J, Zhu P, Wang J, Urbanellis P, Shalev I, Nagao S, Sugioka A, Zhong L, Nonomura N, Takahara S, Levy GA, Li XK. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transpl 2012;18:444-54. [PMID: 22162188 DOI: 10.1002/lt.22480] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
596 Shigeta T, Sakamoto S, Uchida H, Sasaki K, Hamano I, Kanazawa H, Fukuda A, Kawai T, Onodera M, Nakazawa A, Kasahara M. Basiliximab treatment for steroid-resistant rejection in pediatric patients following liver transplantation for acute liver failure. Pediatr Transplantation 2014;18:860-7. [DOI: 10.1111/petr.12373] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
597 González JT, Bellido CB, Riera GJ, Marente VC, Gómez LM, Artacho GS, Martínez JÁ, Díez-canedo JS, Ruíz RP, Bravo MG. Study of Liver Transplant Rejection in Alcoholism-Induced Cirrhosis. Transplantation Proceedings 2013;45:3650-2. [DOI: 10.1016/j.transproceed.2013.10.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
598 Valero-Hervás DM, Sánchez-Zapardiel E, Castro MJ, Gallego-Bustos F, Cambra F, Justo I, Laguna-Goya R, Jiménez-Romero C, Moreno E, López-Medrano F, San Juan R, Fernández-Ruiz M, Aguado JM, Paz-Artal E. Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3. Clin Transplant 2017;31. [PMID: 27801525 DOI: 10.1111/ctr.12866] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
599 Cotler SJ, Kallwitz E, Tencate V, Bhushan A, Berkes J, Benedetti E, Layden-almer J, Layden TJ, Valyi-nagy T, Guzman G. Diabetes and Hepatic Oxidative Damage Are Associated With Hepatitis C Progression After Liver Transplantation. Transplantation 2007;84:587-91. [DOI: 10.1097/01.tp.0000279003.40279.0e] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
600 Wan R, Ying W, Zeng L, Deng X, Chen H, Gao L. Antibody-Mediated Response in Rat Liver Chronic Rejection. Transplantation Proceedings 2011;43:1976-9. [DOI: 10.1016/j.transproceed.2011.03.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
601 Kogiso T, Egawa H, Teramukai S, Taniai M, Hashimoto E, Tokushige K, Sakisaka S, Sakabayashi S, Yamamoto M, Umeshita K, Uemoto S. Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study. Hepatol Commun 2017;1:394-405. [PMID: 29404468 DOI: 10.1002/hep4.1037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
602 Guardia AC, Stucchi RS, Milan A, Costa SC, Boin Ide F. Human herpesvirus-6 and cytomegalovirus DNA in liver donor biopsies and their correlation with HLA matches and acute cellular rejection. Braz J Infect Dis 2014;18:220-4. [PMID: 24275367 DOI: 10.1016/j.bjid.2013.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
603 Worthley DL, Johnson DF, Eisen DP, Dean MM, Heatley SL, Tung JP, Scott J, Padbury RT, Harley HA, Bardy PG. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis. 2009;48:410-417. [PMID: 19143554 DOI: 10.1086/596313] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
604 Nobuoka Y, Mizuno S, Nishikawa K, Nakatani K, Muraki Y, Yamada T, Okuda M, Nobori T, Sugimura Y, Isaji S. Immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity and cytochrome P450 3A5 genotype assay. Clin Dev Immunol 2013;2013:936063. [PMID: 24454479 DOI: 10.1155/2013/936063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
605 Saitoh A, Sakamoto S, Fukuda A, Shigeta T, Kakiuchi T, Kamiyama S, Katsuta T, Shoji K, Ogimi C, Kasahara M. A Universal Preemptive Therapy for Cytomegalovirus Infections in Children After Live-Donor Liver Transplantation. Transplantation 2011;92:930-5. [DOI: 10.1097/tp.0b013e31822d873d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 2.1] [Reference Citation Analysis]
606 Satapathy SK, Jones OD, Vanatta JM, Kamal F, Kedia SK, Jiang Y, Nair SP, Eason JD. Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid. Transplant Direct 2017;3:e178. [PMID: 28706981 DOI: 10.1097/TXD.0000000000000693] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
607 Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, Buelow R. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology. 2002;35:815-823. [PMID: 11915027 DOI: 10.1053/jhep.2002.32467] [Cited by in Crossref: 189] [Cited by in F6Publishing: 174] [Article Influence: 9.5] [Reference Citation Analysis]
608 Lefkowitch JH. Diagnostic issues in liver transplantation pathology. Clinics in Liver Disease 2002;6:555-70. [DOI: 10.1016/s1089-3261(02)00003-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
609 Rodríguez-perálvarez M, Germani G, Tsochatzis E, Rolando N, Luong TV, Dhillon AP, Thorburn D, O’beirne J, Patch D, Burroughs AK. Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count: Eosinophils and rejection after liver transplantation. Transplant International 2012;25:555-63. [DOI: 10.1111/j.1432-2277.2012.01457.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
610 Mengel M, Reeve J, Bunnag S, Einecke G, Jhangri GS, Sis B, Famulski K, Guembes-hidalgo L, Halloran PF. Scoring Total Inflammation Is Superior to the Current Banff Inflammation Score in Predicting Outcome and the Degree of Molecular Disturbance in Renal Allografts. American Journal of Transplantation 2009;9:1859-67. [DOI: 10.1111/j.1600-6143.2009.02727.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 8.7] [Reference Citation Analysis]
611 Naini BV, Lassman CR. Liver Transplant Pathology: Review of Challenging Diagnostic Situations. Surg Pathol Clin 2013;6:277-93. [PMID: 26838975 DOI: 10.1016/j.path.2013.03.004] [Reference Citation Analysis]
612 Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT. Significance of central perivenulitis in pediatric liver transplantation. Am J Surg Pathol. 2008;32:1479-1488. [PMID: 18708942 DOI: 10.1097/pas.0b013e31817a8e96] [Cited by in Crossref: 38] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
613 Sebagh M, Yilmaz F, Karam V, Falissard B, Ichaï P, Roche B, Castaing D, Guettier C, Samuel D, Azoulay D. Cadaveric full-size liver transplantation and the graft alternatives in adults: a comparative study from a single centre. J Hepatol. 2006;44:118-125. [PMID: 16226825 DOI: 10.1016/j.jhep.2005.07.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
614 Verhoeven CJ, Farid WRR, Roest HP, Ramakrishnaiah V, de Ruiter PE, de Jonge J, Kwekkeboom J, Metselaar HJ, Tilanus HW, Kazemier G, Ijzermans JNM, van der Laan LJW. Polarized release of hepatic microRNAs into bile and serum in response to cellular injury and impaired liver function. Liver Int 2016;36:883-92. [DOI: 10.1111/liv.12955] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
615 Demetris A, Nalesnik M, Randhawa P, Wu T, Minervini M, Lai C, Lu Z. Histological Patterns of Rejection and Other Causes of Liver Dysfunction. Transplantation of the Liver. Elsevier; 2005. pp. 1057-128. [DOI: 10.1016/b978-0-7216-0118-2.50074-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
616 Attwell A, Han S, Kriss M. Endoscopic retrograde cholangiopancreatography and liver biopsy in the evaluation of elevated liver function tests after liver transplantation. World J Hepatol 2021; 13(1): 132-143 [PMID: 33584992 DOI: 10.4254/wjh.v13.i1.132] [Reference Citation Analysis]
617 Tamè M, Buonfiglioli F, Del Gaudio M, Lisotti A, Cecinato P, Colecchia A, Azzaroli F, D’Errico A, Arena R, Calvanese C, Quarneti C, Ballardini G, Pinna AD, Mazzella G. Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. World J Gastroenterol 2013; 19(32): 5278-5285 [PMID: 23983430 DOI: 10.3748/wjg.v19.i32.5278] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
618 Kasahara M, Takada Y, Egawa H, Fujimoto Y, Ogura Y, Ogawa K, Kozaki K, Haga H, Ueda M, Tanaka K. Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience. Am J Transplant. 2005;5:558-565. [PMID: 15707411 DOI: 10.1111/j.1600-6143.2005.00717.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
619 de Rooij BJ, van Hoek B, ten Hove WR, Roos A, Bouwman LH, Schaapherder AF, Porte RJ, Daha MR, van der Reijden JJ, Coenraad MJ. Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology. 2010;52:1100-1110. [PMID: 20593422 DOI: 10.1002/hep.23782] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
620 Morgul MH, Splith K, Leonhardt C, Raschzok N, Reutzel-Selke A, Schmuck RB, Andreou A, Atanasov G, Benzing C, Krenzien F, Hau HM, Felgendreff P, Klunk S, Pratschke J, Sauer IM, Schmelzle M. The value of microparticles in detecting acute rejection episodes after liver transplantation. Biomarkers 2018;23:25-32. [PMID: 28303731 DOI: 10.1080/1354750X.2017.1306754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
621 Bartlett AS, McCall JL, Ameratunga R, Yeong ML, Gane E, Munn SR. Analysis of intragraft gene and protein expression of the costimulatory molecules, CD80, CD86 and CD154, in orthotopic liver transplant recipients. Am J Transplant. 2003;3:1363-1368. [PMID: 14525596 DOI: 10.1046/j.1600-6135.2003.00259.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
622 McCabe M, Rush N, Lammert C, Patidar KR, Nephew L, Saxena R, Ekser B, Salven J, Kubal C, Ghabril M. HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation. Transplant Direct 2021;7:e714. [PMID: 34131586 DOI: 10.1097/TXD.0000000000001160] [Reference Citation Analysis]
623 Teperman L, Moonka D, Sebastian A, Sher L, Marotta P, Marsh C, Koneru B, Goss J, Preston D, Roberts JP; Spare-the-Nephron Trial Liver Transplantation Study Group. Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl. 2013;19:675-689. [PMID: 23775875 DOI: 10.1002/lt.23658] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]
624 Idilman R, Erden E, Kuzu I, Ersoz S, Karasu Z, Karayalcin K, Yuce G, Tokat Y, Şahin Y, Tukun A, Akarca US, Karayalcin S. Recipient-Derived Hepatocytes in Sex-Mismatched Liver Allografts after Liver Transplantation: Early versus Late Transplant Biopsies. Transplantation 2004;78:1647-52. [DOI: 10.1097/01.tp.0000144055.78462.4f] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
625 Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011;17:1394-1403. [PMID: 21850690 DOI: 10.1002/lt.22417] [Cited by in Crossref: 84] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
626 Gong N, Jia C, Huang H, Liu J, Huang X, Wan Q. Predictors of Mortality During Initial Liver Transplant Hospitalization and Investigation of Causes of Death. Ann Transplant 2020;25:e926020. [PMID: 33273447 DOI: 10.12659/AOT.926020] [Reference Citation Analysis]
627 Burton JR, Rosen HR. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl 2006;12:S38-47. [DOI: 10.1002/lt.20944] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
628 Fontes P, Lopez R, van der Plaats A, Vodovotz Y, Minervini M, Scott V, Soltys K, Shiva S, Paranjpe S, Sadowsky D, Barclay D, Zamora R, Stolz D, Demetris A, Michalopoulos G, Marsh JW. Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions. Am J Transplant. 2015;15:381-394. [PMID: 25612645 DOI: 10.1111/ajt.12991] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 11.3] [Reference Citation Analysis]
629 Demetris AJ. Immune cholangitis: liver allograft rejection and graft-versus-host disease. Mayo Clin Proc. 1998;73:367-379. [PMID: 9559043 DOI: 10.1016/s0025-6196(11)63705-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
630 Yu X, Liu Z, Wang Y, Wang H, Zhang M, Sun Y, Su H, Jin L, Wang F, Shi M. Characteristics of Vδ1(+) and Vδ2(+) γδ T cell subsets in acute liver allograft rejection. Transpl Immunol 2013;29:118-22. [PMID: 24029467 DOI: 10.1016/j.trim.2013.09.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
631 Weng M, Xu Y, Zhang Y, Zhang J, Quan Z, Xu J, Peng Z. Indoleamine 2,3-Dioxygenase as a Predictor of Acute Rejection After Orthotopic Liver Transplantation in Rat Model. Transplantation Proceedings 2011;43:3969-72. [DOI: 10.1016/j.transproceed.2011.09.061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
632 Demetris AJ, Bellamy C, Hübscher SG, O’Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. Am J Transplant. 2016; Epub ahead of print. [PMID: 27273869 DOI: 10.1111/ajt.13909] [Cited by in Crossref: 230] [Cited by in F6Publishing: 187] [Article Influence: 38.3] [Reference Citation Analysis]
633 El-Refaie AM, Burt AD. Mast cells and c-Kit expression in liver allograft rejection. Histopathology 2005;47:375-81. [PMID: 16178892 DOI: 10.1111/j.1365-2559.2005.02239.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
634 Duclos-vallee J, Yilmaz F, Johanet C, Roque-afonso A, Gigou M, Trichet C, Feray C, Ballot E, Dussaix E, Castaing D, Bismuth H, Samuel D, Guettier C. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clin Transplant 2005;19:591-9. [DOI: 10.1111/j.1399-0012.2004.00323.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
635 Gerlach UA, Vogt K, Schlickeiser S, Meisel C, Streitz M, Kunkel D, Appelt C, Ahrlich S, Lachmann N, Neuhaus P. Elevation of CD4+ differentiated memory T cells is associated with acute cellular and antibody-mediated rejection after liver transplantation. Transplantation. 2013;95:1512-1520. [PMID: 23619734 DOI: 10.1097/tp.0b013e318290de18] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
636 Voutilainen SH, Kosola SK, Lohi J, Mutka A, Jahnukainen T, Pakarinen M, Jalanko H. Expression of 6 Biomarkers in Liver Grafts After Pediatric Liver Transplantation: Correlations with Histology, Biochemistry, and Outcome. Ann Transplant 2020;25:e925980. [PMID: 33060556 DOI: 10.12659/AOT.925980] [Reference Citation Analysis]
637 Manzia TM, Angelico R, Toti L, Bellini MI, Sforza D, Palmieri G, Orlando G, Tariciotti L, Angelico M, Tisone G. Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C. Transpl Int. 2011;24:461-468. [PMID: 21294787 DOI: 10.1111/j.1432-2277.2011.01228.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
638 Martin SR, Russo P, Dubois J, Alvarez F. Centrilobular fibrosis in long-term follow-up of pediatric liver transplant recipients.: . Transplantation 2002;74:828-36. [DOI: 10.1097/00007890-200209270-00017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
639 Boyd A, Brown A, Patel J, Nightingale P, Perera MTPR, Ferguson J, Neuberger J, Rajoriya N. Basiliximab With Delayed Tacrolimus Improves Short-Term Renal Outcomes Post-Liver Transplantation-a Real-World Experience. Transplant Proc 2021;53:1541-7. [PMID: 34074467 DOI: 10.1016/j.transproceed.2021.04.001] [Reference Citation Analysis]
640 Nelson LM, Penninga L, Villadsen GE, Mølgaard H, Eiskjaer H, Hillingsø JG, Rasmussen A. Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy. Clin Transplant 2015;29:1098-104. [PMID: 26361241 DOI: 10.1111/ctr.12633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
641 Asaoka T, Kato T, Marubashi S, Dono K, Hama N, Takahashi H, Kobayashi S, Takeda Y, Takemasa I, Nagano H. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation. Liver Transpl. 2009;15:1738-1749. [PMID: 19938108 DOI: 10.1002/lt.21883] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
642 Béranger A, Capito C, Lacaille F, Ferroni A, Bouazza N, Girard M, Oualha M, Renolleau S, Debray D, Chardot C, Frange P, Moulin F. Early Bacterial Infections After Pediatric Liver Transplantation in the Era of Multidrug-resistant Bacteria: Nine-year Single-center Retrospective Experience. Pediatr Infect Dis J 2020;39:e169-75. [PMID: 32251259 DOI: 10.1097/INF.0000000000002662] [Reference Citation Analysis]
643 Fonseca F, Kulkarni B, Hastak M, Kumaran V, Varma V, Kapoor S. An Overview of Liver Transplant Pathology: Data from a Tertiary Referral Centre in Western India. Ann Hepatol 2018;17:426-36. [PMID: 29735782 DOI: 10.5604/01.3001.0011.7387] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
644 Subramanian V, Seetharam AB, Vachharajani N, Tiriveedhi V, Angaswamy N, Ramachandran S, Crippin JS, Shenoy S, Chapman WC, Mohanakumar T, Anderson CD. Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. Transplantation 2011;92:1259-68. [PMID: 22011763 DOI: 10.1097/TP.0b013e318235a1ab] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
645 Lo RC, Chan KK, Leung CO, Ng IO. Expression of hepatic progenitor cell markers in acute cellular rejection of liver allografts-An immunohistochemical study. Clin Transplant 2018;32:e13203. [PMID: 29345755 DOI: 10.1111/ctr.13203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
646 Komatsu H, Fujisawa T, Inui A, Sogo T, Sekine I, Kodama H, Uemoto S, Tanaka K. Hepatic copper concentration in children undergoing living related liver transplantation due to Wilsonian fulminant hepatic failure. Clin Transplant. 2002;16:227-232. [PMID: 12010149 DOI: 10.1034/j.1399-0012.2002.01074.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
647 Fosby B, Næss S, Hov JR, Traherne J, Boberg KM, Trowsdale J, Foss A, Line PD, Franke A, Melum E, Scott H, Karlsen TH. HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation. World J Gastroenterol 2014; 20(14): 3986-4000 [PMID: 24744588 DOI: 10.3748/wjg.v20.i14.3986] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
648 Xie X, Ye Y, Zhou L, Jiang G, Xie H, Feng X, He Y, Zheng S. Küpffer cells promote acute rejection via induction of Th17 differentiation in rat liver allografts. Transplant Proc 2010;42:3784-92. [PMID: 21094857 DOI: 10.1016/j.transproceed.2010.08.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
649 Mclaughlin K, Rizkalla K, Adams P, Grant D, Wall W, Jevnikar A, Marotta P. Hepatitis C infection is not associated with an increased risk of acute liver allograft rejection. Transplantation Proceedings 2000;32:2814-6. [DOI: 10.1016/s0041-1345(00)01894-7] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
650 Yilmaz F, Aydin U, Nart D, Zeytunlu M, Karasu Z, Kaya T, Ozer I, Yuce G, Aydogdu S, Kilic M. The incidence and management of acute and chronic rejection after living donor liver transplantation. Transplant Proc 2006;38:1435-7. [PMID: 16797325 DOI: 10.1016/j.transproceed.2006.02.108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
651 Bu XM, Zheng ZY, Yu YH, Zeng L, Jiang Y. Signification of C4d deposition in liver rejection. Shijie Huaren Xiaohua Zazhi 2005; 13(11): 1314-1316 [DOI: 10.11569/wcjd.v13.i11.1314] [Reference Citation Analysis]
652 Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 2005;19:110-4. [PMID: 15659143 DOI: 10.1111/j.1399-0012.2004.00310.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
653 Perrakis A, Stirkat F, Croner RS, Vassos N, Raptis D, Yedibela S, Hohenberger W, Müller V. Prognostic and diagnostic value of procalcitonin in the post-transplant setting after liver transplantation. Arch Med Sci 2016;12:372-9. [PMID: 27186183 DOI: 10.5114/aoms.2016.59264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
654 Saab S, Kalmaz D, Gajjar NA, Hiatt J, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Goldstein LI. Outcomes of acute rejection after interferon therapy in liver transplant recipients. Liver Transpl. 2004;10:859-867. [PMID: 15237369 DOI: 10.1002/lt.20157] [Cited by in Crossref: 88] [Cited by in F6Publishing: 67] [Article Influence: 5.2] [Reference Citation Analysis]
655 Raasikh T, Jamali T, Flores A, Cotton RT, Ramanathan V, Tan HP, Hernaez R. Systematic review: hepatitis C viraemic allografts to hepatitis C-negative recipients in solid organ transplantation. Aliment Pharmacol Ther 2021;54:571-82. [PMID: 34265111 DOI: 10.1111/apt.16508] [Reference Citation Analysis]
656 Ito H, Shomori K, Adachi H, Taniyama K. Telepathology for the biopsy specimens from human allografted kidney: effectiveness and pitfalls: Telepathology for allografted kidney. Clinical Transplantation 2001;15:55-8. [DOI: 10.1034/j.1399-0012.2001.0150s5055.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
657 Masetti M, Montalti R, Rompianesi G, Codeluppi M, Gerring R, Romano A, Begliomini B, Di Benedetto F, Gerunda GE. Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function. Am J Transplant. 2010;10:2252-2262. [PMID: 20486905 DOI: 10.1111/j.1600-6143.2010.03128.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 8.6] [Reference Citation Analysis]
658 Siddiqui I, Selzner N, Hafezi-Bakhtiari S, Marquez MA, Adeyi OA. Infiltrative (sinusoidal) and hepatitic patterns of injury in acute cellular rejection in liver allograft with clinical implications. Mod Pathol. 2015;28:1275-1281. [PMID: 26226843 DOI: 10.1038/modpathol.2015.84] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
659 Soliman T, Hetz H, Burghuber C, Györi G, Silberhumer G, Steininger R, Mühlbacher F, Berlakovich GA. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation. Liver Transpl. 2007;13:1039-1044. [PMID: 17600336 DOI: 10.1002/lt.21185] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
660 Keaveny AP, Gordon FD, Goldar-najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Khettry U. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: Impact on posttransplant outcome. Liver Transpl 2004;10:115-22. [DOI: 10.1002/lt.20005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
661 Kishi Y, Sugawara Y, Tamura S, Kaneko J, Akamatsu N, Togashi J, Makuuchi M. Is blood eosinophilia an effective predictor of acute rejection in living donor liver transplantation?*. Transplant Int 2005;18:1147-51. [DOI: 10.1111/j.1432-2277.2005.00189.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
662 Koo J, Wang HL. Acute, Chronic, and Humoral Rejection. Surgical Pathology Clinics 2018;11:431-52. [DOI: 10.1016/j.path.2018.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
663 Lautenschlager I, Halme L, Höckerstedt K, Krogerus L, Taskinen E. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations. Transpl Infect Dis 2006;8:21-30. [PMID: 16623817 DOI: 10.1111/j.1399-3062.2006.00122.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
664 Rigamonti C, Vidali M, Donato MF, Sutti S, Occhino G, Ivaldi A, Arosio E, Agnelli F, Rossi G, Colombo M, Albano E. Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C. Am J Transplant 2009;9:601-9. [PMID: 19191768 DOI: 10.1111/j.1600-6143.2008.02520.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
665 Gopal PB, Kapoor D, Raya R, Subrahmanyam M, Juneja D, Sukanya B. Critical care issues in adult liver transplantation. Indian J Crit Care Med 2009;13:113-9. [PMID: 20040807 DOI: 10.4103/0972-5229.58535] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
666 Bilezikçi B, Şahin F, Uyar P, Yılmaz Z, Demirhan B, Turan M, Arat Z, Haberal M. Frequency of Recipient-Derived Chimerism and Relationship With Acute Rejection and HLA Tissue Typing in Transplanted Livers. Transplantation Proceedings 2006;38:598-601. [DOI: 10.1016/j.transproceed.2005.12.059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
667 Lin NC, Wang HK, Yeh YC, Liu CP, Loong CC, Tsai HL, Chen CY, Chin T, Liu C. Minimization or withdrawal of immunosuppressants in pediatric liver transplant recipients. J Pediatr Surg. 2015;50:2128-2133. [PMID: 26377868 DOI: 10.1016/j.jpedsurg.2015.08.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
668 Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Hossain S, Roayaie S, Schwartz ME, Gondolesi G, Emre S, Schiano TD. Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl. 2005;11:1567-1573. [PMID: 16315297 DOI: 10.1002/lt.20517] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
669 Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Pediatric Transplantation 2006;10:938-42. [DOI: 10.1111/j.1399-3046.2006.00580.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
670 Chopra KB, Demetris AJ, Blakolmer K, Dvorchik I, Laskus T, Wang LF, Araya VR, Dodson F, Fung JJ, Rakela J. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation. 2003;76:1487-1491. [PMID: 14657691 DOI: 10.1097/01.tp.0000088668.28950.7c] [Cited by in Crossref: 57] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
671 Xu M, Tan C, Hu J, Alwahsh SM, Yan J, Hu J, Dai Z, Wang Z, Zhou J, Fan J, Huang X. Expression of hemopexin in acute rejection of rat liver allograft identified by serum proteomic analysis. Shock 2014;42:65-74. [PMID: